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SUMMARY 
A major cause of blindness in the Western world is degeneration of photoreceptors as a result 
of point mutations in genes coding for either phototransduction-related proteins or other 
proteins important for retinal function. Despite the diversity of mutated genes and proteins 
involved in this heterogeneous group of progressive retinal dystrophies with homologous 
phenotypes, the final event leading to blindness is apoptosis of photoreceptors. This has led to 
intensive studies of the effects of neuroprotective agents on the survival of photoreceptors in 
animal models of retinitis pigmentosa. One such effective molecule discovered to date to 
exert substantial rescue of retinal photoreceptors is glial cell line-derived neurotrophic factor 
(GDNF). However, the molecular mechanism of action underlying GDNF-mediated 
neuroprotection remains unresolved. This dissertation and the herein described studies were 
carried out with the goal of elucidating neuroprotective mechanisms using the porcine retina 
as a model. This species was selected due to its morphological and anatomical similarities to 
human retina. In order to clarify possible cellular mechanisms involved in neuroprotection, 
the initial studies involved analysis of GDNF action in porcine retina. It soon became evident 
that the GDNF-receptive cell in retina was not the photoreceptor itself but rather retinal 
Mueller glial cells (RMG), which are the major retinal glial cells. Thus, primary RMG cell 
cultures prepared from porcine retina were established and characterised to analyse this cell 
type without extraneous effects from the retinal environment. Proteomic profiling revealed 
profound changes in expression of RMG-specific marker proteins as an effect of in vitro 
conditions. Thus, the in vitro experiments for studying GDNF-induced signalling were 
performed with primary RMG cultures in an early state (two weeks in vitro) in order to study 
cells resembling the in vivo phenotype. GDNF was found to induce the ERK, SAPK and 
PKB/AKT pathways, as well as upregulating basic fibroblast growth factor (bFGF). 
Application of bFGF to primary porcine photoreceptors in vitro promoted a concentration-
dependent rescue. Therefore a model of RMG-mediated indirect survival promoting 
mechanism induced by GDNF could be proposed. The finding that RMG are mediators of 
photoreceptor survival prompted further screenings for RMG-specific, secreted molecules 
promoting photoreceptor survival. A large-scale primary photoreceptor survival assay (96well 
format) was developed, in which RMG-conditioned medium (RMG-CM) was tested for 
survival activity. Conditioned medium was observed as having specific photoreceptor 
survival-promoting activity stemming from previously unidentified protein/s. Reducing the 
complexity of RMG-CM by anionic chromatography revealed that the activity does not bind 
SUMMARY   
 
4
to anionic resins. Mass spectrometric identifications of the mono-Q flow-through identified 
23 different proteins from the active fraction, among them three potential new candidates for 
neuroprotective activity in the context of photoreceptor survival: connective tissue growth 
factor (CTGF), insulin-like growth factor binding protein 5 (IGFBP5) and insulin-like growth 
factor binding protein 7 (IGFBP7). Expression cloning and re-testing of these candidates for 
their ability to promote photoreceptor survival revealed that CTGF and IGFBP5 were 
effective in protecting photoreceptors when applied in combination with the RMG-
conditioned media. Taken together, these results indicate that such survival-promoting 
activity is multi-factorial. 
RMG are likely to support photoreceptors by either cell to cell-mediated paracrine signalling 
or by secreting factors into the intercellular space between retina and retinal pigment 
epithelium, which consists of a complex matrix of proteins and polysaccharides. This matrix, 
designated as interphotoreceptor matrix (IPM), directly borders three cell types: 
photoreceptors, RMG and the retinal pigment epithelium and predisposes the IPM to function 
as repository of neuroprotective molecules possibly secreted from adjacent cells to protect and 
support photoreceptors. In order to identify such novel neuroprotective substances, the 
composition of IPM was investigated in this thesis by comparative proteomics. Over 140 
different proteins were identified, the majority of which had never been previously detected in 
the IPM. Among these, 13 candidates were found, which in other tissue systems have been 
already reported to have a functional role in neuroprotection. 
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INTRODUCTION 
1 Retina 
1.1  The structure of the mammalian retina 
 
The retina is a specialized sensory organ capable of transforming light into electric 
signals that are transmitted via the optic nerve to the visual centers of the brain. The retina 
derives during embryogenesis from the neuroectoderm, a part of the ectoderm that gives rise 
to formation of the central nervous system (CNS). The mature mammalian retina consists of 
two distinct tissues: the neural retina composed of neurons and glial cells, and the retinal 
pigmented epithelium (RPE), a single epithelial cell layer (Figure 1). The cells of the neural 
retina derive from multipotent progenitor cells and their differentiation follows a precise 
chronological order that is found in many species (Cepko, 1993). The mature neural retina 
shows a highly organized structure composed of three cellular layers: the outer nuclear layer 
(ONL) composed of photoreceptors, the inner nuclear layer (INL) containing neurons 
(horizontal, bipolar, amacrine and interplexiform cells) and retinal Mueller glial cells (RMG), 
and the ganglion cell layer (GCL) that contains in addition to ganglion cells also displaced 
amacrine cells and astrocytes. Two synaptic layers separate these nuclear layers: the outer 
plexiform layer (OPL) and the inner plexiform layer (IPL). The axons of the ganglion cells 
converge to the exit of the optic nerve, forming the nerve fiber layer. 
 
1.2  The retinal pigmented epithelium (RPE) 
 
The RPE consists of a single layer of cuboid shaped epithelial cells, situated between 
the photoreceptors of the neural retina and the choroid, where it controls the flow of nutrients 
from the choroidal vascular system to the retina. The RPE cells are highly polarized, the basal 
cell membranes being in contact with Bruch’s membrane and highly folded to increase the 
surface area allowing the exchange of metabolites, for example retinol, from circulation (Bok, 
1999). The apical membranes of RPE cells terminate in numerous long microvilli that 
intercalate with the photoreceptor outer segments.  
The RPE cells are indispensable for the development and maintenance of the neural 
retina (Raymond and Jackson, 1995). They participate in the formation of the blood-retina 
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barrier and control the transport of ions and metabolites that circle through the retina. RPE 
cells phagocytose continuously the shed discs of photoreceptor outer segments, and recycle 
the visual pigments (Young, 1978;  Bok, 1985; Clark, 1986).  
 
 
Figure 1: Cellular structure of the retina 
A: Porcine eye was fixed and embedded in paraffin, sectioned (5 µm) and nuclei were stained 
with DAPI. Nomarski image and blue fluorescence image were overlaid to visualize retinal 
structures. RPE: retinal pigment epithelium, ROS: rod outer segments, ONL: outer nuclear 
layer, INL: inner nuclear layer, GCL: ganglion cell layer, IPM: interphotoreceptor matrix, OPL: 
outer plexiform layer, IPL: inner plexiform layer. 
B: Schematic of retinal cellular structure 
 
2 Retinal neurons 
Transformation of the light signal into electric signal is performed by photoreceptor 
cells of the retina; further transmission and processing of the signal within the retina is 
conducted by different functional classes of neurons. Bipolar and ganglion cells transmit the 
signals along a “vertical” direct pathway, whereas horizontal, amacrine and interplexiform 
cells modulate the signals. 
2.1 Photoreceptors 
Photoreceptors are polarized neurons that capture light and transform this energy into 
a chemical message through a process called phototransduction. Their cell bodies are 
IPM 
ONL
INL
GCL
RPE
OPL 
IPL 
ROS
A B 
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localized in the outer nuclear layer and are in tight contact with the RPE and retinal Müller 
glial cells (RMG), forming synapses with cells of the inner nuclear layer (bipolar and 
horizontal cells). Photoreceptors are the most abundant cell type in the retina and are divided 
into two types, rods and cones. Rods are responsible for scotopic or nocturnal vision whereas 
cones recept photopic or diurnal color vision.  
The unique morphology of photoreceptors distinguishes them from other neurons of 
the CNS. They have a very short axon and a specialized dendrite constituting the inner and 
outer segment joined by a connecting cilium (Figure 4B). The inner segment and the cell body 
contain the majority of cell organelles involved in metabolic activities. The rod outer segment 
is composed of a stack of flattened discs, surrounded by the plasma membrane. The visual 
pigment rhodopsin is densely packed in the disc membranes but is also found to a lesser 
degree in the surrounding plasma membrane. The cone outer segment differs from the rod in 
that increased surface area is achieved by repeated enfolding of the plasma membrane. The 
cone outer segment is usually shorter than that of the rod and tapers in the distal direction.  
The adult human retina contains about 96 million photoreceptors, of which 
approximately 5% are cones, the remainder are rod photoreceptors (Curcio et al., 1990). In 
mouse, only 1% of the photoreceptors are cones (Jeon et al., 1998). Physiologically, humans 
are trichromats and their cones are separated into three types: dependent on the expression of 
different opsins, the cells are sensitive to short- (S), middle- (M), or long- (L)-wavelength 
light (Nathans et al., 1986). Mice are dichromats expressing an M opsin and an ultraviolet 
(UV)-wavelength sensitive opsin (Jacobs et al., 1991). 
2.2 Bipolar cells 
Bipolar cells are stimulated by photoreceptors and transmit their signals to the 
ganglion cells. Glutamate, the photoreceptor neurotransmitter is constantly released in the 
dark (Trifonov, 1968) rendering the photoreceptor depolarized. Upon light stimulation the 
photoreceptor responds with a hyperpolarization, and inhibition of transmitter release. The 
postsynaptic bipolar cells respond with either hyperpolarization or depolarization of their 
membranes. The hyperpolarizing type of bipolar cell is called an OFF-center cell while the 
depolarizing bipolar cell is called an ON-center cell (Kolb, 2001). Rod photoreceptors transfer 
the signal to ON bipolar cells, cone photoreceptors signal to either ON or OFF bipolar cells 
(see Figure 2). The cone-derived parallel sets of visual channels for ON (detecting light areas 
on dark backgrounds) and OFF (detecting dark areas on light backgrounds; e.g. black letters 
on white paper) qualities of an image are a fundamental for detection of contrast in images. 
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Signals from ON and OFF bipolar cells stimulated by cones are transmitted to ganglion cells, 
signals from ON bipolar cells stimulated by rods are transmitted to amacrine cells. 
 
 
Figure 2: ON and OFF pathways along bipolar cells 
Photoreceptors transmit information to bipolar cells using the molecule glutamate, but different 
bipolar cells respond differently to the presence of the molecule; some fire in response, 
whereas others cease firing, depending on the kind of glutamate receptor on their surface. ON 
bipolar cells have a depolarizing receptive field (a, b); OFF cells have a hyperpolarizing 
receptive field (c). Contrary to what one might expect, photoreceptors stop releasing 
glutamate when stimulated by light, in turn causing ON bipolar cells to release glutamate. 
(from http://www.americanscientist.org/articles/03articles/kolb.html) 
 
 
2.3 Horizontal cells 
The horizontal cells modulate the electric signal coming from photoreceptors laterally 
and provide a first level of treatment of visual information. They are situated in the inner 
nuclear layer neighboring the outer plexiform layer where they form synapses with 
photoreceptors. Morphologically two types of horizontal cells are described for primates: type 
I horizontal cells that form dendritic connections with cones and axonal connections with 
rods, and type II horizontal cells that are uniquely connected to cones. Each horizontal cell 
receives input from many cones, which results in a large receptive field. This receptive field is 
even enlarged by close contact between different horizontal cells through gap junctions.  
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Horizontal cells sharpen the contrasts of the visual image by the so-called “center 
surround” organisation: if stimulated close to the center of the large horizontal cell, it transfers 
an ON signal, but if stimulated in the periphery, it sends an OFF signal. Without this first 
level of signal processing, the images would remain coarse-grained and blurry (Kolb, 2001). 
2.4 Amacrine cells 
The amacrine cells play an important role in transmitting information from rod 
photoreceptors to ganglion cells. The amacrine cells collect messages from many rod-
connected bipolar cells, allowing the perception of very dim light and modulate visual 
information at the level of the inner plexiform layer, where they establish synapses with 
bipolar, ganglion, interplexiform or other amacrine cells. Two major types of amacrine cells 
exist: small-field AII cells, which interconnect approximately 30 bipolar cells and wide-field 
A17 cells, which may collect signals from thousands of rod-bipolar cells. A17 amacrine cells 
usually emit GABA as neurotransmitter and additionally release at least one other neuroactive 
substance. Those secondary substances are neuromodulators, e.g. substance p, somatostatin, 
vasointestinal peptide, serotonin, dopamine, acetylcholine, adenosine or nitric oxide, and they 
rather act more slowly and at longer distances than neurotransmitters. Neuromodulating 
substances are believed to influence retinal circuitry under changing light conditions and 
change retinal activity in response to different day-times as given by the circadian-clock 
(Kolb, 2001). 
2.5 Ganglion cells 
The ganglion cells receive their information directly from cone-bipolar cells or from 
amacrine cells (rod-derived signals) and transmit action potentials along their axons to higher 
brain centers for the treatment of visual information. The converging ganglion cell axons 
constitute the optic nerve. In human retinas, two basic types of ganglion cells exist that 
receive signals from cone-bipolar cells: ON-center ganglion cells are activated when a spot of 
light falls in the center of their receptive field and are inactivated when light falls on the cell’s 
periphery (see Figure 3, left panel). OFF-center ganglion cells react the opposite way (see 
Figure 3, left panel). In the human fovea, which contains only cone photoreceptors, a different 
type of ganglion cells exists: the midget ganglion cell, connected in a one-to-one ratio with 
midget bipolar cells (see Figure 3, right panel). The one-to-one signal transmission produces a 
point-to-point image from the fovea transferred to the brain (Kolb, 2001).  
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Figure 3: Processing of cone-derived signals along ON and OFF pathways 
Human retinas have two types of ganglion cells: ON-center and OFF-center cells. ON center 
ganglion cells are activated when a spot of light falls in the center of their receptive fields, 
whereas OFF-center ganglion cells fire in response to light falling on their fields’ periphery 
leaving their center dark. Horizontal cells convey antagonistic surround signals to bipolar cells 
and thence to ganglion cells. Ganglion cells have receptive fields with a Mexican-hat shape, 
reflecting their integration of opposing information about centers and surrounds. This kind of 
processing helps sharpen the boundaries of images. In the fovea (right), ganglion cells have 
much narrower receptive fields; in fact, each carries information from a single cone. A cone 
feeds information to two of these midget ganglion cells; at all times each foveal cone transmits 
either an ON or an OFF signal to the brain. This signal also carries a colour message 
regarding the type of cone (red or green) it comes from. 
(from http://www.americanscientist.org/articles/03articles/kolb.html) 
 
2.6 Interplexiform cells 
The interplexiform cells represent a rare cell type in the retina and modulate 
information in the inner nuclear layer. Interplexiform cells extend their neurites in the outer 
and inner plexiform layers or establish synaptic contacts with other neurons in the inner 
nuclear layer. In primates two types have been described based on their neurotransmitter: 
GABA-positive interplexiform cells and tyrosine-hydroxylase-positive interplexiform cells. 
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3 Retinal glial cells 
Three different types of glial cells are found in mammalian retina: retinal Mueller glia, 
astrocytes and microglia. 
3.1 Retinal Mueller glial cells (RMG) 
The RMG are the principal glial cells of the retina. They are elongated cells that span 
radially throughout the entire neural retina and make close contact to every retinal cell type 
(Figure 4 A). The terminations of the RMG form the inner and outer limiting membrane, 
while their cell bodies are situated in the inner nuclear layer. The apical portions of the RMG 
envelop completely the photoreceptor cell bodies within the outer nuclear layer, and 
secondary extensions envelop dendritic or axonal processes of other retinal neurons (see 
Figure 4). RMG derive from the same progenitor cells as neurons during retinal development 
and they play a primordial role in the orientation, migration and movement of neurons (Rakic, 
1981). In the mature retina RMG act as support cells but also possess crucial metabolic 
functions, important for the survival of retinal neurons. In detail RMG are involved in a wide 
range of functions:  
(1) regulation of the extracellular homeostasis, pH and water content of the extracellular 
space, as well as homeostasis of K+ ions: active retinal neurons release K+ ions, and RMG 
siphon K+ from the extracellular space and redistribute it into different sinks, such as the 
vitreous body, blood vessels, and the subretinal space (Karwoski et al., 1989; Newman et al., 
1984; Reichenbach et al., 1992);  
(2) delivery of trophic substances to neurons and removal of metabolic endproducts (Poitry, et 
al., 2000); and  
(3) metabolism of glucose to lactose, which is preferentially taken up by photoreceptors as a 
source of energy for their oxidative metabolism (Poitry-Yamate et al., 1995). In addition, 
RMG contribute to neuronal information processes through the fast reuptake of released 
neurotransmitters, by providing neurons with precursors of neurotransmitters and by 
reabsorbing neuronally released glutamate via the glutamate-aspartate transporter (GLAST) 
(Derouiche and Rauen, 1995; Otori et al., 1994); the latter is expressed exclusively by RMG 
and astrocytes. Glutamate reuptake is crucial for the rapid termination of light-evoked activity 
in retinal ganglion cells (Matsui et al., 1999), as well as maintaining low extracellular 
glutamate levels for prevention of glutamate excitotoxicity and disturbances in neuronal 
processing. The main degradation pathways of glutamate in RMG are the synthesis of 
glutamine by glutamine synthetase (Linser and Moscona, 1979) and the synthesis of 
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glutathione from glutamate, cysteine, and glycine; glutathione acts as an intraretinal 
antioxidant (Huster et al., 1998; Makar et al., 1994). Moreover, supported by increasing 
amount of evidence (Bringmann and Reichenbach, 2001), RMG also support photoreceptor 
and ganglion cell survival by yet unknown mechanisms (Garcia et al., 2002). RMG have been 
shown to play a crucial role in trophic factor-induced signalling within the retina (Wahlin et 
al., 2000) and are implicated in mediating photoreceptor rescue effects of several neurotrophic 
factors (Frasson et al., 1999a, Wahlin et al., 2001). 
 
 
Figure 4: (A) Retinal Mueller glial cell (RMG) and (B) rod photoreceptor 
A: Retinal Mueller glial cells span the entire thickness of the retina and ensheath every 
neuron. They form the outer limiting membrane (OLM) and the inner limiting membrane (ILM). 
RL: receptor layer, ONL: outer nuclear layer, INL: inner nuclear layer, GCL: ganglion cell layer, 
IPM: interphotoreceptor matrix, OPL: outer plexiform layer, IPL: inner plexiform layer (drawing 
by A. Reichenbach). 
B: Rod photoreceptor cell is highly compartimentalised in an outer segment, where light is 
recepted and phototransduction occurs, an inner segment containing most organelles, and the 
cell body with the nucleous and the synaptic region, where the photoreceptor cells form 
synapses with bipolar cells (picture from “Molecular Biology of the Cell”, New York, 2002) 
 
A B
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3.2 Astrocytes 
Astrocytes are not intrinsic to the retina, but during development they migrate along 
the optic nerve and insert into the retina (Watanabe and Raff, 1988). The positioning of 
astrocytes in the retina depends on the co-migration of vascular endothelium cell precursors 
(Chan-Ling and Stone, 1991); this explains their absence in non-vascularized retinas. In the 
mature retina, astrocytes are found in the ganglion cell layer and optic fiber layer where also 
numerous blood vessels are situated (Bussow, 1980). Astrocytes play a role in the 
construction of the blood-retina barrier and can modulate the growth of endothelial cells 
(Jiang et al., 1993). 
3.3 Microglia 
The third glial cell type in the retina is originating from mesoderm and not from 
ectoderm like RMG and astrocytes. These cells enter the retina along with mesenchymal 
precursors of retinal blood vessels in development (Chan-Ling, 1994). Microglial cells are 
found in every retinal layer and can be stimulated into macrophagic function upon trauma to 
the retina (http://webvision.med.utah.edu/). 
 
4 Interphotoreceptor matrix 
The interphotoreceptor matrix (IPM) is a carbohydrate-rich complex occupying the 
extracellular compartment between the outer neural retina and the apical surface of the retinal 
pigment epithelium (RPE) in the vertebrate eye (Figure 1) (Rohlich, 1970). As such, it 
surrounds the elongate, light sensitive photoreceptors extending from the outer retinal surface. 
Several structural and functional activities, with a fundamental importance to vision have 
been proposed to occur within the IPM, including visual pigment chromophore exchange, 
retinal adhesion, metabolite trafficking, photoreceptor alignment and cell-cell interactions, 
thought to be involved in photoreceptor membrane turnover (reviewed in Hageman and 
Johnson, 1991). 
IPM consists of two different structural compartments, which are classified by their 
solubility in phosphate buffered saline (PBS): saline rinses of the outer retinal surface 
removes “soluble” IPM components, such as interphotoreceptor retinoid-binding protein 
(IRBP), a variety of enzymes, mucins and immunoglobins (Hageman and Johnson, 1991). 
Resistant to saline rinses are the distinct matrix domains surrounding rod and cone 
photoreceptors which are accordingly called “insoluble” IPM. Nevertheless, these IPM 
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components can be released as a relatively intact, sheet-like unit by hypotonic treatment of the 
retina (Hollyfield et al., 1990a; Hollyfield et al., 1990b; Johnson and Hageman, 1991). 
“Insoluble” IPM consists of a scaffold of hyaluronan (HA) to which the secreted glycoprotein 
SPACR and chondroitin sulfate proteoglycan SPACRCAN bind via HA-binding motifs in 
their polypeptides (Hollyfield, 1999). Other molecules containing specific HA-binding motifs 
have been identified in the plasma membranes of adjacent cells, e.g. CD44 expressed in the 
apical region of retinal Mueller glial cells (RMG) (Chaitin, et al., 1994) and RHAMM in the 
apical region of RPE (Chaitin, et al., 1999) (see Figure 5).  
 
 
Figure 5: The structure of Interphotoreceptor Matrix 
The left panel depicts the possible antiparallel alignment of linear hyaluronan molecules 
forming the basic matrix scaffold structure. The center panel depicts the continuous three-
dimensional scaffold complex (not to scale) in the extracellular compartment, adapted from 
electron microscope images of the IPM (http://www.glycoforum.gr.jp/science/hyaluronan/). The 
right panel depicts the interaction of the scaffold (not to scale) with hyaluronan-binding motifs 
on cells that border the IPM: CD44 is present in the apical microvilli of Müller cells, and 
RHAMM has been identified on apical RPE processes) and secreted molecules within the IPM 
(SPACR, SPACRCAN, pigment epithelium derived factor PEDF and interphotoreceptor 
matrix-binding protein IRBP). Since IRBP can be removed from the IPM with saline rinses, it is 
not considered part of this insoluble IPM complex. (Drawing by David Schumick, Medical 
Illustrator, the Cleveland Clinic Foundation.) 
 
Additionally to structural proteins, some ubiquitous growth, survival and neurotrophic 
factors have been identified in IPM of normal and pathological retinas: basic fibroblast 
growth factor (bFGF) (Hageman and Johnson, 1991; Gao and Hollyfield, 1992; Gao and 
Hollyfield, 1995; Hanneken and Baird, 1992), insulin-like growth factor 1 (IGF-I) and 
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insulin-like growth factor binding-protein (IGF-BP) (Waldbillig et al., 1991). Pigment-
epithelium derived factor (PEDF), a member of the serine protease inhibitor family (Steele et 
al., 1993) is presumably secreted by RPE cells into IPM (Becerra et al., 2004; Tombran-Tink 
et al., 1995). PEDF carries a RHAMM-type motif in its primary sequence through which it 
binds HA, being thus strongly attached to the insoluble IPM scaffold (Hollyfield, 1999).  
 
5 Phototransduction 
Light enters the mammalian eye through the pupil and after transversion of the 
vitreous body enters the retina. The photons pass all retinal layers and are finally absorbed at 
the outer segments of rod and cone photoreceptors where the electromagnetic wave is 
transformed into an electrochemical signal (phototransduction) (reviewed in Molday, 1998). 
The phototransduction cascade (Figure 6) in rods is initiated by rhodopsin, a seven-pass 
transmembrane protein covalently linked to an 11-cis retinal chromophore. Photoexitation 
converts 11-cis retinal to its all-trans isomer, creating Meta II rhodopsin, which catalyses the 
activation of the G-protein transducin. This in turn leads to the activation of 
phosphodiesterase (PDE), which hydrolyses cGMP to 5´-GMP. One rhodopsin molecule can 
activate multiple PDE molecules, amplifying the signal. The decrease in intracellular cGMP 
causes the cGMP-gated cation channels in the outer segment membrane to close. Without the 
balanced influx of Ca2+ the cell becomes hyperpolarized. This leads to inhibition of release of 
neurotransmitter glutamate from the synaptic region of the photoreceptors and subsequently to 
the generation of an electric signal in the downstream neuron of the activated photoreceptor 
(bipolar cell) which is finally sent to the visual cortex.  
The resting phase is restored when Meta II rhodopsin is inactivated by rhodopsin 
kinase and binds to arrestin (S-antigen). Transducin and PDE are inactivated and disassociate 
due to the hydrolysis of the bound GTP by intrinsic GTPase activity of the transducin α 
subunit. The low level of intracellular Ca2+ caused by the closure of the cGMP-gated channels 
activates guanylate cyclase, which synthesizes cGMP. As intracellular levels of cGMP 
increase, the cGMP-gated Na+ and Ca2+ channels reopen and a depolarized dark state is re-
established. As Ca2+ levels raise again, guanylate cyclase activity is inhibited and cGMP 
synthesis returns to basal levels. 
INTRODUCTION   
 
16
 
 
Figure 6: Phototransduction cascade 
Light induced phototransduction takes place in the membrane discs of rod outer segments. 
The absorbtion of a photon induces the formation of activated rhodopsin, which then activates 
transducin. Activated transducin activates phosphodiesterase, which then catalyses the 
hydrolysis of cyclicGMP to GMP. This leads to a closure of cGMP-gated cation channels in the 
outer segment membrane and to a hyperpolarisation of the photoreceptor cell (from Farrar et 
al., 2002). 
 
 
6 Retinal degeneration 
In some eye diseases the retina becomes damaged or compromised and degenerative 
changes eventually lead to death of the retinal neurons and, as a consequence to loss of vision. 
Major retinal pathologies include glaucoma, where elevated pressure in the eye leads to death 
of retinal ganglion cells; diabetic retinopathy, where blood vessels in the retina become leaky 
with serious consequences; age related macular degeneration and retinitis pigmentosa. 
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6.1 Inherited degenerative diseases 
6.1.1 Retinitis pigmentosa: 
 
The disease named retinitis pigmentosa (RP) describes a heterogeneous group of 
inherited progressive retinal dystrophies, primarily affecting the photoreceptors. Main 
symptoms include progressive loss of visual functions with night blindness, narrowing of the 
visual field, reduced central vision and increasing sensitivity to glare. It is the most common 
inherited retinal dystrophy, affecting approximately 1 in 3,500 people or around 2 million 
patients worldwide (Hims et al., 2003). RP can be inherited in autosomal dominant, 
autosomal recessive, X-linked and rare mitochondrial and digenic forms. Mutations in many 
different genes have been shown to cause retinal degenerations and to date 39 loci have been 
found for non-syndromic RP (retinal degeneration in the absence of other defects). For 30 of 
these loci the disease-causing gene has been identified, for 9 loci the responsible gene-
mutation remains unknown. Further 33 genes or loci have been implicated in various 
syndromic forms of RP and in total, 158 genes or loci have been shown to underlie all the 
different forms of human retinal dystrophies (RetNet; http://www.sph.uth.tmc.edu/RetNet/). 
The knowledge of 30 different genes causing non-syndromic RP when mutated, enabled a 
functional grouping of the protein products of these genes (summarized in Table 1; adapted 
from Hims et al., 2003). 
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Table 1 (according to Hims et al., 2003): adRP: autosomal dominant RP; arRP: autosomal 
recessive RP; adCSNB: autosomal dominant congenital stationary night blindness; arCSNB: 
autosomal recessive congenital stationary night blindness; LCA: Leber congenital amaurosis 
 
Gene: Protein: Associated dystrophies: 
1. phototransduction cascade   
RHO Rhodopsin adRP, arRP and adCSNB 
PDE6A Phosphodesterase α subunit arRP 
PDE6B Phosphodesterase β subunit arRP 
SAG Arrestin arRP, arCSNB 
CNGA1 Rod cGMP-gated channel α subunit  arRP 
CNGB1 Rod cGMP-gated channel  β subunit arRP 
2. visual cycle   
RPE65 Retinal pigment epithelium-specific 65kd protein arRP, LCA 
RLBP Cellular retinaldehyde-binding protein arRP, rRPalbescens 
ABCA4 ATP-binding cassette transporter arRP, CRD, AMD 
LRAT Lecithin retinol acyltransferase arRP 
RGR RPE-retinal G protein-coupled receptor arRP, dominant choroidal sclerosis 
3. structural proteins   
RDS Peripherin/RDS adRP, LCA, adCRD 
ROM1 Retinal outer segment protein 1 adRP 
RHO Rhodopsin adRP, arRP and adCSNB 
4. transcription factors   
CRX Cone-rod otx-like homeobox transcription factor adRP 
NRL Neural retinal leucine zipper adRP 
NR2E3 Nuclear receptor subfamily 2 group E3 adRP 
5. splicing factors   
PRPF8 Pre-mRNA processing factor 8 adRP 
PRPF3 Pre-mRNA processing factor 3 adRP 
PRPF31 Pre-mRNA processing factor 31 adRP 
6. intracellular transport   
FSCN2 Retinal fascin adRP 
RP1 RP1 protein adRP 
RPGR Retinitis pigmentosa GTPase regulator X-linked RP 
RP2 RP2 protein X-linked RP 
TULP1 Tubby-like protein arRP 
7. cell-cell adhesion/signalling   
MERTK C-mer proto-oncogene receptor tyrosine kinase arRP 
CRB1 Crumbs homolog 1 arRP, LCA 
USH2A Usherin arRP, Ushers syndrome 
8. miscellaneous   
IMPDH1 Inosine monophosphate dehydrogenase 1 adRP 
RP9 RP9 protein adRP 
CERKL Ceramide kinase arRP 
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Mutations for non-syndromic RP are found in all major proteins involved in 
phototransduction cascade, namely rhodopsin, phosphodiesterase, arrestin and cGMP-gated 
channel (see Table 1). For rhodopsin alone, over 100 different disease-causing mutations have 
been reported. Additionally to RP, mutations in components of the phototransduction cascade 
have also been implicated in other retinal dystrophies: retina-specific guanylate cyclase 
(GUCY2D) in cone-rod dystrophy or Leber´s amaurosis; guanyate cyclase-activating protein 
1A (GUCA1A) in cone dystrophy; rhodopsin kinase (RHOK) and rod transducin a subunit 
(GNAT1) in recessive CSNB; cone cyclic nucleotide-gated channel (CNGA3) in 
achromatopsia (RetNet; http://www.sph.uth.tmc.edu/RetNet/sum-dis.htm). 
The visual cycle, reviewed by  Thompson and Gal (2003), is the name given to a 
series of biochemical steps that recycle the chromophore component of rhodopsin. 11-cis 
retinal is converted by photoexcitation into all-trans retinal, which is then released from 
rhodopsin, bound to phosphatidylethanolamine and transported from the interior of the rod-
discs into photoreceptor cytoplasm by the ATP-binding cassette transporter (ABCA4). Within 
the cytoplasm the chromophore is converted into all-trans retinol and released from the cell 
for transportation to the RPE (bound to transporting protein IRBP). Inside the RPE, all-trans 
retinol is bound to cytosolic retinoid-binding protein (CRBP) and is esterified by lecithin 
retinol transferase (LRAT) to all-trans retinol ester, followed by isomerisation into 11-cis-
retinol, a process believed to involve the RPE-specific protein RPE65. 11-cis retinol is then 
bound by cellular retinaldehyde-binding protein (CRALBP) and converted into 11-cis retinal 
by catalysis of 11-cis dehydrogenase 5 (RDH5). The 11-cis retinal is again transported via the 
IPM (and bound to IRBP) from the RPE to the photoreceptor and subsequently bound to 
rhodopsin, thus completing the cycle. Mutations causing recessive RP have been found in 
four genes encoding components of the visual cycle, namely RPE65, CRALBP, LRAT and 
ABCA4 (see Table 1). 
Several structural proteins have been implicated in RP when mutated: the 
photoreceptor-specific proteins peripherin/RDS and ROM1 are thought to be vital for the 
maintenance of the flattened shape of the discs in the photoreceptor outer segments. 
Additionally, rhodopsin, which accounts for 70% of outer segment protein content (Hamm 
and Bownds, 1986), has been suggested to have an important role in the morphology of the 
rod outer segments (van Soest et al., 1999) 
The transcription factors encoded by CRX, NRL and NR2E3 genes, namely cone-rod 
homeobox protein, neural retina-specific leucine zipper protein and photoreceptor-specific 
nuclear receptor, are all thought to be specifically involved in the control of many 
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photoreceptor-specific genes (Furukawa et al., 1997; Kobayashi et al., 1999; Kumar et al., 
1996). This explains why mutations described for those transcription factors cause different 
retinal degeneration phenotypes (see Table 1). 
Most astonishingly, mutations in three different pre-mRNA splicing factors, which are 
ubiquitously expressed in all cells of the body and not only in retinal cells, have been 
identified to cause autosomal dominant RP in patients without other pathologic phenotype. 
The implicated genes PRPF8, PRPF31 and HPRP3 all encode small nuclear ribonucleoprotein 
(snRNP) proteins that are essential components of the U4/U6:U5 tri-snRNP which is a major 
component of the spliceosome (McKie et al., 2001; Vithana et al., 2001; Chakarova et al., 
2002). All three splicing factors are expressed ubiquitously and it is unresolved why their 
mutation leads to a dominant retina-specific disease. It has been speculated that the 
continuous need of large amounts of proteins of the phototransduction cascade renders the 
photoreceptors particularly vulnerable to defects in translation machinery. Or else, a 
photoreceptor-specific transcript is specifically affected by these mutations (Hims et al., 
2003). 
Efficient transportation of proteins within photoreceptor cells from the site of 
synthesis in the cell body and inner segment to the outer segment has to pass the connecting 
cilium and would be expected to be essential to photoreceptor function. Accordingly, several 
genes involved in this transport have been linked to RP: tubby related protein 1 (gene: 
TULP1) (Hagstrom et al., 2001) and the product of the RPGR gene (X-linked retinitis 
pigmentosa GTPase regulator) (Roepman et al., 2000). Furthermore, three genes found to 
cause RP appear to have a role in the formation of the cell cytoskeleton and may thus be also 
involved in intracellular transport mechanisms. The RP1 gene shows homology to 
doublecortin, which is believed to regulate microtubule dynamics and stability during 
neuronal development (Bowne et al., 1999). The RP2 gene is mutated in some forms of X-
linked RP and shares homology to human cofactor C, which is involved in β-tubulin folding 
(Schwahn et al., 1998; Schwahn et al., 2001). The retina-specific gene FSCN2 (retinal fascin), 
which has been associated with dominant RP, is believed to play a role in actin bundling 
(Tubb et al., 2000). 
Proteins involved in intercellular signalling have been shown to be mutated in some 
cases of RP: the C-mer proto-oncogene tyrosine kinase (MERTK) is thought to have a role in 
cell-cell signalling between the RPE and photoreceptor cells (Feng et al., 2002) and is 
essential for proper function of PR-outer segment phagocytosis by the RPE (D'Cruz et al., 
2000a); the transmembrane protein crumbs (gene: CRB1) has been shown to be essential for 
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correct photoreceptor morphogenesis (Izaddoost et al., 2002); the usherin gene USH2A 
product is thought to be a cell-cell adhesion molecule (Rivolta et al., 2000). 
6.1.2 Age-related macular degeneration (AMD) 
AMD is one of the most common causes of vision loss in developed countries. The 
most characteristic clinical finding in the retinae of patients with AMD are so called drusen, 
an extracellular deposit of protein, lipid and debris that accumulate underneath the retinal 
pigment epithelium (RPE). In AMD the area of the retina which is responsible for acute bright 
light vision, the macula which contains predominantly cone photoreceptors is affected. Loss 
of vision from AMD occurs either as a result of choroidal neovascularisation with exudation 
and haemorrhage (the “wet” form) or by slow atrophy of the RPE and adjacent photoreceptors 
(the “dry” form). Wet AMD is twice as common as the dry type and causes rapid vision loss 
(Constable, 2004). Prevalence of AMD in population is high with a distinct trend of increase: 
about 10-20% of people over the age of 65 suffer from an early-state maculopathy or overt 
macular degeneration. In US, about 1.75 million people suffer from AMD, this number will 
increase to about 3 million in 2020 (Friedman et al., 2004). While the pathogenesis of AMD 
is likely to result from several interacting components such as mutations in potential causative 
or susceptibility genes, metabolic stress on the RPE and adjacent tissues and exogenous 
factors (Silvestri, 1997; Hayward et al., 2003; Tomany et al., 2004), other forms of macular 
disease are inherited, like Stargardt´s or Best´s disease, Sorsby´s fundus dystrophy or cone 
dystrophies (Kellner et al., 2004). 
6.2 Degeneration pathways in retinal diseases 
Apoptosis of photoreceptors (and the RPE) is the final cell death pathway in RP and in 
AMD (Chang et al., 1993; Portera-Cailliau et al., 1994). While the apoptotic end stage is well-
documented in animal models and in human autopsy eyes, there is a large gap between the 
profound knowledge of gene mutations (see, for example, RetNet at 
http://www.sph.uth.tmc.edu/Retnet/) on the one hand, and events on the cellular and 
molecular levels leading to cell death including signalling and death pathways on the other 
hand. It remains unresolved, how cells, carrying a gene mutation, can survive for extended 
periods before undergoing apoptosis. Which are the intrinsic factors enabling prolonged cell 
survival under those pathological conditions? And which factors eventually trigger the cell 
death? In the case of RP, mutations in different genes and different mutations in the same 
gene can result in similar phenotypes; however, different phenotypes may also be caused by 
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the same mutation. Maculopathy and “physiological” ageing of the retina remain without 
severe visual disturbances in many people, while in others disease with loss of central vision 
is developing from those stages. Molecular components of drusen can differ in AMD-eyes 
and healthy age-matched controls (Crabb et al., 2002; Dentchev et al., 2003) thus offering 
potential clues to the pathogenesis.  
6.3 Animal models of retinal degeneration 
The inherent complexity of both RP and AMD requires the elucidation of common 
neuroprotective pathways and common death mechanisms in order to develop possible 
therapies. An important prerequisite for studying retinal degeneration is the availability of 
appropriate animal models. For research in RP there is by now a multitude of animal models 
available reflecting the human disease, but animal models are rare for AMD. Only recently a 
mouse model was described which showed several morphological features typical for AMD 
including apoptotic cell death (Ambati et al., 2003). 
In general two different approaches to access animal models exist: screening for 
naturally occurring models and genetical engineering of artificial mutations leading to retinal 
degeneration and mimicking mutations found in patients.  
6.3.1 Naturally-occurring animal models: 
The models most commonly studied are the naturally occuring rd1 mouse (retinal 
degeneration 1), the rds mouse (retinal degeneration slow) and the Royal College of Surgeons 
(RCS) rat. The rd1 mouse carries a mutation on the gene encoding the β-subunit of the cyclic 
GMP-phosphodiesterase, an essential enzyme of the phototransduction cascade (Bowes et al., 
1990), leading to very rapid loss of rods, followed by loss of cones (Carter-Dawson et al., 
1978). The rds mouse lacks the gene encoding peripherin 2, which is required for normal 
development of photoreceptor outer segment discs (Travis et al., 1991). Finally, the RCS rat 
presents a mutation in the receptor tyrosine kinase gene Mertk which is responsible for 
ineffective phagocytosis of outer segments by the RPE and ultimately causes the 
photoreceptors to die (D'Cruz et al., 2000b). 
Several canine models of inherited retinal degeneration have been identified, namely 
the Irish setter, carrying a nonsense mutation in PDEβ-subunit (Aguirre et al., 1978); the 
Cardigan Welsh corgi, carrying a truncated PDEα-subunit and the Swedish Briard/Briard 
Beagle dog, carrying a 4-bp deletion in RPE65 gene leading to early onset retinal 
degeneration including Leber´s congenital amaurosis (a group of autosomal recessive retinal 
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dystrophies characterized by visual impairment identified at or within a few months from 
birth) (Narfstrom et al., 1989). 
A line of chicken (Rhode Island Red Chicken) was identified with very rapid retinal 
degeneration. The cause is a deletion/rearrangement of the guanylate cyclase-1 gene, resulting 
in a null allele and very low cGMP levels (Ulshafer et al., 1984; Semple-Rowland et al., 
1998). 
6.3.2 Transgenic animal models 
Due to rapidly advancing transgenic and gene targeting technologies, the number of 
laboratory-generated vertebrate animals in which specific genes are targeted is increasing. 
Transgenic technology is based on the incorporation into the genome of a transgene construct 
which often contains a mutation linked to disease. The mutant transgene is expressed in 
specific cell types (photoreceptors) or tissues (retina) of the animal, and transmitted to 
progeny. Thus, the consequence of a mutation on the development, differentiation and 
metabolism of a cell can be studied. Knockout technology is based on targeted replacement of 
a gene by a construct that disrupts (knocks out) expression of the gene. As a consequence, the 
gene product cannot be produced, leading in many cases to specific phenotypes. Aditionally, a 
gene can be replaced by a construct with flanking loxP sites. In a second step, the 
bacteriophage enzyme cre recombinase is expressed in the desired cell type by standard 
transgenic technology; when expressed, cre recognizes loxP sites and excises DNA flanked by 
loxP. Thus, a gene is knocked out only in tissues or cells expressing cre. Conditional or 
tissue-specific knockouts are particularly desirable if a universal knockout is lethal during 
embryonic development. Currently, these techniques are applied mostly in rodents; however, 
other species (pig, Xenopus) are increasingly used in research.  
Gene knockout mouse models comprise rhodopsin (Rho-/-) (Humphries et al., 1997), 
rhodopsin kinase (RK-/-) (Chen et al., 1999a), cone-specific cyclic nucleotide gated channel 
(CNG3-/-) (Biel et al., 1999), arrestin (arrestin-/-) (Chen et al., 1999b), RPE65 (Rpe65-/-) 
(Redmond et al., 1998), retinal-specific ATP-binding cassette transporter (ABCR-/-) (Weng et 
al., 1999) and interphototreceptor retinoid-binding protein (IRBP-/-) (Liou et al., 1998). 
Transgenic mouse models comprise P23H, P347S, V20G, P27L, Q334ter rhodopsin 
mutants (Olsson et al., 1992; Chang et al., 1993; Huang et al., 1993; Naash et al., 1993; 
Portera-Cailliau et al., 1994; Roof et al., 1994; Goto et al., 1995) and P216L peripherin 
mutant (Kedzierski et al., 1997) 
Two widely used transgenic rat models are S334ter (Liu et al., 1999) and P23H 
(Lewin et al., 1998b) rhodopsin mutants. 
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Rat and mouse eyes are very small and not ideally suited for subsequent manipulations 
of the retina, such as injections of viral constructs for somatic gene therapy. Moreover, rodent 
eyes do not have a macula, and are therefore not suitable for macular degeneration models. 
The pig eye is more similar to the human eye in terms of the size and ratio of rod/cone 
photoreceptors (Hendrickson and Hicks, 2002). Therefore, efforts have been made to engineer 
a pig transgenic model for RP. The transgenic animals express a mutated rhodopsin gene 
(Pro347Leu) and develop early rod cell loss with slower cone cell degeneration (Li et al., 
1998; Petters et al., 1997; Tso et al., 1997). 
6.3.3 Animal models of light-induced retinal degeneration  
The protracted cell death in most animal models (and humans) renders the study of 
apoptotic mechanisms rather difficult due to non-synchronic apoptosis. Only few animal 
models have a short period of accumulated cell death that might provide a fair amount of 
material to study and a time frame for experimental manipulations. However, in those cases 
disease-induced cell death coincides with histogenetic, developmental cell death, such as in 
the rd1 mouse, a condition that could mask the mechanisms of degenerative apoptosis.  It has 
been observed that bright light damages vision in laboratory animals (Noell et al., 1966). 
Consequently several setups for controlled light-induced retinal degeneration have been 
developed (reviewed in Reme et al., 1998; Wenzel et al., 2005). These models have several 
advantages: (1) light exposure triggers apoptosis of photoreceptors in a synchronized way, (2) 
apoptosis is rapid and (3), although it is not an exact model for mutation-induced retinal 
degeneration, light appears to be a disease-triggering cofactor in most inherited forms of RP.  
 
7 Therapeutic strategies in retinal degenerative diseases 
Several strategies to preserve visual functions are developed in animal models. They 
comprise transplantation of stem cells, RPE or retina, delivery of a large number of 
neuroprotective cytokines, gene therapy including replacement of missing proteins or removal 
of harmful molecules, implantation of subretinal or epiretinal chips or cortically based 
electrodes (Eckmiller, 1997; Zrenner, 2001; Alteheld et al., 2004). At present, neuroprotection 
and certain gene-therapies appear to be among the most promising approaches. Because 
apoptosis is the final pathway of cell removal, prevention of apoptosis is conceptually feasible 
for all types of mutations and for AMD. This is advantageous to gene therapy, where genetic 
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screening for each patient needs to be performed before a therapy strategy can be developed. 
Either the inhibition of apoptosis as the downstream final event in retinal degeneration or 
prolongation of photoreceptor survival by neuroprotective molecules appears to be a 
reasonable approach. However, successful prevention of apoptosis will require, at least in 
part, the understanding of neuroprotective signalling and apoptotic death mechanisms in the 
retina.  
7.1 Gene therapy 
Different gene-mediated therapy strategies have been developed for the treatment of 
inherited retinal degenerations. In mutations leading to loss of function (mostly autosomal 
recessive or X-linked retinal degenerations), the principle of gene therapy is to correct the 
genetic defect by the introduction of a wild-type version of the mutated gene into the cells in 
which normal functioning of this gene is required. Gene therapy has been performed using 
several different vectors and has resulted in the slowing down of the photoreceptor 
degeneration process in the rd1 mouse (Bennett et al., 1996; Jomary et al., 1997; Kumar-
Singh and Farber, 1998; Takahashi et al., 1999), in the rds mouse (Ali et al., 2000) and in the 
RCS rat (Vollrath et al., 2001). The most conclusive result was observed in the RPE65-/- dog. 
By injecting a recombinant AAV carrying the missing wild-type RPE65 cDNA into the 
subretinal space, recovery of visual function was obtained as assessed by psychophysical and 
behavioral tests (Acland et al., 2001). 
In mutations leading to a toxic gain of function (autosomal dominant retinal 
degenerations), the principle of gene therapy is to inhibit the expression of the gene 
responsible for deleterious effects. Gene silencing can be obtained by the use of single-
stranded antisense oligonucleotides or the use of ribozymes (Farrar et al., 2002). The potential 
effects of ribozyme therapy was evaluated in the P23H transgenic rat (LaVail et al., 2000; 
Lewin et al., 1998a). They demonstrated that in vivo expression of either a hammerhead or 
hairpin ribozyme specific to the mutant transcript significantly delays the degeneration of the 
photoreceptors in transgenic rats for at least 8 months.  
Additionally, several antiapoptotic gene therapies have been developed. In mutant 
drosophila, it was demonstrated that targeted transfer of antiapoptotic gene p35 blocked 
apoptotic mechanisms in retinal cells and preserved visual function (Davidson and Steller, 
1998). Bcl-2 is known to control mitochondrial membrane permeability (Sharpe et al., 2004) 
and integrity in general (Donovan and Cotter, 2004). Several experiments using expression of 
Bcl-2 in photoreceptors in a variety of models have been performed with the aim to stabilize 
INTRODUCTION   
 
26
mitochondria and thus prevent photoreceptor apoptosis. The results are controversial: no 
protection resulted from transgenic Bcl-2 overexpression in the rd1 mouse in one study 
(Joseph and Li, 1996), while protection was achieved in another study (Chen et al., 1996) or 
with Bcl-2 expressed from a viral vector (Bennett et al., 1998). Furthermore, while Bcl-2 
overexpression was without effect in mice expressing a K296E mutation in rhodopsin (Joseph 
and Li, 1996), but animals with S334ter rhodopsin mutation were protected (Chen et al., 
1996) and in the rds mouse, Bcl-2 overexpression had a very robust effect (Nir et al., 2000). 
7.2 Transplantation   
Numerous attempts have been made to transplant tissue into animal models of retinal 
degeneration. Two different types of tissue have been transplanted: RPE transplantation 
attempts to obtain beneficial effects upon the adjacent photoreceptors, and retinal neuronal 
transplantation, on the other hand, aims at replacing the degenerate tissue altogether. 
In the RCS rat, RPE fails to phagocytose shed outer segments, and the photoreceptor 
cells subsequently die. Using this model, studies showed that fresh RPE cell transplants 
considerably delayed the loss of photoreceptors (Li and Turner, 1988; Sheedlo et al., 1989; 
Gouras and Lopez, 1989), restored normal metabolism (Lavail et al., 1992) and improved 
visual function (Jiang and Hamasaki 1994; Whiteley et al., 1996). It has been proposed that 
additionally to direct rescue from the transplant, there is indirect rescue by trophic factor 
release in these studies, because rescue effects are also observed in untransplanted areas of the 
eye (Sahel et al., 2001).  
Neuronal transplantation aims at replacing lost photoreceptor cells. Transplantation of 
either embryonic dissociated cells or retinal sheets into the subretinal space of rodent models 
of retinal degeneration demonstrate that transplants survive and differentiate and that neuronal 
fibers originating from the transplant develop synapses with the remaining host retina which 
are at least sufficient to mediate a simple light-dark preference (Kwan, et al., 1999; Aramant 
and Seiler, 1995). Still, numerous obstacles remain before RPE or retinal transplantations may 
be used in clinical therapy (see reviews by Berson and Jakobiec, 1999;  Lund et al., 2003).  
Beyond the interesting prospect of replacing the lost cells, retinal transplants were 
shown to exert trophic effects on the remaining host retina. Transplantation of rod-rich 
photoreceptor sheets into the subretinal space of rd1 mice, which at this age contain few 
remaining rods but numerous surviving cones, induced a significant increase in host cone 
survival (Mohand-Said et al., 1997; Mohand-Said et al., 2000).  
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7.3 Pharmacological treatment  
7.3.1 Anti-apoptotic treatment 
Calcium overload has been a prime candidate for the induction of neuronal apoptosis 
and in retinal light damage it seems to be involved in the early phase of apoptotic cell death of 
photoreceptors (Donovan et al., 2001). Accordingly, application of the calcium channel 
blocker D-diltiazem prevented light damage as revealed by the absence of TUNEL positive 
cells in the ONL (Donovan and Cotter, 2002). Reports analyzing effects of calcium 
antagonists on photoreceptor dystrophy in animal models of RP are conflicting: D-diltiazem 
was reported to be protective in the rd1 mouse in one report (Frasson et al., 1999b), while no 
effect was reported in two other studies using the rd1 mouse (Pawlyk et al., 2002; Takano et 
al., 2004) or in a corresponding dog model (Pearce-Kelling et al., 2001). In the study by 
Takano et al., however, the calcium antagonists nilvadipine and nicardipine slowed the course 
of degeneration (Takano et al., 2004). Further evidence for a deleterious effect of calcium was 
derived from rd1 mice additionally lacking L-type voltage gated calcium channels. In these 
mice, retinal degeneration was slowed as compared to rd1 mice expressing the calcium 
channel (Read et al., 2002). Calcium antagonists have also been tested in two other models: 
D-diltiazem had no protective effect in the P23H transgenic rat (Bush et al., 2000). On the 
other hand, nilvadipine and not D-diltiazem caused a slowing of retinal degeneration and 
some preservation of function in the RCS rat (Yamazaki et al., 2002; Sato et al., 2003). 
Exposure of photoreceptors to blue light in vitro results in the generation of reactive 
oxygen species by a mechanism involving mitochondrial electron transport (Yang et al., 
2003). In several studies using prolonged exposure to broad band green or white light, 
antioxidants like dimethylthiourea (DMTU) and phenyl-N-tert-butylnitrone (PBN) were 
shown to be protective against light damage (Organisciak et al., 1999; Ranchon et al., 1999;  
Specht et al., 1999 ; Ranchon et al., 2001). The anti-oxidant had to be applied before the onset 
of light to be protective; indicating that reactive oxygen species generation in fact is an early 
event (Organisciak et al., 2000). Likewise injection of recombinant thioredoxin (TRX) or 
transgenic expression of TRX, an endogenous redox-regulating protein, conferred protection 
by reducing oxidative stress (Tanito et al., 2002a; Tanito et al., 2002b). DMTU and PBN have 
consequently been tested for a protective effect against the deleterious effect of light in two 
models of inherited retinal degeneration. While DMTU could protect photoreceptors of P23H 
and S334ter transgenic rats (Organisciak et al., 2003), PBN only protected P23H transgenic 
rats. PBN had no effect on either P23H or S334ter caused degeneration in the absence of 
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additional light insults (Ranchon et al., 2003). These results indicate that anti-oxidative 
treatments may have beneficial effects on certain forms of retinal degeneration by reducing 
the disease-accelerating effects of light. 
The involvement of caspases in retinal apoptosis is still unresolved due to conflicting 
results. In the rd1 mouse, Doonan and colleagues did not observe caspase-3 activation or a 
protection of the rd1 retina by caspase inhibitors (Doonan et al., 2003), other studies reported 
an activation of caspase-3 (Jomary et al., 2001; Kim et al., 2002) and indicate a role of this 
protease in the rd1 degeneration by showing that inhibition of caspase-3 delayed cell death 
(Yoshizawa et al., 2002; Sharma and Rohrer, 2004) and that ablation of caspase-3 led to a 
transient mild preservation of retinal morphology (Zeiss et al., 2004). Similarly, the 
involvement of caspase-8 appears unclear in the rd1 model: Activation was observed by 
Jomary et al. (Jomary et al., 2001), but not by Doonan (Doonan et al., 2003).  Caspase-3 
inhibitors provided protection in two other models of inherited retinal degeneration: the 
S334ter rat (Liu et al., 1999) and the tubby mouse (Bode and Wolfrum, 2003). Furthermore, 
activation of caspases-1 and -2 was demonstrated in the RCS rat and caspase-1 inhibition 
transiently reduced the number of apoptotic photoreceptors (Katai et al., 1999). 
Exposure to acute bright white light induces the expression of caspase-1 (Grimm et 
al., 2000) and its protein levels increase in the photoreceptor layer following exposure to 
intense green light (Wu et al., 2003). Both findings suggest an involvement of at least 
caspase-1 in light induced photoreceptor apoptosis. However, no activation (cleavage) of 
caspases-1, -3, -7, -8 or -9 was observed after acute light damage (Donovan et al., 2001) 
(Donovan and Cotter, 2002).  
7.3.2 Neuroprotective cytokines and growth factors 
Several compounds have been tested for their neuroprotective potential in retinal 
degeneration based on evidence derived from other systems, in particular the CNS. Attempts 
for neuroprotection in the retina involve a broad spectrum of cytokines (Chaum, 2003). 
 
7.3.2.1 LEDGF 
Lens epithelium derived growth factor (LEDGF) promotes survival of cells against 
stress by inducing the expression of heat shock proteins, antioxidant proteins, and 
detoxication enzymes (Shinohara et al., 2002). Injection of LEDGF into the vitreous of rats 
prior to 48 h of light exposure resulted in protection of retinal function and preservation of 
retinal morphology. The number of surviving photoreceptors was twice as high as compared 
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to the vehicle injected eye (Machida et al., 2001). Similar effects on morphology were 
observed when LEDGF was applied to retinas derived from rd1 mice in organ culture, where 
it caused an increased survival of photoreceptors (Ahuja et al., 2001). Likewise, LEDGF 
prolonged the survival of functional photoreceptors in the RCS rat (Machida et al., 2001). On 
the other hand, no protection resulted from LEDGF application in the P23H rat (Machida et 
al., 2001). 
7.3.2.2 b-FGF 
Basic fibroblast growth factor (bFGF) has been extensively studied as neuroprotective 
cytokine in the retina. It seems to play a major role in the endogenous defence against stress 
of retinal cells. Endogenous b-FGF is released from retinal cells as an answer to different 
stress-stimuli and subsequently protects retinal cells from apoptosis.  
b-FGF has been studied for its neuroprotective capacity in several models of inherited 
retinal degeneration: Attempts to decrease retinal degeneration in several mouse models by 
intravitreal injections of the recombinant protein failed (LaVail et al., 1998). However, longer 
lasting expression of b-FGF from a virally delivered transgene in rats transgenic for rhodopsin 
carrying the S334ter mutation led to conservation of retinal morphology, but not function 
(Lau et al., 2000). Similarly, viral transfer of b-FGF to the retina of the RCS rat protected 
retinal morphology (Akimoto et al., 1999). In the same model, intravitreal implantation of 
encapsulated cells expressing b-FGF slowed the course of degeneration (Uteza et al., 1999) 
(Neuner-Jehle et al., 2000). Two other members of the FGF family (FGF-5 and FGF-18) have 
been shown to rescue morphology but not the function in transgenic rats carrying the 
rhodopsin mutations P23H and S334ter (Green et al., 2001). Even though species differences 
may underlie the variation in rescue, it appears that the route of application and the duration 
of the presence of high FGF levels might define the success of treatment.  
Intravitreal injections of recombinant b-FGF was neuroprotective in two light damage 
setups using constant exposure to white light (LaVail et al., 1998; Cao et al., 2001). The 
neuroprotective effect could be enhanced by a combination of b-FGF and PEDF (Cao et al., 
2001). In contrast, no protection against constant light exposure for 1 week was achieved 
when b-FGF was expressed locally from a transgene delivered by a AAV vector (Lau and 
Flannery, 2003). In a very similar setup, transgenic expression of b-FGF protected 
photoreceptor morphology, but not the function (Spencer et al., 2001). Pre-conditioning with 
light increases the expression of b-FGF and protects against damaging doses of light (Liu et 
al., 1998; Li et al., 2003). Light pre-treatment also enhanced photoreceptor survival in RCS 
rats, but failed to do so in P23H rats. In both cases b-FGF was up regulated. Light pre-
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treatment may have failed to rescue the P23H-induced degeneration due to the intrinsic 
susceptibility of P23H photoreceptors to light damage (Nir et al., 1999; Nir et al., 2001). 
Ischemic pre-conditioning of the retina by elevation of the intraocular pressure likewise 
resulted in an increased resistance against light damage and was accompanied by increased 
expression of b-FGF (Casson et al., 2003). Similarly, induction of ganglion cell death yielded 
the same effects (Casson et al., 2004).  
7.3.2.3 PEDF 
Pigment epithelium derived factor (PEDF) is considered a potent neuroprotective 
factor against, for example, glutamate excitotoxicity and oxidative damage (Tombran-Tink 
and Barnstable, 2003) for neurons from CNS. Consequently, it was also tested for 
neuroprotective activity at the site of its origin, the eye. Intraocular injection of PEDF slowed 
degeneration in two mouse models of inherited degeneration, rd1 and rds (Cayouette et al., 
1999). SIV-mediated PEDF gene transfer preserved morphology and function in the RCS rat 
(Miyazaki et al., 2003). Injection of recombinant PEDF prior to light exposure doubled the 
number of surviving photoreceptors and rescued retinal function following constant light 
exposure for up to 10 days (Cao et al., 2001).  
7.3.2.4 CNTF 
Ciliary neurotrophic factor (CNTF) is a very well-studied molecule with regard to 
retinal degeneration. Like b-FGF it seems to be part of an intrinsic retinal response to stress. 
CNTF has been applied to a large variety of inherited retinal degenerations: intraocular 
injections failed to display a protective effect in several models (LaVail et al., 1998) but 
expression from a virally delivered transgene slowed photoreceptor loss in the rd2 mouse 
(Cayouette et al., 1999; Liang et al., 2001; Schlichtenbrede et al., 2003), the P216L transgenic 
mouse (Bok et al., 2002), the rhodopsin S334ter and P23H transgenic rats (Liang et al., 2001), 
the RCS rat (Huang et al., 2004) and the rhodopsin knock-out mouse (Liang et al., 2001). 
Interestingly, retinal function turned out to be less (or not) protected than morphology. CNTF, 
released by engineered cells, slowed retinal degeneration in the rcd1 dog model (Tao et al., 
2002) and, after intravitreal injection, in an autosomal dominant feline model of rod-cone 
dystrophy (Chong et al., 1999). Protective effects were also reported for the rd1 mouse on 
retinas in organ culture (Caffe et al., 2001). CNTF expression was found to be upregulated by 
pre-conditioning with light (Liu, C., et al., 1998) or by injury to ganglion cells (Casson et al., 
2004). Recombinant CNTF injected intravitreally protected against exposure to white light for 
1–2 weeks (LaVail et al., 1998). 
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Interestingly, the receptors for CNTF (CNTFα) are mainly expressed in inner retina 
on neurons and glial cells and on RPE, but do not appear to be expressed by photoreceptors 
(Chaum, 2003). This leads to the hypothesis that the survival signal promoted by CNTF, is 
transduced indirectly by other retinal cells, e.g. retinal Mueller glial cells (RMG). 
7.3.2.5 NGF 
Reports about neuroprotective effects of nerve growth factor (NGF) in retinal 
degeneration have been contradicting. Intravitreal injection of NGF in an autosomal dominant 
feline model of rod-cone dystrophy slowed degeneration (Chong et al., 1999). 
In light-induced retinal degeneration NGF may have deleterious effects by reducing 
the endogenous b-FGF response. This activity seems to involve activation of p75NTR receptors 
on retinal Müller glial cells, as blocking or knock-out of this receptor increases retinal 
resistance in acute bright light damage (Harada et al., 2000). No effect of p75NTR receptor 
knock-out on light damage susceptibility, however, was found with a different light damage 
setup using constant exposure for 2–3 weeks (Rohrer et al., 2003).  
7.3.2.6 NT-3 
Neurotrophin-3 (NT-3) has been shown to exert effects opposite from NGF in light-
induced retinal degeneration by activating TrkC-induced signalling in RMG which resulted in 
increased release of b-FGF from RMG.  This intrinsically released b-FGF may be responsible 
for the increased retinal defence against light toxicity (Harada et al., 2000). 
7.3.2.7 BDNF 
Intravitreal injection failed to protect the retina in a variety of mutant mice (LaVail et 
al., 1998) and in a model for autosomal dominant feline rod-cone dystrophy (Chong et al., 
1999). Viral delivery of a BDNF transgene delayed degeneration induced by the Q344ter 
mutation in rhodopsin (Okoye et al., 2003). Likewise, prolonged release from transgenic cell 
transplants into the eye slowed degeneration in RCS rats (Lawrence et al., 2004) and rd1 
retinal explants cultured in the presence of BDNF showed better preserved morphology 
(Caffe et al., 2001).  
BDNF applied by intravitreal injection of the recombinant protein or released from 
transgenic cell transplants (Kano et al., 2002) protects the retina against 1–2 weeks of 
constant light exposure. 
Surprisingly, the BDNF receptor, TrkB, is expressed in retinal ganglion cells (RGC), 
amacrine cells (Cellerino and Kohler 1997; Chaum 2003; Jelsma et al., 1993; Maisonpierre et 
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al., 1990) and RPE (Bennett et al., 1999); additionally TrkB is expressed by cone 
photoreceptors but not by rods. This indicates the existence of paracrine survival pathways in 
cases of BDNF-induced enhanced rod survival. 
7.3.2.8 RdCVF 
Rod-derived cone viability factor (RdCVF) is a truncated TRX-like protein 
specifically expressed by rod photoreceptors. RdCVF is hypothesized to protect cones in 
retinal diseases where cone loss follows secondary to rod loss. RdCVF was shown to be 
expressed by rods and to promote the survival of cones in the rd1 mouse (Leveillard et al., 
2004). 
7.3.2.9 GDNF 
Glial cell-line derived neurotrophic factor (GDNF) has been shown to prolong suvival 
of rod photoreceptors in the rd1 mouse model of retinal degeneration (Frasson et al., 1999a). 
Additionally, this study demonstrated that GDNF was able to also preserve function of rods 
for an extended period of time. It has been hypothesized that this rod rescue may be due to an 
unknown paracrine effect, because (a) the GDNF receptor components could not be localized 
on photoreceptors (unpublished observations) and (b) RMG responded with upregulation of 
glial fibrillaric acidic protein (GFAP) to GDNF.  
Transplantation of a Schwann-cell line producing GDNF into the RCS rat significantly 
slowed degeneration (Lawrence et al., 2004), virally delivered GDNF increased rod 
photoreceptor survival and function in the transgenic S334ter rhodopsin rat (Sanftner et al., 
2001) and GDNF prolonged survival of photoreceptors in an in vitro culture of retinal neurons 
(Politi et al., 2001). Furthermore, GDNF has protective effects on retinal ganglion cells, as 
was shown by several studies (Klocker et al., 1997; Koeberle and Ball, 1998; Yan et al., 1999;  
Koeberle and Ball, 2002; Schmeer et al., 2002; Straten et al., 2002; Ishikawa et al., 2005). 
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8 The role of RMG in neuroprotection 
Glial cells are thought to protect neurons from various neurologic insults. Retinal 
disease or injury is often accompanied by significant morphological, cellular and molecular 
changes in RMG. Some of these changes may reflect the involvement of RMG in protecting 
the retina from further damage.  
8.1 Protection from glutamate toxicity 
The excitatory amino acid neurotransmitters, and particularly glutamate, can have potent 
neurotoxic activity if their extracellular concentration becomes elevated in the central 
nervous system including the retina. Hence, excessive glutamate is thought to be responsible 
for a variety of acute neurologic insults, including ischemia and anoxia, hypoglycemia, 
trauma, and several chronic neurodegenerative diseases. The primary glutamate transporter 
expressed by retinal astrocytes and RMG is GLAST (Otori et al., 1994), which has been 
postulated to contribute to the clearance of glutamate and protect retinal ganglion cells from 
glutamate neurotoxicity (Kawasaki et al., 2000). It has been shown that RMG can protect 
against the excitotoxic effects of glutamate in the whole retina and increase survival of 
ganglion cells in culture (Heidinger et al., 1999; Izumi et al., 1999; Kawasaki et al., 2000). In 
physiological conditions, after its release from neurons, glutamate is quickly taken up by 
glial cells and amidated to form the non-neuroactive compound glutamine. This amidation is 
catalyzed by the enzyme glutamine synthetase, which is present only in glial cells and which 
is confined exclusively to RMG in the retina. Glutamine is then released by the glial cells 
and taken up by neurons for conversion back to glutamate. Glutamine synthetase is involved 
directly in neuroprotection since it has been found that chick retinas treated with cortisol 
induce expression of high levels of glutamine synthetase and as a consequence are more 
resistant to glutamate-induced damage (Vardimon et al., 1988). Beside, by using mixed 
cultures of neuronal cells seeded onto adult RMG as feeder cells, it has been demonstrated 
that glutamate induces an increase in glutamine synthetase activity and protection from 
glutamate toxicicity (Heidinger et al., 1999). 
8.2 Protection from reactive oxygen species 
Reactive oxygen species are generated in the retina under various conditions such as 
anoxia, ischemia and reperfusion. One of the crucial substances protecting the retina against 
reactive oxygen species is glutathione, a tripeptide constituted of glutamate, cysteine and 
glycine. Glutathione is synthesized extramitochondrially and transported into the 
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mitochondrial matrix of RMG. Glutamate is the rate-limiting substance in the glutathione 
synthesis. High levels of reduced glutathione have been localized to RMG (Pow and Crook 
1995), suggesting that RMG play a critical role in regulating the content of potentially 
damaging oxidative species in the retina. Supply of reduced glutathione from RMG to retinal 
neurons has been proposed as a major protective mechanism against ischemia/reperfusion 
injury in rat retina (Schutte and Werner, 1998). 
8.3 RMG-derived neurotrophic factors 
Several in vitro studies demonstrated that cultured RMG release neuroprotective 
substances into the culture medium. RMG-conditioned medium increases the long term 
survival of developing retinal ganglion cells in culture. It has been demonstrated in cultures 
from adult pig retinas that factors secreted by RMG increase the survival and enhances the 
neuritogenesis of retinal ganglion cells (Garcia et al., 2002). Other authors have found that 
RMG have a neurite-promoting effect on retinal ganglion cells only when there is a direct 
cell-to-cell contact whereas soluble factors released by RMG do not induce significant neurite 
outgrowth in retinal ganglion cells (Raju and Bennett, 1986). In either case, the nature of the 
respective factors is unknown.  
Recent work has demonstrated in in vitro cultures of purified cone photoreceptors 
from pig retinae that RMG-conditioned medium has a pronounced effect on survival. Above 
60% of the cultured cones survived for more then 7 days in vitro, compared to only 4% in the 
control-medium (Balse et al., 2005). This leads to the hypothesis that RMG secrete 
neuroprotective factors, which have not yet been identified. 
In vivo, RMG have also been implicated in determination of photoreceptor survival. It 
has been demonstated that RMG increase secretion of bFGF in response to injection of NT-3. 
The release of bFGF by RMG leads to protection of photoreceptors from light induced 
apoptosis (Harada et al., 2000). On the other hand, the low affinity neurotrophin receptor 
p75NTR, which is expressed in RMG (Garcia et al., 2003), is activated by application of NGF 
and subsequently decreases bFGF production in RMG. Thus, it has been hypothesized that 
RMG transduce both, neuroprotective and apoptotic stimulus by either increase or decrease of 
secreted bFGF.  
Injection of brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor 
(CNTF) and fibroblast growth factor (bFGF) into eyes of wildtype mice leads to increase in 
phosphorylated extracellular receptor kinase (pERK) and transcription factor c-fos only in 
cells of the inner retina and not in photoreceptors. This again indicates that these molecules 
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may exert their effects on photoreceptors by acting indirectly through activation of RMG 
(Wahlin et al., 2000). 
 
9 GDNF signalling 
9.1 GDNF  family 
Glial cell line-derived neurotrophic factor (GDNF) was originally purified 
biochemically from a rat glioma cell-line supernatant as a growth factor promoting the 
survival of embryonic dopaminergic neurons of midbrain (Lin et al., 1993). Later, neurturin 
(NRTN) was purified biochemically by virtue of its biological activity (Kotzbauer et al., 
1996). The other GDNF-family ligands (GFLs) artemin (ARTN) (Baloh et al., 1998; Masure 
et al., 1999) and persephin (PSPN) (Milbrandt et al., 1998) were then isolated by a database 
search and homology cloning (Baloh et al., 2000). Analysis of the near-complete public 
human genome database indicates that further functional GFL members are unlikely to exist 
(Airaksinen and Saarma, 2002). 
GFLs belong to the transforming growth factor-β (TGF-β) superfamily, containing 
seven cysteine residues with the same relative spacing as other members of this family. 
Despite low amino-acid sequence homology, GDNF and other structurally characterized 
members of the TGF-β superfamily have similar conformations (Ibanez, 1998). They all 
belong to the cysteine-knot protein family, and they function as homodimers. 
GFLs are produced as a precursor protein, preproGFL. The signal sequence is cleaved 
upon secretion, and activation of the proGFL probably occurs by proteolytic cleavage. GFLs 
seem to bind heparin-sulphate side chains of extracellular-matrix proteoglygans, which might 
restrict their diffusion and raise their local concentration (Hamilton et al., 2001). The specific 
proteases that cleave and activate GFL precursors have not yet been identified.  
 
9.2 GDNF receptors 
9.2.1 GFRα coreceptors 
All GFLs signal via transmembrane receptor tyrosine kinase RET (rearranged during 
transfection), but the binding of GFLs is indirect, mediated by a family of proteins named 
GDNF receptor-α family. Those proteins are linked to the plasma membrane by a glycosyl-
phosphatidylinositol (GPI) anchor. Four different GFRα receptors have been characterized 
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(GFRα1-4), which determine the ligand specificity of the GFRα-RET complex. Dimeric 
GDNF binds to GFRα-1 which then binds to RET and leads to a dimerisation of the 
transmembrane tyrosine kinase. This in turn leads to phosphorylation of intracellularly located 
tyrosine residues of RET. Neurturin (NRTN) binds to GFRα-2, artemin (ARTN) binds to 
GFRα-3 and persephin (PSPN) binds to GFRα-4 (see Figure 7). NRTN and ARTN may bind 
weakly to GFRα-1, and GDNF was shown to interact weakly with GFRα-2 and GFRα-3. 
PSPN, so far has been shown to bind exclusively to GFRα-4 (Airaksinen et al., 1999; Baloh 
et al., 2000; Lindahl et al., 2001; Takahashi, 2001) (Figure 7). 
GFRα receptors are usually bound to the plasma membrane by their GPI anchor. 
However, it has been shown that cleavage by a yet unidentified phospholipase or protease 
produces soluble forms of these co-receptors (Paratcha et al., 2001). Additionally, alternative 
splicing can produce soluble forms of the co-receptors (shown for GFRα-4, Lindahl et al., 
2001). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: GDNF family ligands and receptor interactions  
All GFRα receptors can bind to Ret (indicated by black arrows) and each GFRα receptor 
has a preferred ligand. Some GFLs can interact with 2 or 3 GFRas (dashed arrows). GFRα 
proteins are attached to the plasma membrane by a GPI anchor located in raft membranes. 
At least four tyrosine residues present on the intracellular part of RET serve as docking sites 
for adaptor proteins (red circles) (from Airaksinen and Saarma, 2002). 
INTRODUCTION   
 
37
9.2.2 RET transmembrane tyrosine kinase  
The RET proto-oncogene encodes a receptor tyrosine kinase with a cadherin-related 
motif and a cysteine-rich domain in the extracellular domain and is located on human 
chromosome 10q11.2 (Takahashi et al., 1988; Ishizaka et al., 1989; Takahashi et al., 1989;  
Iwamoto et al., 1993). Three isoforms that are generated by alternative splicing in the 3′ 
region have been cloned (Tahira et al., 1990; Myers et al., 1995). The three isoforms, short 
(RET9), middle (RET43) and long (RET51) differ in the amino acid sequence of the C-
terminal tail; RET9 has nine additional amino acids from the common sequence between 
RET9 and RET51, while RET51 has 51 amino acids from the common sequence. 
Accordingly, RET43 has 43 amino acids at C-terminus not homologue to the other Ret 
isoforms (Ivanchuk et al., 1998). From these isoforms, RET9 and RET51 are the 
predominantly expressed products in vivo. The generation of mice that expressed either only 
RET9 or only RET51, demonstrated that RET9 is crucial for kidney morphogenesis and 
enteric nervous development, whereas RET51 is dispensable (De Graaff et al., 2001). 
Monoisoformic RET9 mice, which lacked RET51, were viable and appeared normal. In 
contrast, monoisoformic RET51 mice, which lacked RET9, had kidney hypodysplasia and 
lacked enteric ganglia from the colon. On the other hand, another study showed that only 
RET51 but not RET9 could promote the survival and tubulogenesis of mouse inner-medullary 
collecting duct cells in the kidney, suggesting that RET51 signalling participates in the 
differentiation event in later kidney organogenesis (Lee et al., 2002). Recently it was 
demonstrated that the signalling complex associated with RET9 was markedly different from 
that associated with RET51 (Tsui-Pierchala et al., 2002) thus further underlining their 
differential function in signalling. 
9.2.3 GDNF-induced intracellular signalling 
Upon GDNF stimulation, RET receptor is dimerized and specific C-terminal tyrosine 
residues are autophosphorylated. RET short and middle isoforms contain 16 tyrosine residues, 
including 10 tyrosine residues in the kinase domain, two in the juxtamembrane domains, one 
in the kinase insert and three in the carboxy-terminal tail, and RET long isoform has two 
additional tyrosines in the carboxy-terminal tail. Among these tyrosines, tyrosine 905, 1015, 
1062 and 1096 represent binding sites for GRB7/10, phospholipase Cγ (PLCγ), SHC and 
GRB2, respectively (Pandey et al., 1995; Asai et al., 1996; Borrello et al., 1996; Arighi et al., 
1997; Lorenzo et al., 1997; Ohiwa et al., 1997; Alberti et al., 1998;  Durick et al., 1998; van 
Weering and Bos, 1998). The former three tyrosines are conserved in all three RET isoforms 
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but tyrosine 1096 is present in the long isoform only. Interestingly, tyrosine 1062 is so far 
turned out to be the binding site of at least five different docking proteins, SHC, FRS2, 
DOK4/5 (downstream of tyrosine kinase 4/5), IRS1/2 (insulin receptor substrate 1/2) and 
Enigma. 
Like other receptor tyrosine kinases, RET can activate various signalling pathways 
including RAS/extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase 
(PI3K)/AKT, p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase 
(JNK) pathways (see Figure 8) (Chiariello et al., 1998; Feng et al., 1999; Hayashi et al., 2000; 
Melillo et al., 1999; Murakami et al., 1999a; Murakami et al., 1999b; Ohiwa et al., 1997; 
Segouffin-Cariou and Billaud, 2000; Soler et al., 1999; Trupp et al., 1999, van Weering, D.H. 
and Bos, J.L., 1997, van Weering et al., 1995; Worby et al., 1996; Xing et al., 1998). 
Astonishingly, all of the RAS/ERK, PI3K/AKT, p38MAPK and JNK pathways are activated 
mainly through tyrosine 1062 (Hayashi et al., 2000). After binding of SHC to phosphorylated 
tyrosine 1062, SHC further associates with GAB1/2 adaptor proteins and GRB2/SOS 
complex, leading to the activation of PI3K/AKT and RAS/ERK signalling pathways, 
respectively. GAB1/2 directly associates with p85 subunit of PI3K, resulting in the activation 
of PI3K (Murakami et al., 1999b; Besset et al., 2000; Hayashi et al., 2000). However, the fact 
that mutation of tyrosine 1062 did not completely abolish the activation of RAS/ERK and 
PI3K/AKT pathways suggests the presence of alternative signalling pathways. The activation 
of RAS/ERK and PI3K pathways via tyrosine 1062 are important for activation of CREB and 
NFκ-B transcription factors, respectively (Hayashi et al., 2000), as well as for PC12 cell 
survival (De Vita et al., 2000). In addition, RAS activation is essential for RET-induced cell 
differentiation in PC12 cells (Califano et al., 2000), whereas PI3K signalling independent of 
AKT is necessary for lamellipodia formation that is a critical event in neuritogenesis (van 
Weering and Bos, 1997; van Weering and Bos, 1998). It is still unknown, how 
phosphorylated tyrosine 1062 activates p38MAPK, JNK, and ERK5 signalling pathways 
(Hayashi et al., 2000; Hayashi et al., 2001). Recently, the neuron-specific adaptor protein Rai 
(ShcC) was found to be specifically activated by RET (Pelicci et al., 2002). Rai protein forms 
a constitutive complex with the p85 subunit of PI3K and the Rai-PI3K complex is recruited to 
phosphorylated tyrosine 1062 of RET. This triggers the activation of PI3K-AKT and 
promotes the neuronal cell survival. RET may potentiate prosurvival effect through the 
activation of Rai even in adult nervous tissues, because Rai is expressed in both developing 
and adult nervous system (O'Bryan et al., 1996; Sakai et al., 2000). 
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Figure 8: Intracellular signalling pathways activated by RET phosphorylation (from 
Ichihara et al., 2004) 
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9.2.4 Differential signalling inside and outside of lipid rafts 
Lipid rafts are lipid micro-domains constituted of sphingolipids and cholesterol within 
the plasma membrane and play important roles in cellular signalling, because Src family 
kinases and a number of other signalling proteins are localized and enriched in the lipid rafts. 
Recent evidences indicate that lipid rafts are crucial for abundant biological events including 
growth factor-receptor signalling, cellular adhesion, synaptic transmission and membrane-
associated proteolysis (Simons and Toomre, 2000). In the RET functional receptor, GFRα co-
receptors are anchored to the plasma membrane by the glycosylphosphatidyl-inositol, and 
hereby localized mainly to the lipid rafts. It has been demonstrated that RET is localized 
outside of lipid rafts in the inactive form and GFRα-1 recruits RET to lipid rafts upon 
stimulation with GDNF (Tansey et al., 2000). Disruption of RET localisation to lipid rafts 
resulted in the profound attenuation of intracellular signalling events and subsequent 
diminished neuronal differentiation and survival, although RET was phosphorylated after the 
GDNF stimulation. Interestingly, it was suggested that RET which moves to lipid rafts 
following GDNF stimulation triggers the signal through FRS2, while activated RET located 
outside of rafts triggers the signal through SHC (Paratcha et al., 2001; Tansey et al., 2000). 
Additionally, it has been demonstrated that soluble GFRα-1, which binds GDNF and activates 
RET initially outside rafts, can recruit RET to the rafts with delayed kinetics (Paratcha et al., 
2001).  Inside or outside of rafts, or the balance between the binding to SHC and to FRS2 may 
be a tool to differentially influence the nature of the intracellular signalling in target cells, 
because FRS2 and SHC share their docking site at tyrosine 1062 in RET.  
9.2.5 RET-independent GDNF signalling 
9.2.5.1 The role of glycosaminoglycans 
It has been demonstrated that GDNF signalling depends in addition to the direct 
receptors GFRα and RET on the presence of heparin sulphate glycosaminoglycans (Barnett et 
al., 2002; Tanaka et al., 2002). In the absence of these cell-surface molecules, GDNF-
dependent RET phosphorylation and in consequence GDNF-induced axonal growth is 
abolished (Barnett et al., 2002). It is evident that heparin sulphate proteoglycans, such as 
syndecans, may be able to locally concentrate GDNF in the neighbourhood of GFRa and 
RET, because GFLs generally bind to heparan-sulphate side chains of extracellular-matrix 
proteoglygans. Application of very high concentrations of GDNF can overcome the lack of 
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heparin sulphates in respective cells in vitro and activate RET, thus underlining the hypothesis 
that heparin sulphates act as important local concentrators for GFLs. 
Further it has been shown that GDNF is able to induce Met receptor tyrosine kinase 
signalling in several RET-deficient but GFRα-1 positive cells as well as in cells expressing 
both GDNF-receptor components (see Figure 9A) (Popsueva et al., 2003). A direct interaction 
between GDNF and Met is unlikely, because GDNF does not immunoprecipitate Met in these 
cell systems. The GDNF-induced RET-independent Met activation has been shown to be 
dependent on activation of Src-family kinases and may be mediated by the heparin sulphate 
proteoglycan syndecan (Figure 9A). 
9.2.5.2 Neural cell adhesion molecule NCAM 
GDNF can signal through GFRα-1 in a RET-independent way and activate Src family 
kinases (SFK) (Poteryaev et al., 1999; Trupp et al., 1999). In RET-deficient cells, GDNF 
triggers SFK activation and subsequent phosphorylation of MAPK, PLC-g, cAMP response 
element-binding protein (CREB) and induces c-FOS (Poteryaev et al., 1999; Trupp et al., 
1999). This RET-independent signalling predicts another yet unidentified transmembrane 
receptor, because the GPI-anchored GFRα-1 should not be able to transmit a signal across the 
plasma membrane. This hypothesis is further strengthened by the fact that GFRα-1 is 
expressed in many tissues without coexpression of RET (Trupp et al., 1997; Kokaia et al., 
1999; Ylikoski et al., 1998). Recently it has been demonstrated that neural cell adhesion 
molecule NCAM functions as an alternative signalling receptor for GFLs (Paratcha et al., 
2003). When GFRα-1 is associated with NCAM, GDNF binds with high affinity to 
p140NCAM and activates the cytoplasmic Src-like kinase Fyn and focal adhesion kinase 
FAK (Paratcha et al., 2003) (see Figure 9B). By binding to NCAM, GDNF stimulates 
Schwann cell migration and axonal growth in hippocampal and cortical neurons. Even in the 
absence of GFRα-1, GFLs interact with NCAM with low affinity; additionally in the absence 
of GFLs, association of GFRα-1 with NCAM alone influences NCAM-mediated cell 
adhesion. This ability of GFRα-1 to modulate NCAM-mediated cell adhesion suggests 
distinct roles for GFRα-1-NCAM and GDNF-GFRα-1-NCAM signalling. In another study, it 
could be demonstrated that the effects of GDNF on midbrain dopaminergic neurons are 
inhibited by a NCAM-blocking antibody (Chao et al., 2003), which suggests a profound role 
of NCAM for GDNF-signalling even in the presence of RET. 
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Figure 9: Ret-independent signalling for GDNF and RET activation by crosstalk with 
TrkA (from Sariola and Saarma, 2003) 
A: GDNF promotes phosphorylation of Met. Met activation is indirect and is mediated by 
Src-type kinases. Evidence suggests that GDNF is locally concentrated by heparan 
sulphate proteoglycans, such as syndecan. By contrast, RET is phosphorylated, by an 
unknown mechanism, through the activation of TrkA.  
B: NCAM is an alternative signalling receptor for GFLs. GDNF-GFRa complex interacts with 
NCAM leading to activation of Fyn, a Src-like kinase. 
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9.3 Crosstalk with other growth factors or receptors 
9.3.1 TGFβ 
Transforming growth factor betas (TGF-βs) are widely distributed and act as cytokines 
in development and cell-cycle control (Sporn and Roberts, 1990). Moreover, TGF-βs have 
been involved in the regulation of neuronal survival (Martinou et al., 1990; Chalazonitis et al., 
1992; Krieglstein and Unsicker, 1994) but it has been suggested that TGF-β requires a 
cofactor for eliciting this neuroprotective effect. GDNF was suggested as a possible candidate 
cofactor, and indeed it has been demonstrated that GDNF requires TGF-β for trophic support 
of neurons in vitro (Krieglstein et al., 1998) and in vivo (Schober et al., 1999). TGF-β seems 
to be able to recruit GFRα into lipid rafts of the plasma membrane and thus enabling effective 
GDNF-induced ERK signalling (Schober et al., 1999). 
9.3.2 BDNF 
It has been suggested from experiments with knock-out mice that some neurons, 
namely nodose-petrosal ganglion complex (NPG) of primary cranial sensory neurons, require 
both, GDNF and BDNF for survival in vivo. Accordingly, it has been demonstrated that 
BDNF and GDNF exert additive survival-promoting effects on neurons in vitro (Erickson et 
al., 2001); the mechanism of this synergistic effect is unresolved. 
9.3.3 NGF 
Nerve growth factor (NGF) is a classical trophic factor for developing sympathetic 
neurons and acts through its specific receptor TrkA. There has been experimental evidence 
that GFLs also enhance survival of adult sympathetic neurons (reviewed by Airaksinen and 
Saarma, 2002). It has been demonstrated that NGF is able to phosphorylate the long isoform 
of RET (RET51) independently of either GFLs or GFRα coreceptors and thus maintains the 
trophic status of mature neurons (Tsui-Pierchala et al., 2002). This specific phosphorylation 
of the long RET isoform indicates that the mechanism is not dependent on simple 
upregulation of GDNF. It has been hypothesised that there is a direct interaction between 
RET51 and TrkA receptors (see Figure 9A), although the mechanism of this crosstalk is 
unknown. 
9.3.4 cAMP 
Cyclic AMP (cAMP) is a second messenger in the cAMP/Protein kinase A (PKA) 
signalling cascade and functions as a key regulator for neuronal survival and regeneration 
(Cai et al., 1999; Cui and So, 2004; Hanson et al., 1998). Intracellular cAMP concentration is 
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regulated through the balance between synthesis of cAMP by adenylyl cyclase and hydrolysis 
of cAMP by cyclic AMP phosphodiesterase. Adenylyl cyclase is activated by trimeric GTP-
binding proteins (G-proteins) after stimulation of G-protein-linked receptors by specific 
ligands. It has been demonstated that GDNF enhances the intracellular cAMP level in 
neuronal cells (Engele and Franke, 1996) and regulation of cAMP level is mediated through 
phosphorylation of serine 696 of RET receptor (Fukuda et al., 2002). It is presumed that 
Ser696 is phosphorylated by PKA and a point mutation of this serine in RET completely 
abolished lamellipodia formation induced by GDNF (see Figure 8). However, the exact 
mechanism of the hypothesized crosstalk between RET and a yet unidentified G-protein-
linked receptor remains unresolved. 
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AIM OF THE THESIS 
Inherited retinal degenerations as well as degeneration processes triggered by age or 
environmental factors result in eventual loss of photoreceptors, which leads to loss of vision. 
Due to the complexity of insults leading to degeneration of photoreceptors, it is essential for 
development of therapeutical strategies to understand the molecular mechanisms of apoptosis 
in retina and further, to learn about intrinsic neuroprotective pathways. It is a paradox that in 
inherited retinal degenerations, disease-causing mutations are present from the beginning, but 
the affected cells may survive extended periods of time, as many of these diseases progress 
slowly. Thus, the retinal photoreceptors are obviously neuroprotected by intrinsic processes. 
Many neuroprotective substances, originally found and tested in brain, have been tested for 
their efficacy against retinal degeneration in different animal models. One of the most 
effective molecules tested was glial cell-line derived neurotrophic factor (GDNF), which not 
only preserved histology, but also function of photoreceptors when injected subretinally in 
rd1 mice (Frasson et al., 1999a). However, the mechanism of GDNF-induced signalling in 
retina is unknown. It has been speculated that retinal Mueller glial cells (RMG) might respond 
to GDNF, because upon injection of GDNF RMG were found to react with upregulation of 
glial fibrillary acidic protein (Frasson et al., 1999a). Likewise, injection of NGF and NT-3 in a 
light-induced animal model of retinal degeneration leads to a reaction of RMG but not 
photoreceptors. RMG decreased or increased the production and release of bFGF (Wahlin et 
al., 2000), respectively, which is a protective factor for photoreceptors. Thus, RMG may be 
the crucial cell modulating neuroprotection in retinal degeneration. 
In order to characterize the role of RMG in mediating neuroprotection, the objectives 
of this thesis were: 
• Establishment of primary RMG in vitro culturing system as a prerequisite for 
characterisation of GDNF-induced signalling. 
• Investigation of expression of the family of GDNF ligand receptors (Ret, 
GFRα-1, -2, -3) in retina followed by analysis of GDNF-induced signalling in 
RMG. 
• Screening and characterisation of factors secreted by RMG which support 
survival of photoreceptors in vitro. 
• Identification of neuroprotective factors in interphotoreceptor matrix. 
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SUMMARY OF PAPERS 
1 Proteomic profiling of primary retinal Mueller glial cells reveals a shift in 
expression patterns upon adaptation to in vitro conditions 
Glia 2003 Dec; 44(3):251-63 
 
Primary retinal Mueller glial cells (RMG) were accessed by establishing a large-scale 
preparation combined with a cell culture method. Porcine retinae were first processed by 
enzymatic trituration followed by enrichment of RMG through exploiting their ability to 
attach to uncoated culture plastic ware. After an initial attachment phase, RMG were purified 
from non-attached neurons by panning, enabling the preparation of large quantities of these 
primary cells as prerequisite for further investigations. Purity of RMG cultures was assessed 
by immunohistochemical staining with RMG-specific marker proteins (vimentin and 
glutamine-synthetase). Initial purity was demonstrated at above 70% and increased to above 
90% after 8 days in vitro. Comparative analysis of protein expressions patterns by 2D-gel 
electrophoresis of freshly prepared RMG to those of RMG cultivated at 4, 8 and 14 days, 
revealed profound changes in protein expression at the various time points. Whereas a large 
set of proteins, including the RMG-marker protein glutamine-synthetase, were downregulated 
within 8 days in vitro, other proteins were simultaneously upregulated. Identification of 
regulated proteins by mass spectrometry and subsequent functional grouping revealed that 
downregulated proteins were specific to energy metabolism, detoxification and glutamate 
metabolism functions in vivo. In contrast, many proteins related to cytoskeletal reorganisation 
e.g. focal adhesion proteins were upregulated. The expression of proteins involved in 
intracellular signalling processes was also found altered e.g., downregulation of Raf kinase 
inhibitor protein leading to liberation of the MAP-kinase pathway, which mediates cell 
proliferation activity in response to extracellular stimuli. The herein observed profound RMG 
protein expression changes in response to in vitro culturing is proposed to reflect the 
transition of retinal Mueller glial cells from a highly specialized cell type in the natural 
surrounding to a proliferating cell under in vitro conditions. 
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2 GDNF family ligands trigger paracrine neuroprotective signalling in retinal 
glial cells 
Manuscript submitted 
 
Previous reports have shown that glial cell-line derived neurotrophic factor (GDNF) very 
effectively rescues retinal photoreceptors in an animal model of inherited retinal degeneration 
(Frasson, et al, 1999a). However, the mechanism underlying the GDNF-induced rescue, as 
well as the GDNF-receptive cell type in retina have not been yet elucidated. In order to 
identify the target cells of GDNF signalling in retina and examine whether retinal Mueller 
glial cells are involved in GDNF action, the receptor components essential for GDNF 
signalling were investigated in vivo and in vitro. Immunohistochemical analysis showed that 
not photoreceptors but retinal Mueller glial cells (RMG) expressed all components necessary 
for GDNF signalling: GFRα-1, transmembrane tyrosine kinase RET and additionally express 
the high affinity coreceptors for neurturin and artemin, GFRα-2 and GFRα-3, respectively. 
The expression of these components co-localised with RMG cell membranes in situ and the 
expression in vitro remained stable during entire cell culture experiments. Phosphorylation 
studies showed that rapid phosphorylation of RET receptor occurred in vitro following GDNF 
treatment and was accompanied by activation of various intracellular signalling cascades 
(ERK, SAPK and PKB/AKT pathways). Activation of similar signalling cascades was also 
found in response to neurturin and artemin. GDNF stimulation of RMG in vitro caused an 
upregulation of basic fibroblast growth factor (bFGF), which itself was found to increase 
photoreceptor survival in vitro. Furthermore, at least one of these signalling pathways (ERK) 
could be also activated by GDNF in distinct cells of the intact retina; these cells may likely be 
RMG. These results indicate that RMG are the major GDNF-receptive cells in the retina and 
transmit the neuroprotective effect of GDNF to photoreceptors. In this context, bFGF 
promoted photoreceptor survival in vitro and may be most likely one of the in vivo one factors 
also supporting photoreceptor survival in response to GDNF. 
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3 Secreted proteins from retinal Mueller glial cells enhance photoreceptor 
survival: an approach to detection of new candidates for neuroprotection 
 
Manuscript 
 
Cultured retinal Mueller glial cells (RMG) release substances into the culture medium 
(conditioned medium) which induce neurite sprouting retinal ganglion cells in vitro (Garcia et 
al., 2002), and enhance cone survival in vitro (Balse et al., 2005). Despite available 
information on effects, the identity of these factor(s) remains unknown. In order to define 
RMG-derived neuroprotective factors, a large-scale photoreceptor survival assay was 
developed that enabled monitoring of survival of freshly prepared porcine photoreceptors in 
vitro at extended times. RMG-conditioned medium (RMG-CM) was found to promote 
photoreceptor survival, but the protective activity of secreted factors was lost with prolonged 
RMG culturing. The activity present in RMG-CM proofed to be a protein, as demonstrated by 
proteinase K treatment and enriched into size-fractions above 10 kDa. Subsequent sub-
fractionation experiments of RMG-CM by mono-Q FPLC demonstrated that the active factor 
did not bind to anionic chromatography resins and the composition of the flowthrough was 
determined by liquid mass spectrometry (LC-Q-TOF). Among the 23 different proteins 
identified from this active subfraction were three proteins which have been previously 
described as growth factors in other contexts: insulin-like growth factor binding protein 5 and 
7 (IGFBP-5 and IGFBP-7) and connective tissue growth factor (CTGF). Stable expression of 
these three candidate factors in HEK293 cells yielded media enriched with the respective 
factor that, although inactive on its own, enhanced the protective activity of RMG when 
supplemented to its original conditioned medium. This indicated that the survival promoting 
activity in RMG-CM is multifactorial and triggered by IGFBP-5 and CTGF. 
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4 Proteomic analysis of porcine interphotoreceptor matrix 
 
Proteomics. 2005 Sep;5(14):3623-36 
 
The interphotoreceptor matrix (IPM) is the extracellular compartment located between the 
retina and retinal pigment epithelium (RPE). Due to its key location, this compartment has 
been speculated to be rich in neuroprotective substances. Microvilli from retinal Mueller glial 
cells (RMG) and RPE project into IPM, such that proteins secreted by these cells could 
potentially augment the neuroprotective function of this structure. This study analysed the 
IPM proteome and identified 140 different proteins, the majority of which had not been 
previously described in this structure. Since IPM preparations are easily susceptible to 
contamination by intracellular proteins of neighboring, fragile cells, a strategy discriminating 
bona fide IPM-proteins from contaminant proteins due to cell disruption had to be established. 
Comparison of 2D gel protein patterns between two different IPM preparation methods 
increased the likelyhood of predicting the presence of IPM proteins in vivo. In addition, a 
computational prediction method was used to score the likelyhood extracellular occurrence 
for the identified proteins. Combining both prediction methods generated a subset of proteins 
fulfilling both conditions and which were judged most likely to occur in the IPM in vivo. 
Interestingly, the majority of these have been described in the literature as playing a 
functional neuroprotective role but have not yet been associated to IPM. One such example, 
78 kDa glucose-regulated protein (GRP78) was confirmed in the IPM in situ by 
immunohistochemical staining of porcine eye sections, thus validating the proposed 
prediction method. 
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FUTURE RESEARCH 
Neuroprotection is a promising strategy for the development of therapies against 
neurodegenerative diseases. In order to minimally disturb the delicate balance of the retina by 
therapeutic intervention, it is essential to identify intrinsic neuroprotective molecules and 
clearly elucidate their mechanisms of action in retinal tissue. 
Finding substances intrinsically neuroprotective in retina prompted us initially to investigate 
the retinal Mueller glial cell (RMG) secretome, since this cell type has been implicated to play 
a fundamental role in supporting the survival of retinal neurons (paper 3). This analysis 
involved a combination of biochemical purification methods with functional testing of 
subfractions on a herefore developed photoreceptor survival assay. Subsequent mass 
spectrometric protein identifications of the active RMG-secretome subfraction led to the 
identification of two proteins which may be regarded as candidates for neuroprotective 
activity: insulin-like growth factor binding protein 5 (IGFBP5) and connective tissue growth 
factor (CTGF). Both proteins have been reported to bind to insulin-like growth factor and 
modulate its activity, thus suggesting that the main activity secreted from RMG may be IGF-1 
or IGF-2. Since both insulin-like growth factors have been reported to be expressed in retina 
and IGF-1 has beeen demonstrated to enhance survival of retinal amacrine cells, further 
studies are planned to investigate the survival-promoting effect of both molecules on survival 
of retinal photoreceptors in vitro, either applied alone or in combination with IGFBP5 and 
CTGF. Should significant neuroprotection be achieved, such agents may be further evaluated 
in an already existing retinal explant model (collaboration with Prof. T. VanVeen, Lund 
University). 
Another approach to identify intrinsically active molecules involves analysis of the 
interphotoreceptor matrix proteome, an extracellular compartment directly surrounding 
photoreceptor inner and outer segments (paper 4). Several molecules, which have been 
described as having neuroprotective function in other contexts, were identified in this 
structure. Further studies are aimed at investigating the photoreceptor survival promoting 
potential of some of these molecules. 
In this thesis, the mechanism of GDNF-mediated neuroprotective action was adressed in 
detail (paper 2). However, essential parts of this molecular mechanism still remain to be 
solved. Although an upregulation of basic fibroblast growth factor (bFGF) was found in RMG 
in response to GDNF, and bFGF treatment does prolong photoreceptor survival in vitro, it 
fails however to rescue photoreceptor function in the in vivo situation. Therefore, the 
existence of additional, as of yet unidentified molecules induced by GDNF, necessary and/or 
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essential for exerting a functional rescue of photoreceptors, is hypothesised. In order to find 
these molecules, transcriptome studies will be performed with RMG prepared from transgenic 
mouse retina. The transgenic mice express green fluorescent protein under the glial fibrillary 
acidic protein promoter resulting in green fluorescing RMG in the retina (mouse developed by 
Dr. M. Götz, ISF, GSF). Thus, primary RMG can be enriched to very high purity by FACS-
sorting and immediately stimulated with GDNF. The transcriptional effects of GDNF on 
genes will be then monitored by Affymetrix arrays. Potential genes coding for secreted 
proteins as possible candidates participating in neuroprotective effects involved in GDNF-
induced photoreceptor rescue will be selected. The activity of candidate proteins will be 
evaluated using the photoreceptor survival assay developed in this thesis. 
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Proteomic Proﬁling of Primary
Retinal Mu¨ller Glia Cells Reveals a
Shift in Expression Patterns Upon
Adaptation to In Vitro Conditions
STEFANIE M. HAUCK, SABINE SUPPMANN, AND MARIUS UEFFING*
GSF Research Center for Environment and Health, Institute of Human Genetics and Ludwig-
Maximilian University, Clinical Cooperation Group for Ophthalmogenetics, Munich, Germany
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ABSTRACT Cultured primary retinal Mu¨ller glia cells (RMG), a glia cell spanning
the entire neuroretina, have recently gained increased attention, especially with respect
to their presumed in vivo role in supporting photoreceptor function and survival. Cul-
tured RMG cells, however, are at risk to lose much of their in vivo features. To determine
the conditions of isolated primary RMG cells best corresponding with their physiological
role in the intact retina, we proﬁled the respective proteomes of RMG freshly isolated
from intact pig eye, as well as from cultured material at different timepoints. Protein
samples were separated by high-resolution two-dimensional electrophoresis (2-DE), and
isolated proteins were identiﬁed by matrix-assisted laser desorption ionization time-of-
ﬂight (MALDI-TOF) peptide mass ﬁngerprint. Compared with freshly isolated RMG, the
in vitro protein expression patterns remain relatively stable for the ﬁrst 3 days in
culture but change dramatically thereafter. Proteins involved in speciﬁc RMG physio-
logical functions, such as glycolysis, transmitter recycling, CO2 siphoning, visual pig-
ment cycle, and detoxiﬁcation, are either downregulated or absent. In contrast, cytoskel-
etal proteins, as well as proteins involved in motility and in proliferation, are
upregulated during culture. In the present report, we show for the ﬁrst time, on a
systematic level, that profound changes in the RMG proteome reﬂect transdifferentia-
tion from a multifunctional, highly differentiated glial cell to a dedifferentiated ﬁbro-
blast-like phenotype in culture. © 2003 Wiley-Liss, Inc.
INTRODUCTION
Retinal Mu¨ller glia (RMG) are the main glial cells of
the neuronal retina. While astrocytes surround blood
vessels in the nerve ﬁber layer, RMG are the only
macroglial cell that span the entire thickness of the
retina and make contact with virtually all retinal neu-
rons; RMG also provide structural stability to the ret-
ina. Moreover, supported by an ever increasing amount
of evidence (for review, see Bringmann and Reichen-
bach, 2001), RMG also support photoreceptor and gan-
glion cell survival by yet unknown mechanisms (Garcia
et al., 2002), suggesting a crucial role of these cells in
the maintenance of retinal functional integrity, as well
as a potential role within retinal degenerative diseases
and their future therapy.
RMG span a wide range of functions: (1) regulation of
the extracellular homeostasis of relevant ions, including
pH and water content of the extracellular space; active
retinal neurons release K ions, and RMG siphon K
from the extracellular space and redistribute it into dif-
Abbreviations used: RMG, retinal Mu¨ller glia cells; 2-DE, two-dimensional elec-
trophoresis; MALDI-TOF, matrix-assisted laser desorption ionization time of ﬂight;
GLAST, glutamate-aspartate transporter; CRALBP, cellular retinaldehyde-binding
protein; -SMA, -smooth muscle actin; PBS, phosphate-buffered saline; FCS, fetal
calf serum; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis;
TFA, triﬂuoracetic acid; PMF, peptide mass ﬁngerprint; ppm, parts per million; GS,
glutamine synthetase; GFAP, glial ﬁbrillary acidic protein.
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ferent sinks, such as the vitreous body, blood vessels, and
the subretinal space (Newman et al., 1984; Karwoski et
al., 1989; Reichenbach et al., 1992); (2) delivery of trophic
substances to neurons and removal of metabolic end-
products (Poitry et al., 2000); and (3) metabolism of glu-
cose to lactose, which is preferentially taken up by pho-
toreceptors as a source of energy for their oxidative
metabolism (Poitry-Yamate et al., 1995).
In addition, RMG contribute to neuronal information
processes through the fast reuptake of released neuro-
transmitters, by providing neurons with precursors of
neurotransmitters and by reabsorbing neuronally re-
leased glutamate via the glutamate-aspartate trans-
porter (GLAST) (Otori et al., 1994; Derouiche and
Rauen, 1995); the latter is expressed exclusively by
RMG and astrocytes. Glutamate reuptake is crucial for
the rapid termination of light-evoked activity in retinal
ganglion cells (Matsui et al., 1999), as well as main-
taining low extracellular glutamate levels for preven-
tion of glutamate excitotoxicity and disturbances in
neuronal processing. The main degradation pathways
of glutamate in RMG is the synthesis of glutamine by
glutamine synthetase (Linser and Moscona, 1979) and
the synthesis of glutathione from glutamate, cysteine,
and glycine; glutathione acts as an intraretinal antiox-
idant (Makar et al., 1994; Huster et al., 1998). RMG
have been also shown to play a crucial role in trophic
factor-induced signaling within the retina (Wahlin et
al., 2000) and are implicated in mediating photorecep-
tor rescue effects of several neurotrophic factors (Fras-
son et al., 1999; Wahlin et al., 2001).
Cultured RMG are widely used in physiological and
signal transduction studies. It has been reported, how-
ever, that characteristic RMG features may shift or
disappear; for example, cellular retinaldehyde-binding
protein (CRALBP) is downregulated in vitro within 2
weeks, and de novo expression of -smooth muscle
actin (-SMA) is induced after 2 weeks in culture
(Guidry, 1996). These observations, indicative of a shift
in protein expression, prompted us to conduct a sys-
tematic analysis of protein expression changes on a
global proteomic level and to acquire information about
distinct RMG-associated changes in function. Proteins
expressed in dynamic compositions determine the phe-
notypic expression of genomic information. An impor-
tant advantage of global protein expression proﬁling,
as compared to individual gene regulation studies, is
the ability to monitor simultaneous changes in several
functional groups. Thus, we compared RMG protein
expression patterns, either cultured for various periods
of time or freshly isolated from the intact eye. Result-
ant protein expression patterns were taken as a ﬁnger-
print of the physiological state of RMG, with the aim of
ﬁrst identifying individual changes followed by cluster-
ing protein sets attributable to speciﬁc functional net-
works and their corresponding physiological features.
In this study, we present proteomic RMG ﬁngerprints
showing the onset and dynamics of pronounced alter-
ations in expression patterns resulting from dramatic
environmental changes that these cells are exposed to
when shifted from organotypic conditions after pri-
mary isolation to prolonged, rather synthetic cell cul-
ture conditions.
MATERIALS AND METHODS
RMG Preparation and Cell Culture
Adult porcine eyes were provided by a local slaugh-
terhouse. They were removed from the animals within
5 min after death and kept on ice in CO2-independent
medium (GIBCO) until further use. Retinae were pre-
pared as described previously (Gaudin et al., 1996).
Brieﬂy, major blood vessels were removed and the ret-
ina was washed twice in Ringer’s solution without Ca2
supplemented with 2.5 mM EGTA. Dissociation of ret-
inal tissue was obtained by treating each retina with
2.2 U of activated papain (Worthington Biochemical)
for 40 min at 37°C; papain enzyme activity was stopped
by the addition of DMEM with 10% fetal calf serum
(FCS). Then, 160 Kunitz-units of DNase (Sigma) was
added and the tissue was further dissociated by gentle
trituration using a ﬁre-polished Pasteur pipette.
Preparation of day 3–23 samples: dissociated cells were
collected by centrifugation (800g, 5 min), resus-
pended in DMEM containing 10% FCS and plated
directly onto cell culture plates (NUNC). The plated
cells were allowed to attach for 16 h at 37°C in an
incubator. The nonattached cells were then removed
by gentle agitation (panning), and the purity of the
cultures was assessed immunohistochemically.
Preparation of day 0 samples: the papain-digested ret-
inal cells were layered on a 10 ml linear density
gradient composed of 0–50% Percoll (Pharmacia
LKB Biotechnology, Uppsala Sweden) in 0.9% NaCl
and separated at 2,800g for 5 min. RMG were en-
riched to approximately 25% Percoll and subjected to
a second Percoll gradient centrifugation (Guidry,
1996). Purity of RMG samples after the second gra-
dient was also tested immunohistochemically.
Immunohistochemistry
RMG grown on glass coverslips within the culture
plates or Percoll gradient-enriched RMG were spun
down onto glass coverslips with a cytospin centrifuge at
1,000g for 5 min.
Coverslips were rinsed in phosphate-buffered saline
(PBS) and ﬁxed in 4% paraformaldehyde in PBS for 10
min at 37°C. Cells were permeabilized for 5 min with
0.1% Triton X-100 in PBS, preincubated in PBS con-
taining 5% FCS and 0.1% Triton X-100 (blocking
buffer) for 10 min, and then incubated with one of the
following antibodies in blocking buffer: anti-vimentin
(Sigma, clone V9; 1:200) or anti-glutamine synthetase
(BD Transduction Laboratory; 1:200) for 2 h. After
washing in PBS, RMG samples were incubated with an
anti-mouse alexaFluor 488 (Molecular Probes; 1:200)
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secondary antibody combined with DAPI (Sigma, 1 g/
ml) in the dark for 1 h at room temperature. Coverslips
were washed and cells examined with a Zeiss Fluores-
cence Axioskop. DAPI-positive nuclei were counted on
3 to 5 ﬁelds of 3 separate coverslips per experiment,
and compared to the number of vimentin or glutamine
synthetase (GS)-positive cells on the respective ﬁelds.
Immunostaining experiments were conducted in tripli-
cate.
Protein Extract Preparation and 2D
Electrophoresis
Both freshly isolated (day 0) and cultured RMG cells
(day 3–23) were washed three times with DMEM and
once with PBS before incubating with lysis buffer (9 M
urea, 2 M thiourea, 1% DTE, 4% CHAPS, and 2.5 M of
both EGTA and EDTA) and protease inhibitors (com-
plete mini, Roche) for 10 min at room temperature.
Lysates were then centrifuged through a QIAshredder
Mini Column (Qiagen) and samples were stored at
70°C until further use.
Electrophoretic separation was carried out ﬁrst by
pre-swelling Immobiline dry strips (Pharmacia, pH
3–10 NL, 18 cm) overnight in lysis buffer containing
additional 1% Pharmalyte, pH 3–10, and 0.5% brom-
phenol blue (BPB w/v 0.5% in water).
Protein loading was normalized by a Bradford assay
(Bio-Rad); 100 g of whole cell extracts were then ap-
plied to the pre-swollen IPG strips by sample cup load-
ing, followed by isoelectric focusing on a Multiphor
(Amersham Biosciences) at 20°C. Initial voltage was
limited to 300 V (3 h) and then increased stepwise to
8,000 V, where it was held until 120 kV/h was reached.
Prior to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), the focused IPG strips
were washed in equilibration buffer (6 M urea, 2%
SDS, 50 mM Tris-HCl pH 6.8, 30% glycerol and BPB
traces) for 10 min at 25°C under reducing conditions
(65 mM DTE added). This was followed by another
incubation under alkylating conditions (135 mM iodac-
etamide added) for 10 min. Equilibrated strips were
loaded onto gradient SDS-PAGE gels (20.5  17.5 cm;
9–16%), sealed with 0.5% agarose in running buffer
(384 mM glycine, 50 mM Tris, and 0.2% SDS) and
electrophoresed overnight at constant 10 mA per gel
(Bio-Rad Protean IIxi Multicell). Gels were silver
stained according to Blum et al. (1987) and dried be-
tween cellophane sheets.
Image Analysis
Silver-stained 2-DE gels were scanned and digital
images were analyzed for changes in protein pattern
using the Proteom Weaver image analysis software
(release 1.3; Deﬁniens, Germany). For a qualitative
evaluation of pattern changes, raw master gels were
created with Z3 software (Compugen, Israel) by merg-
ing two real gel images for each master gel.
Preparation of Samples for Mass Spectrometry
Selected spots were excised from wet or dried silver-
stained gels, washed for 30 min in 100 l nanopure
water, destained (Gharahdaghi et al., 1999) and dehy-
drated in 100 l 40% acetonitrile (3  15 min). Follow-
ing the removal of acetonitrile, protein samples were
digested in 5–10 l 1 mM Tris-HCl, pH 7.5, containing
0.01 g/l trypsin (Sequencing Grade Modiﬁed Tryp-
sin; Promega). In-gel digestion was performed over-
night at 37°C under humid conditions to prevent dry-
ing out of the samples.
Matrix-assisted laser desorption ionization time-of-
ﬂight (MALDI-TOF) peptide mass ﬁngerprints were
obtained on a Bruker Reﬂex III mass spectrometer
(Bruker Daltonics, Bremen, Germany) equipped with a
Scout 384 inlet. Aliquots of the digests (0.5 l) were
mixed with 0.5 l matrix consisting of 2,5-dihydroxy-
benzoic acid (Sigma) (20 mg/ml in 20% acetonitrile,
0.1% TFA) and 2-hydroxy-5-methoxybenzoic acid
(Fluka) (20 mg/ml in 20% acetonitrile, 0.1% TFA) in a
9:1 ratio (v/v), and spotted onto an 400-m anchor steel
target (Bruker Daltonics). During evaporation, matrix-
analyte co-crystals concentrated on the hydrophilic an-
chor. Mass analyses obtained in the positive ion reﬂec-
tor mode were run manually or automatically. For
calibration purposes, angiotensin-2-acetate (Mr 1046.54),
substance P (Mr 1347.74), bombesin (Mr 1619.82), and
ACTH 18-39 (Mr 2465.20) spectra were recorded. When
required, mass spectra were internally calibrated refer-
ring to autoproteolytic trypsin fragments of 1045.564 Da
and 2211.10 Da.
Database Searching
Trypsin cleaves proteins speciﬁcally at the C-termi-
nus of lysine and arginine residues, generating a ﬁn-
gerprint of peptide masses (PMF) that can be located
on database searches. These were performed using the
Mascot software (Perkins et al., 1999) at the following
parameter settings: 150 ppm mass accuracy, one mis-
cleavage allowed, search in eukarya sequences. Peptide
masses of the tryptic digests were compared to the
virtually generated tryptic peptide masses of the pro-
tein databases NCBInr and MSDB. A protein was re-
garded as identiﬁed if four criteria were fulﬁlled: (1)
the MOWSE score (Pappin, 1997) was above the 5%
signiﬁcance threshold for the respective database; (2)
the matched peptide masses were abundant in the
spectrum; (3) the theoretical isoelectric point and mo-
lecular weight of the search result could be accommo-
dated with the 2-DE position of the corresponding spot;
and (4) the matched sequence did not contain more
than 20% uncleaved peptides. All proteins identiﬁed
during this study are summarized in Table 2.
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RESULTS
RMG Can Be Isolated and Maintained as a
Highly Enriched Culture
During the course of experimentation, we found the
panning method to be best for generating pure high-yield
RMG cultures. Using this method, single retinal cells are
plated following papain digestion and are then left un-
touched for 16 h. After this time, RMG attached to the
surface and nonattached cells (mainly neuronal cells) can
be washed off by slight agitation and removal of the
culture medium. The RMG purity on the day of panning
(day 1) was found to be greater than 80% (Fig. 1). Nev-
ertheless, enrichment of RMG directly after the dissocia-
tion process was not possible with this method. To obtain
working samples from freshly prepared RMG, cells had to
be enriched by Percoll gradient centrifugation. Indeed,
greater than 70% RMG purity could be reached by apply-
ing the cells on two successive Percoll gradients.
To determine the precise proportion of RMG in Per-
coll-puriﬁed cytospinned samples and cells grown in
culture for 1–14 days, cells were stained with antibod-
ies against vimentin and GS. Positive cells were re-
lated to the numbers of total, DAPI-positive cells (Figs.
1A and 2).
In Percoll-enriched preparations, immunohistochem-
istry for GS and vimentin showed that 70.4% (3.4%)
and 75.7% (5.4%) of cells, respectively, were immu-
noreactive (Fig. 1A). On in vitro day 1 these propor-
tions were 88.1% (5.6%) and 82.0% (8.7%), respec-
tively, in preparations puriﬁed by panning; on in vitro
day 3 the proportions were 76.9% (2.9%) and 81.8%
(5.0%) positive cells, respectively. Although the pro-
portion of vimentin-positive cells, between days 1 and 3
was identical, the proportion of GS-positive cells at day
3 was slightly decreased. This difference may be due to
most RMG expressing GS on day 3 (cf. Fig. 4 protein
spots indicated and Fig. 5A GS position of GS on day 0
2-DE gels), but some cells may already have downregu-
lated GS expression. After 8 days in vitro GS expres-
sion is strongly downregulated, so that only 7.6%
(10.6%) of the cells are GS-reactive. Vimentin levels
remain unchanged (cf. Figs. 2 and 4A). On days 8 and
14, 96.6% (1.4%) and 99.2% (1.3%) of the cells,
respectively, were vimentin positive, whereas GS ex-
pression continued to decrease to 0.9% (1.0%) on day
14 (Fig. 1A).
Both vimentin and GS have been also reported to be
expressed by retinal astrocytes, which are found in
vascularized retinae. CRALBP, another candidate
RMG marker, has been reported to be transiently ex-
pressed in developing mouse retinal astrocytes (P.T.
Johnson et al., 1997).
However, whereas no unambiguous marker exists to
distinguish between porcine RMG and retinal astro-
cytes, the distinct RMG morphology maintained after
papain digestion (Guidry, 1996; Sarthy and Bunt,
1982) is instrumental for validation of cell identity.
Percoll-enriched RMG stained with anti-vimentin an-
tibodies showed that 87.5% (1.3%) of vimentin-posi-
tive cells were elongated and bipolar in shape, with
extensive membrane rufﬂing typical for RMG (Fig. 1B).
The remaining proportion of vimentin-stained cells
could not be clearly classiﬁed and were thus regarded
as possible candidates for retinal astrocytes.
Protein Changes Correlate With Morphological
and Histochemical Alterations in Culture
RMG begin to retrieve their elaborate processes,
which are characteristic in vivo, as they are released
Fig. 1. Purity of freshly isolated and cultured retinal Mu¨ller glia
cells (RMG). (A) Isolated RMG were cytospinned (day 0) or grown
(days 3, 8, and 14) on glass coverslips and stained with anti-glutamine
synthetase (GS) and anti-vimentin antibodies. The percentage of pos-
itive cells was calculated based on the number of total DAPI-stained
nuclei on the same area of the coverslip. Error bars are SEM (n  3).
GS expression is downregulated within 14 days in vitro, whereas
vimentin expression is stable and underlines the increasing purity of
RMG in vitro over time. (B) Isolated RMG 2 h after papain digestion
cytospinned on glass coverslips and labeled with anti-vimentin anti-
bodies. RMG cells were identiﬁed by their characteristic elongated
morphology. 400. [Color ﬁgure can be viewed in the online issue,
which is available at www.interscience.wiley.com].
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from the retina through papain digestion. However, 2 h
after digestion, at the time point when day 0 samples
were prepared, RMG still showed distinct morphologi-
cal features, such as an elongated cell body with a
centrally located nucleus (Figs. 1B, 3A,B). After 3 days
in culture most of the adherent cells showed a round
shape morphology (Fig. 2). No signiﬁcant changes be-
tween the 2-DE protein patterns of day 3 and day 0
were detected (Fig. 4). After 8 days in vitro, cells con-
verted into larger, spindle-shaped, ﬂat cells resembling
cultured ﬁbroblasts. Along with these morphological
changes, the most prominent alterations in the spot
pattern of the respective 2-DE gels were observed (Fig.
4). Based on morphology and the 2-DE protein pattern
these cultured cells remained unchanged from day 8 to
day 14 and day 23 (passage 1 cells) (Figs. 3 and 4).
Changes in Protein Pattern Are Fundamental
Within the First 2 Weeks in Cell Culture
The 2-DE protein pattern of RMG lysates after 3, 8,
14, and 23 days in vitro was monitored and compared
to that of freshly isolated cells (day 0). The proteome
pattern changes are fundamental and the most prom-
inent changes occurred between days 3 and 8 in culture
(Fig. 4).
In an attempt to quantify changes in the proteome
pattern, virtual average gels were created from three
gels at each experimental time point, using Proteom
Weaver software default settings (for details, see Ma-
terials and Methods). At days 0 and 14, the program
detected 1,300 and 1,900 spots, respectively, from the
average gels. These spots were sorted by intensity in
the average gel at day 0 (deﬁned by an internal algo-
rithm of the software). The 300 most intensive spots
were further analyzed, results showed that 29% of
these spots (87 of 300) were absent on the average gel
at day 14. Further, 25% of the proteins (75 of 300) at
day 0 were downregulated more than two-fold, and
40.7% (122 of 300) of the spots were up- or downregu-
lated at 2- to 0.5-fold and were therefore regarded as
slightly or unchanged. In summary, 54% of the 300
most intensive spots at day 0 were downregulated by
more than two-fold during the ﬁrst 2 weeks in culture.
In contrast, 5.3% of the spots (16 of 300) were upregu-
Fig. 2. Morphological changes of retinal Mu¨ller glia cells (RMG)
during culture. RMG were cytospinned (day 0) or grown (days 3, 8,
and 14) on glass coverslips, labeled with anti-vimentin or anti-glu-
tamine synthetase antibodies. Nuclei were stained with DAPI. RMG
show morphological changes in adaption to in vitro conditions and by
entering mitotic cycles. Labeled cells on left side; nuclei of the same
ﬁeld on right side. 200. [Color ﬁgure can be viewed in the online
issue, which is available at www.interscience.wiley.com].
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lated more than twofold on the average gel at day 14
compared to the average gel at day 0.
Mass Spectrometry Identiﬁcations Reveal
Downregulation of Proteins Participating in
Mu¨ller Cell-Speciﬁc Function
After comparison of the RMG protein patterns from
days 0 and 14, spots that were only present in day 0
gels, spots which were unchanged and spots only
present or strongly upregulated at day 14 gels (Fig.
5A,B) were excised out of the gels. The proteins were
subjected to tryptic digestion, peptide mass ﬁngerprint
spectra were recorded on a MALDI-TOF mass spec-
trometer and were then identiﬁed by comparison with
public databases (for details, see Materials and
Methods).
Strongly downregulated proteins sampled at day 0
included enzymes involved in glycolysis (-enolase,
fructose-bisphosphate aldolase C, GAPDH, LDH-B,
6-phosphofructokinase, and phosphoglycerate kinase)
and energy metabolism (aconitate hydratase, aldehyde
dehydrogenase, creatine kinase, malate dehydroge-
nase, phosphoglucomutase, pyruvate carboxylase, and
transketolase) (Fig. 5A and Tables 1 and 2).
Also downregulated were proteins involved in visual
pigment recycling (CRALBP) and enzymes involved in
detoxiﬁcation processes (glutathione S-transferase,
peroxiredoxin 2, PHGPX nonselenium, and superoxide
dismutase). Proteins involved in the phototransduction
process (S-arrestin, phosducin, and recoverin) are
found on the 2-DE gels of day 0 RMG and are derived
most likely from contamination of these samples with
photoreceptors. Glutamine synthetase (GS), the main
enzyme for transmitter recycling in the RMG, was com-
pletely downregulated and disappeared after 8 days in
vitro. Experiments with 35S-pulse labeling on day 3 in
vitro showed that even at this early time point no GS de
novo synthesis could be detected (data not shown).
Carbonic anhydrase II, the enzyme involved in CO2
siphoning in vivo was also completely suppressed in
culture; similarly, an enzyme from the amino acid me-
tabolism (glutamate dehydrogenase) was also down-
regulated.
At day 0, strong expression of glial ﬁbrillary acidic
protein (GFAP) was found. As GFAP upregulation has
been reported in response to many retinal diseases and
injuries (Bignami and Dahl, 1979; Wen et al., 1995),
the observed level of GFAP expression at day 0 may, at
least in part, also reﬂect the impact of injury from
tissue disruption. With advancing time in culture,
GFAP was downregulated, whereas other cytoskeleton
proteins, such as vimentin, coﬁlin, and gelsolin, re-
mained unchanged. Another group of 10 cytoskeleton
proteins was found to be strongly upregulated during
culture (actin, actin-like protein 3, -actinin 1, -acti-
nin 4, annexin II, L -caldesmon, HSP27, T-plastin, vin-
culin, and WD repeat protein 1) (Tables 1 and 2 and
Fig.5B).
Other proteins involved in signaling processes were
either downregulated (ERK2, 1433 epsilon, CRABPI,
BFABP), upregulated (adenylyl cyclase-associated pro-
tein 1, LASP1, EFABP), or unchanged (rab GDP disso-
ciation inhibitor, DJ1).
Several molecular chaperones could be also identi-
ﬁed (endoplasmin, HSP70-2, Hsp60, Hsc73), but no
changes in expression were noted. Two proteins in-
volved in Ca2 binding were found to be upregulated
(calumenin and annexin V) and two unchanged (an-
nexin VI and calreticulin).
Lastly, other identiﬁed, downregulated proteins
were reticulocalbin, DPY2, hemoglobin -chain and
DDH2; unchanged were esterase D, protein disulﬁde
isomerase, S-adenosylhomocystein hydrolase, and TER
ATPase; upregulated proteins were elongation factor 2,
major vault protein, ubiquitin hydrolase L1, ALG2 in-
teracting protein, and translationally controlled tumor
protein 23 (Tables 1 and 2 and Fig. 5).
DISCUSSION
Primary cells or cells derived from primary tissue are
increasingly being used as replacement for intact, or-
ganotypic tissues. In addition, they often represent the
only possible means of deﬁning speciﬁc functions at-
tributed to a speciﬁc cell within a complex tissue of
cellular heterogeneity. Although this bares great po-
tential, a major question lies in how well cultured cells
represent a given cell in a given intact tissue. Here, a
caveat lies in their natural plasticity in response to
such stimuli as addition of culture medium, gas con-
centrations and serum factors, as well as removal of
Fig. 3. Changes of retinal Mu¨ller glia cells (RMG) morphology, in
detail. Examples of labeled RMG A, C, anti-vimentin; B, D, and
anti-glutamine synthetase (GS) at days 0 (A,B) and 14 (C,D) at higher
magniﬁcation. At day 14 in culture, several strongly GS-positive cells
are still visible (D).  600. [Color ﬁgure can be viewed in the online
issue, which is available at www.interscience.wiley.com].
256 HAUCK ET AL.
PAPER 1 79
natural stimuli provided by the organ context into
which they are naturally embedded. It has been previ-
ously shown that avian RMG are even able to trans-
form into phenotypic lens cells upon disruption from
the intact retina (Moscona et al., 1983).
Although we took great care to isolate RMG at the
highest degree of purity, we retain an initial contami-
nation of these isolates by retinal neurons. In fact, this
most likely reﬂects the tight initial interconnection
between RMG and retinal neurons. In consequence,
proteins known to be expressed in retinal neurons,
most notably proteins involved in phototransduction
appear as protein spots on the 2-DE gels of RMG days
0 and 3.
Phenotypic Characterization of RMG
In vascularized retinae, two types of macroglial cells
are found: RMG and astrocytes (for review, see Will-
bold and Layer, 1998). These two cell types are poten-
tially able to grow under in vitro conditions following
cultivation of dissociated porcine retinal cells. There-
fore, the ability to differentiate between RMC and as-
trocytes in primary cultures is of great importance. GS,
a candidate marker for RMG is found expressed only in
cat retina RMG (Lewis et al., 1988) but in rat retina,
GS was noted in RMG and astrocytes (Derouiche and
Rauen, 1995). For CRALBP, another candidate RMG
marker, no expression proﬁling in porcine retina exists
and it has been reported to be transiently expressed in
developing mouse retinal astrocytes (P.T. Johnson et
al., 1997). Given the lack of information on the anti-
genic differences between astrocytes and RMG in pig
retina, we decided to base the identiﬁcation of RMG
following papain digestion on their morphological fea-
tures. In contrast to astrocytes, RMG have long cell
bodies with a centrally localized nucleus (Guidry, 1996;
Sarthy and Bunt, 1982); these features can still be
found about 1 h after papain digestion. We were thus
able to identify most (87.5% 1.3%) vimentin-positive
cells as morphologically distinct RMG when analyzed
on a coverslip of a cytospinned fraction subsequent to
Percoll enrichment. Cells not clearly displaying these
Fig. 4. Changes of the protein pattern of retinal Mu¨ller glia cells
(RMG) with time in vitro. Images of two-dimensional electrophoresis
(2-DE) gels of RMG protein extracts prepared directly after RMG
preparation (day 0) or after different timepoints in vitro, as indicated
above the gel images. 2-DE was performed on precast IPG strips, pH
3.5–10 NL, with 100 g protein load and focused for a total of 120 kV/h
to equilibrium; the strips were loaded on 9–16% polyacrylamide gel
electrophoresis (PAGE), and proteins were separated due to their
molecular weight at a constant 10 mA overnight. Gels were silver
stained and dried. Each image is an average from two real gel images,
which were merged into a raw master gel with Z3 software (Compu-
gen). The main changes in protein pattern occur at 3–8 days in vitro,
whereas during the ﬁrst 3 days the protein expression remains rela-
tively stable. The expression pattern at days 14 and 23 passage 1 cells
does not differ. Glutamine synthetase (GS) spots are boxed and en-
larged in day 0 and day 3 gels. Corresponding boxes indicated at days
8, 14, and 23 passage 1 gel display the similar position, but GS spots
are no longer present.
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Fig. 5. Mass spectrometric protein identiﬁcation. (A) Two-dimen-
sional electrophoresis (2-DE) of retinal Mu¨ller glia cells (RMG) gel at
day 0. The protein spots that are downregulated in vitro are circled,
with their respective identiﬁcation. (B) 2-DE RMG gel at day 14.
Identiﬁcation of protein spots that are upregulated in vitro indicated
in roman type; identiﬁcation of protein spots that are unchanged in
vitro indicated italics.
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morphological features were regarded as potential as-
trocytes, although it may have been likely that these
cells were either already completely rounded up or
unfavorably plated on the coverslip due to sheer forces
from the cytospin procedure.
Changes in RMG-Speciﬁc Protein Proﬁles
Our results show that several distinct interrelated
functional groups of proteins attributable to speciﬁc
functions of RMG demonstrated shifts in expression
patterns. These alterations in proteomes suggest that
in addition to the known interrelation of single pro-
teins, at the level of functional protein networks, there
is co-regulation of functionally interrelated proteins in
RMG at the level of protein expression. At least six sets
of markedly distinct RMG marker proteins shift in
expression with prolonged culture conditions:
1. Enzymes involved in glycolysis and energy metabo-
lism are downregulated during culture: This may be
a consequence of the unlimited supply of nutrients
in the culture medium. In vivo RMG are the princi-
pal storage site for retinal glycogen (Kuwabara and
Cogan, 1961) and metabolize glucose to lactose that
is subsequently taken up by photoreceptors to fuel
their oxidative metabolism (Poitry-Yamate et al.,
1995). Since glycolysis in RMG is activated upon
NH4-release by photoreceoptors (Tsacopoulos et al.,
1997), the downregulated expression of glycolytic
enzymes may be linked to the loss of close contact to
photoreceptors.
2. GS expression is reduced after only 8 days: In vivo
RMG regulate extracellular transmitter levels in
the retina. This uptake is essential for terminating
synaptic transmission, as well as preventing the
spread of transmitters away from the synaptic cleft
(E. Newman and Reichenbach, 1996). We did not
TABLE 1. Functional Grouping of RMG Proteins Regulated upon Adaption to In Vitro Conditions
Downregulated Unchanged Upregulated
Glycolysis -Enolase Phosphoglycerate mutase
Fructose-bisphosphate aldolase C Triosphosphate isomerase
GAPDH
LDH-B
6-Phosphofructokinase
Phosphoglycerate kinase
Energy metabolism Aconitate hydratase Glucosidase II
Aldehyde dehydrogenase
Creatine kinase
Malate dehydrogenase
Phosphoglucomutase
Pyruvate carboxylase
Transketolase
Visual pigment recycling CRALBP
Detoxiﬁcation Glutathione S-transferase P
Peroxiredoxin 2
PHGPX non-selenium
Superoxide dismutase
Transmitter recycling Glutamine synthetase
CO2 siphoning Carbonic anhydrase II
Amino acid metabolism Glutamate dehydrogenase
Cytoskeleton GFAP Coﬁlin Actin
Gelsolin Actin-like protein 3
Vimentin -Actinin 1
-Actinin 4
Annexin II
L-Caldesmon
HSP27
T-Plastin
Vinculin
WD-repeat protein 1
Chaperone Endoplasmin
Hsc73
Hsp60
Hsp70-2
Signaling 14-3-3 epsilon Rab GDP dissociation inhibitor Adenylyl cyclase-associated protein 1
CRABP-1 (RET3) DJ1 LASP-1
B-FABP E-FABP
ERK-2
RKIP
Ca2 -binding Annexin IV Annexin V
Calreticulin Calumenin
Miscellaneous DDH2 S-Adenosylhomocysteine
hydrolase
ALG-2 interacting protein
DPY2 Esterase D Elongation factor 2
Hemoglobin -chain Protein disulﬁde isomerase A3 Major vault protein
Reticulocalbin TER ATPase Translationally controlled tumor
protein 23
Ubiquitin hydrolase L1
RMG, retinal Mu¨ller glia; CRALBP, cellular retinaldehyde-binding protein; GFAP, glial ﬁbrillary acidic protein.
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TABLE 2. Proteins From RMG Identiﬁed by Searching Peptide Mass Fingerprint Spectra in Publicly Available Databases
Top
MOWSE
score
Swissprot entry
name
SwissProt/
Trembl
accession
no. Protein name Organism
Mr
(dalton)
Sequ.
cov.
(%) pI
196 143E_HUMAN P42655 14-3-3 protein epsilon Homo sapiens 29,174 52 4.63
95 RSP4_CRIGR P38982 40S ribosomal protein SA (P40) (34/67-kDa laminin receptor) Cricetulus gris 32,881 46 4.84
132 K6PF_CANFA P5274 6-Phosphofructokinase (EC 2.7.1.11) Canis familiaris 86,231 26 8.36
92 ACON_BOVIN P20004 Aconitate hydratase, mitochondrial (EC 4.2.1.3) Bos taurus 85,357 20 8.08
172 ACON_PIG P16276 Aconitate hydratase, mitochondrial (EC 4.2.1.3) Sus scrofa 83,197 30 7.42
181 ACT2_XENLA P12557 Actin, -sarcomeric/cardiac (2) Xenopus laevis 41,989 51 5.22
199 ARP3_HUMAN P32391 Actin-like protein 3 (actin-related protein 3) (actin-2) Homo sapiens 47,371 47 5.61
93 CAP1_RAT Q08163 Adenylyl cyclase-associated protein 1 (CAP 1) Rattus norveg. 51,547 29 7.16
114 DHAM_BOVIN P20000 Aldehyde dehydrogenase, mitochondrial precursor (EC
1.2.1.3)
Bos taurus 57,129 28 7.55
104 Q9UKL5 ALG-2 interacting protein 1 Homo sapiens 96,079 18 6.13
141 ENOA_HUMAN P06733 -enolase (EC 4.2.1.11) Homo sapiens 47,350 39 6.99
238 AACT_HUMAN P12814 -actinin 1 (actinin cytoskeletal isoform) Homo sapiens 102,974 31 5.22
266 AAC4_MOUSE P57780 -actinin 4 (F-actin cross- linking protein) Mus musculus 104,976 36 5.24
98 ACY1_PIG P37111 Amihoacylase-1 (EC 3.5.1.14) (ACY-1). Sus scrofa 45,216 31 5.61
291 ANX2_BOVIN P04272 Annexin II (Lipocortin II) (Calpactin I heavy chain) Bos taurus 38,742 62 6.9
245 ANX5_HUMAN P08758 Annexin V (Lipocortin V) (Endonexin II) Homo sapiens 35,805 63 4.94
131 ANX6_BOVIN P79134 Annexin VI Bos taurus 34,230 14 5.4
154 CRTC_RAT P18418 Calreticulin precursor (ERp60) Rattus norveg 48,137 28 4.33
226 CRTC_RABIT P15253 Calreticulin precursor (ERp60) Oryctolag. cuni. 48,275 45 4.33
162 CALU_HUMAN O43852 Calumenin precursor Homo sapiens 37,198 41 4.47
CAH2_HUMANa P00918 Carbonic anhydrase II (EC 4.2.1.1) (carbonate dehydratase II) Homo sapiens 29,115 6.86
78 CRAL_MOUSE Q9Z275 Cellular retinaldehyde-binding protein CRALBP Mus musculus 36,277 19 4.98
87 CLI1_HUMAN O00299 Chloride intracellular channel protein 1 Homo sapiens 26,922 37 5.09
220 COF1_PIG P10668 Coﬁlin, nonmuscle isoform Sus scrofa 18,518 67 8.16
160 KCRB_CANFA P05124 Creatine kinase, B chain (EC 2.7.3.2) (B-CK) Canis familiaris 42,960 43 5.47
155 DPY2_BOVIN O02675 Dihydropyrimidinase-related protein-2 (DRP-2) Bos taurus 62,277 44 5.95
194 DPY2_RAT P47942 Dihydropyrimidinase-related protein-2 (DRP-2) Rattus norveg. 62,277 61 5.95
82 Q99497 DJ-I protein Homo sapiens 20,063 30 6.33
154 EF2_HUMAN P13639 Elongation factor 2 (EF-2) Homo sapiens 95,207 27 6.41
129 ENPL_CANFA P41148 Endoplasmin precursor (94-kDa glucose-regulated protein) Canis familiaris 92,513 23 4.74
74 Q9GJT2 Esterase D Sus scrofa 31,975 18 6.54
218 IF41_RABIT P29562 Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) Oryctolag. cuni. 44,818 42 5.32
81 FABB_HUMAN O15540 Fatty acid-binding protein, brain (B-FABP) Homo sapiens 14,862 47 5.41
68 FABE_BOVIN P55052 Fatty acid-binding protein, epidermal Bos taurus 15,350 29 7.57
94 ALFC_RAT P09117 Fructose-bisphosphate aldolase C (EC 4.1.2.13) Rattus norveg. 39,152 47 6.67
158 ALFC_HUMAN P09972 Fructose-bisphosphate aldolase C (EC 4.1.2.13) Homo sapiens 39,324 46 6.46
147 GELS_PIG P20305 Gelsolin precursor, plasma (actin-depolymerizing factor) Sus scrofa 84,775 28 5.93
201 GFAP_HUMAN P14136 Glial ﬁbrillary acidic protein, astrocyte (GFAP) Homo sapiens 49,880 41 5.42
159 P79403 Glucosidase II Sus scrofa 106,661 15 5.64
248 DHE3_MOUSE P26443 Glutamate dehydrogenase (EC 1.4.1.3) (GDH) Mus musculus 61,336 51 8.05
117 DHE3_BOVIN P00366 Glutamate dehydrogenase (EC 1.4.1.3) (GDH) Bos taurus 55,561 24 8.66
172 GLNA_PIG P46410 Glutamine synthetase (EC 6.3.1.2) (glutamate-ammonia
ligase)
Sus scrofa 42,030 37 6.28
143 GTP_PIG P80031 Glutathione S-transferase P (EC 2.5.1.18) (GST P1-1) Sus scrofa 23,497 50 8.07
185 G3P_PIG P00355 Glyceraldehyde 3-phosphate dehydrogenase (EC 1.2.1.12) Sus scrofa 35,705 32 6.9
103 HS27_CANFA P42929 Heat-shock 27-kDa protein HSP 27 Canis familiaris 22,939 30 6.23
145 HS72_BOVIN Q27965 Heat-shock 70-kDa protein 2 (HSP70-2) Bos taurus 70,228 27 5.68
257 HS7C_MOUSE P08109 Heat-shock cognate 71-kDa protein HSC73 Mus musculus 70,871 43 5.37
224 HS7C_HUMAN P11142 Heat-shock cognate 71-kDa protein Homo sapiens 70,898 43 5.37
176 HBB_PIG P02067 Hemoglobin chain Sus scrofa 16,034 92 6.76
82 CH60_CRIGR P18687 Hsp60 60 kDa heat-shock protein (Hsp60) Cricetulus gris 60,988 23 5.91
161 Q99MZ8 LASP-1 Rattus norveg 29,970 46 6.61
169 Q28708 L-Caldesmon Oryctolag. cuni. 61,482 20 8.44
144 LDHB_PIG P00336 L-Lactate dehydrogenase B chain (EC 1.1.1.27) Sus scrofa 36,481 42 5.57
111 MVP_HUMAN Q14764 Major vault protein (MVP) (lung resistance-related protein) Homo sapiens 99,327 24 5.34
131 MDHC_PIG P11708 Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) Sus scrofa 36,323 31 6.15
108 MK01_BOVIN P46196 Mitogen-activated protein kinase 1 (EC 2.7.1.-) (ERK-2) Bos taurus 41,375 35 6.5
72 DDH2_HUMAN O95865 NG,NG-dimethylarginine dimethylaminohydrol.2 (EC
3.5.3.18)
Homo sapiens 29,644 23 5.66
240 Q9TSX9 Nonselen. glutat.phospholip.hydroperox.peroxidase (PHGPx) Sus scrofa 25,037 80 5.73
102 PDX2_PIG P52552 Peroxiredoxin 2 (EC 1.11.1.-) (thioredoxin peroxidase 1) Sus scrofa 14,163 42 4.7
71 PHOS_BOVIN P19632 Phosducin Bos taurus 28,231 24 4.92
116 PEBP_HUMAN P30086 Phosphatidylethanolamine-binding protein RKIP Homo sapiens 20,925 49 7.42
123 PGMU_MOUSE Q9D0F9 Phosphoglucomutase (EC 5.4.2.2) (PGM) Mus musculus 61,386 30 6.32
148 PGK_HORSE P00559 Phosphoglycerate kinase (EC 2.7.2.3) Equus caballus 44,842 51 8.64
184 PMG1_HUMAN P18669 Phosphoglycerate mutase 1 (EC 5.4.2.1)(EC 3.1.3.13)PGAM-B Homo sapiens 28,672 80 6.75
224 PDA3_HUMAN P30101 Protein disulﬁde isomerase A3 (EC 5.3.4.1) ERp60 Homo sapiens 56,782 35 6.1
144 PYC_RAT P52873 Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) Rattus norveg 129,689 29 6.25
122 GDIB_MOUSE P50397 Rab GDP dissociation inhibitor  (Rab GDI ) (GDI-2) Mus musculus 50,512 35 6.02
93 RECO_BOVIN P21457 Recoverin (P26) Bos taurus 23,202 30 5.32
80 RCN1_MOUSE Q05186 Reticulocalbin 1 Mus musculus 38,090 30 4.7
194 RET3_HUMAN P29762 Retinoic acid-binding protein I, cellular (CRABP-I) Homo sapiens 15,434 77 5.3
131 GDIR_BOVIN P19803 Rho GDP-dissociation inhibitor 1 (Rho GDI 1) Bos taurus 23,421 58 5.12
135 CAD19504 S-adenosylhomocysteine hydrolase (EC 3.3.1.1) Sus scrofa 48,176 32 6.08
119 ARRS_PIG P79260 S-arrestin (retinol S-antigen) (48-kDa protein) (S-AG) Sus scrofa 45,102 37 5.58
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identify the main transporter for glutamate uptake
in RMG (GLAST), most likely because membrane
proteins are underrepresented on 2-DE gels. Since
GS and GLAST have been shown to be functionally
linked and their regulation synchronized (Rauen
and Wiessner, 2000), the transporter may thus be
downregulated as well. Heidinger et al. (1999) were
able to show that cocultivation of RMG and retinal
neurons resulted in a three-fold higher GS activa-
tion upon glutamate treatment than did cultivation
of RMG alone. Therefore, the cocultivation of RMG
with retinal neurons appear necessary and essential
to yield high GS expression levels in vitro, which
would suggest that together with other factors, the
intimate interconnection between glia and neuron
ensures functional differentiation. Limb et al. (2002)
recently described a spontaneously immortalized
human RMG cell line (MIO-M1) that stably retains
high GS and CRALBP levels in vitro. This cell line
may represent a more appropriate model to in vivo
RMG than 2-week-old primary RMG itself, given
that the expression of these markers for RMG dif-
ferentiation would reﬂect a more general mainte-
nance of the differentiated phenotype. We are cur-
rently investigating the protein expression pattern
of this cell line by 2-DE gels and will conduct a
detailed comparison to freshly prepared primary
RMG.
3. Proteins related to phototransduction disappear:
This in vitro downregulation of both GS and
CRALBP has been observed (P.J. Linser and
Moscona, 1981; Guidry, 1996; Germer et al., 1997;
Winkler et al., 2000). In the present study, the loss
of CRALBP, involved in the visual pigment cycle,
might reﬂect the interrupted phototransduction cy-
cle and might be accompanied by a downregulation
of the corresponding transporters within the cell
membrane. It is worthwhile to mention that down-
regulation of GS, CRALBP, and CAII is character-
istic during gliotic processes in the retina, especially
in complement to proliferative retinopathy (PVR)
(Lewis et al., 1989, 1994). S-arrestin, phosducin, and
recoverin are found here in freshly isolated RMG.
Their appearance on 2-DE gels at days 0 and 3 most
likely stems from contamination of the enriched
RMG preparations with photoreceptors, but it could
also be derived from endocytosized photoreceptor
fragments. However, it cannot be ruled out that
RMG express very minute levels of these proteins as
well. As already mentioned, a proportion of contam-
inating cells on days 0 and 3 (24.3% and 18.2%,
respectively) exists, which may include photorecep-
tors. After 8 days, the cultures contain only 3.4%
vimentin-negative cells, but the 2-DE gels nonethe-
less show weaker s-arrestin and phosducin spots
and a more prominent recoverin spot; these spots
were absent after 2 weeks in culture.
4. All enzymes responsible for detoxiﬁcation processes
in vivo appear completely downregulated after 2
weeks in culture: Since glutamate is the rate-limit-
ing substance in glutathione synthesis (Huster et
al., 1998), in vitro conditions lacking glutamate may
lead to downregulation of glutathione-producing en-
zymes and thus to low glutathione levels. Lacking
its substrate, this may consequently lead to down-
regulation of glutathione S-transferase expression.
Downregulation of the antioxidant enzymes super-
oxide dismutase, PHGPX and thioredoxin peroxi-
dase underlying the deactivation of reactive oxygen
species in vivo may result from the loss of light-
induced radical production.
5. Pattern shifts of proteins related to proliferative sig-
naling appear inconclusive with respect to the over-
all changes seen after prolonged culture: However,
Raf kinase inhibitor protein (RKIP), a suppressor of
Raf kinase activity, and mitogen-activated kinase
(MAPK) signaling (Yeung et al., 1999), are strongly
downregulated. RKIP is highly expressed in differ-
entiated resting cells and is almost absent in highly
proliferating cells and certain tumors (W. Kolch,
personal communication). The MAPK pathway is a
major route in the transduction of mitogen triggered
signals into the nucleus. Disinhibition by RKIP
downregulation after 3 days most likely liberates
TABLE 2. (continued).
Top
MOWSE
score
Swissprot entry
name
SwissProt/
Trembl
accession
no. Protein name Organism
Mr
(dalton)
Sequ.
cov.
(%) pI
163 GDIR_BOVIN P38647 Stress-70 protein, mitochondrial GRP 75 (mortalin) Mus musculus 73,528 29 5.81
123 SODC_PIG p04178 Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) Sus scrofa 15,922 61 6.04
139 S31765 T-plastin (fragment) Rattus norveg 70,773 31 5.42
192 PLST_HUMAN P13797 T-plastin Homo sapiens 70,435 29 5.52
117 AAB02844 T-plastin Homo sapiens 64,281 22 5.73
214 TERA_PIG P03974 Transitional endoplasmic reticulum ATPase (TER ATPase) Sus scrofa 89,288 34 5.13
93 TKT_RAT P501137 Transketolase (EC 2.2.1.1) Rattus norveg 67,643 20 7.23
99 TCTP_HUMAN P43348 Translationally controlled tumor protein p23 Homo sapiens 19,697 56 4.84
147 TPIS_MOUSE P17751 Triosephosphate isomerase (EC 5.3.1.1) (TIM) Mus musculus 26,581 65 7.08
122 UBL1_HORSE Q9GM50 Ubiquitin C-terminal hydrolase isoz.L1 EC 3.4.19.12 Equus caballus 25,245 48 5.14
141 VIME_CRIGR P48670 Vimentin (fragment) Cricetulus gris 51,848 31 4.94
149 Q8WMK3 Vinculin Sus scrofa 116,876 22 5.89
152 WDR1_HUMAN O75083 WD-repeat protein 1 (actin interacting protein 1) (NORI-1) Homo sapiens 66,193 28 6.11
RMG, retinal Mu¨ller glia
aIdentiﬁcation by sequencing the peptide VDVLDSIK in a micromass Q-TOF mass spectrometer.
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this pathway in RMG for responding to serum fac-
tors. Indeed, this observation correlates with the
onset of RMG proliferation in culture at this time
point. Suppression of RKIP expression may be
therefore a prerequisite for RMG proliferation onset
in culture, whereas its expression may partly ex-
plain the absence of RMG proliferation in vivo, even
when mitogens such as ﬁbroblast growth factors are
present.
6. Expression of proteins related to cytoskeletal reorga-
nization and dynamics increase with prolonged cul-
turing: Upon adaptation to cell culture, RMG begin
to express vinculin, actin-related protein 3, and
-actinin 1 and 4. These are major components of
focal adhesion complexes (FA), which are special-
ized extracellular matrix attachment and signaling
organelles, located along the ventral plasma mem-
brane of adherent cultured cells. Here, they are
linked to the actin cytoskeleton via a web of mem-
brane-associated anchor proteins (for review, see
Zamir and Geiger, 2001). Vinculin, a key anchor
protein, is able to cross-link F-actin with talin (R.P.
Johnson and Craig, 1994; Huttelmaier et al., 1997))
upon activation by phosphatidylinositol 4,5-bisphos-
phate (Gilmore and Burridge, 1996), and talin docks
onto membrane-spanning integrin receptors during
this process (Janmey, 1994; Martel et al., 2001). FA
are prerequisites for establishing cell contacts, ad-
hesion to extracellular matrix, morphological
changes, and migration. Furthermore, they promote
survival signals through activation of protein kinase
B (Frisch et al., 1996; Khwaja et al., 1997), and cell
proliferation signals through the activation of ras
(Assoian and Schwartz, 2001; Schwartz and As-
soian, 2001). The upregulation of vinculin in RMG
can thus be linked to proliferation and the ability of
RMG to migrate. Actin-related protein 3 is one of
seven proteins forming the Arp2/3 complex, which
nucleates actin polymerization and thus drives
membrane protrusion. Recently the presence of a
transient interaction between the Arp2/3 complex
with vinculin has been shown, which is stimulated
by matrix adhesion and by growth factor treatment
(DeMali et al., 2002). The reported upregulation of
actin-related protein 3 in RMG in vitro thus corre-
lates with the already known increase of the ability
of RMG to generate tractional forces during dedif-
ferentiation in culture (Guidry, 1997). This ﬁnding
is in agreement with the premise that dedifferenti-
ated RMG, together with RPE cells (Campochiaro,
1997; Francke et al., 2001), may participate in pro-
liferative vitreal retinopathy (PVR), the most com-
mon complication following surgical treatment of
rhegmatogeneous retinal detachment. In a parallel
study from our laboratory, the effects of culture on
proteomic changes in primary RPE cells were inves-
tigated. Here we found an upregulation of proteins
related to cytoskeletal organization, cell shape, mo-
tility, and mediation of proliferative signal trans-
duction (Alge et al., in press). In comparison to RMG
cells in the present study, RPE cells do, however,
appear to retain much more of their initial expres-
sion proﬁle.
In summary, RMG lose their differentiated protein
proﬁle when cultured. In contrast, as some RMG mark-
ers such as vimentin do not change their expression
level in vitro (Guidry, 1996), cultured primary RMG
are generally considered appropriate for the study of
RMG physiology in vitro. However, our results show,
that this must be restricted to very early stage RMG
cultures. The profound proteomic changes occurring
after 3 days within the ﬁrst 2 weeks in vitro indicate
that RMG adaptation to culture conditions results in a
transformation from a highly differentiated RMG phe-
notype to a much less differentiated ﬁbroblast-like cell
type. Moreover, additional studies are under way to
determine how the differentiated RMG phenotype may
be maintained by designing culturing conditions that
more closely mimic an in vivo environment.
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Abstract 
Apoptotic cell death of photoreceptors is the final event leading to blindness in the 
heterogeneous group of inherited retinal degenerations. GDNF was found to rescue 
photoreceptor function and survival very effectively in an animal model of retinal 
degeneration (15). However, the cellular mechanism of GDNF action remained unresolved. 
We show here that in porcine retina, GDNF receptors GFRα-1 and RET are expressed on 
retinal Mueller glial cells (RMG) but not on photoreceptors. Additionally, RMG express the 
receptors for the GFL-family members Artemin and Neurturin (GFRα-2 and GFRα-3). We 
further investigated GDNF-, Artemin- and Neurturin-induced signalling in isolated primary 
RMG and demonstrate three intracellular cascades, which are activated in vitro: MEK/ERK, 
SAPK and PKB/AKT pathways with different kinetics in dependence of stimulating GFL. We 
correlate the findings to intact porcine retina, where GDNF induces phosphorylation of ERK 
in perinuclear region of RMG located in the inner nuclear layer. GDNF signalling resulted in 
transcriptional upregulation of bFGF, which in turn was found to support photoreceptor 
survival in an in vitro assay. We provide here a detailed model for GDNF-induced signalling 
in mammalian retina and propose that the GDNF-induced rescue effect on mutated 
photoreceptors is an indirect effect mediated by retinal Mueller glial cells. 
PAPER 2   
 
89
Introduction 
A major cause of blindness in the western world is the degeneration of photoreceptors (PR) as 
a result of point mutations in genes coding for either phototransduction-related proteins or 
other proteins important for retinal function (reviewed in 22). Irrespective of the diversity of 
mutated genes and proteins involved in this heterogeneous group of progressive retinal 
dystrophies with homologous phenotypes, the final event leading to blindness is apoptosis of 
PR. This has prompted investigation on the effects of neuroprotective agents on PR survival 
in animal models of retinitis pigmentosa. One of the major effective molecules discovered to 
rescue retinal PR was glial cell line-derived neurotrophic factor (GDNF), initially purified 
from a rat glioma cell-line supernatant as a trophic factor for embryonic midbrain dopamine 
neurons (31) and later found to have pronounced effects on other neuronal subpopulations 
(reviewed in (1). GDNF is a distant member of the transforming growth factor (TGF)-ß 
superfamily and founder protein of the GDNF family ligand (GFL), which includes neurturin 
(NRTN), artemin (ARTN) and persephin (PSPN). GFLs bind specific GFRα1−4 co-receptors 
that are either linked to the plasma membrane by a glycosyl posphatidylinositol (GPI) anchor 
or, by cleavage through an unknown protease, provided as a soluble co-receptor. All four 
different GFLs (GDNF, NRTN, ARTN, PSPN) signal via the activation of the RET receptor 
tyrosine kinase, a single-pass transmembrane protein containing four cadherin-like repeats in 
the extracellular domain and a typical intracellular tyrosine kinase domain (reviewed in (1). 
GDNF is widely distributed in the central and peripheral nervous systems, and is also 
expressed in the inner ear, olfactory epithelium, carotid body, kidney and gastrointestinal tract 
(35). In the eye, GDNF is primarily expressed in the retina and several investigators have 
shown its potential therapeutic value by providing neuroprotection in the context of retinal 
degeneration. GDNF has been shown to rescue retinal ganglion cells after axotomy (25, 46) 
and proven to be very effective in retarding retinal PR degeneration in the rd1-mouse (15). 
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Subretinal application of GDNF has led to decreased loss of PR, as well as a significant 
functional rescue, shown by recordable ERG on PN22 compared to untreated animals. 
Recent evidence has proposed that neurotrophic rescue of PR may be indirect, mediated by 
interaction of neurotrophic factors with retinal Mueller glial cells (RMG), which in turn 
release or present secondary factors acting directly on PR (6, 39, 44, 45). Upon subretinal 
injection of GDNF in the rd1-mouse, RMG react by upregulation of glial fibrillary acidic 
protein, indicating that GDNF-induced regulation in RMG gene expression and subsequent 
effects on PR may be mediated through an indirect pathway.  
To elucidate the role of RMG in GDNF-mediated protection of PR, we analyzed expression 
and activity of transducer elements involved in GDNF signalling in porcine retina and further 
analyzed candidate target genes of GDNF signalling. 
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Materials and Methods 
Adult porcine eyes were provided by a local slaughterhouse. They were removed from the 
animals within 5 minutes after death and kept on ice in CO2-independent medium (GIBCO) 
until further use. Within one hour after the death of the animals, the eyes were either fixed for 
immunohistochemistry or retinae were dissected for preparation of RMG or PR. 
Immunohistochemistry 
Porcine eyes were fixed in 10% formalin. For adequate and fast fixation both cornea and lens 
were removed and the aqueous humor was replaced by fixative. After dehydration, the eyes 
were embedded in paraffin.  
Tissue sections (5 µm) were mounted on coated slides (Super Frost Plus), deparaffinized and 
rehydrated. High temperature antigen retrieval was performed using 1mM EDTA buffer pH 
8.0 as described (34). Slides were rinsed in phosphate buffered saline (PBS) with 0.1% 
Tween20 (PBS-T, pH 7.3) and nonspecific binding was blocked with 3% BSA in PBS-T. 
Sections were then incubated with primary antibodies (anti-RET, anti-GFRα-1, anti-GFRα-2, 
anti-GFRα-3, R&D, 1:200 in 3% BSA-PBS-T) overnight at 4°C in a humid chamber, 
followed by incubation with alexa546 donkey anti-goat IgG conjugate (Molecular Probes, 
1:200) and DAPI (Sigma, 4,6-diamidino-2-phenylindole, 200nM) for two hours at room 
temperature. After washing, sections were incubated for another 8 hours at 4°C with primary 
antibodies anti-glutamine-synthetase (Transduction Laboratories, 1:500) or anti-GLAST 
(Alpha Diagnostic, 1:200), followed by incubation for two hours with alexa488 anti-mouse or 
anti-rabbit IgG, respectively and, after final washing, mounted in FluorSave (Calbiochem). 
Images were obtained with a Zeiss APO-TOME. 
Immunohistochemistry on GDNF-stimulated retina sections 
Retinae were dissected from porcine eyes as described (14), cut into equal-sized pieces and 
placed into 12-well dishes containing DMEM/F12 medium (Gibco) at one piece per well. 
After an initial incubation phase (10 minutes), stimulation was performed with 100ng/ml 
GDNF (PeproTech) in DMEM/F12 or medium alone. After the indicated time points, the 
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medium was replaced by ice-cold paraformaldehyde (4% in PBS, 5% sucrose) and the tissue 
was fixed for one hour at 4°C. Cryopreservation was performed by incubation for one hour in 
each 5% and 10% sucrose in PBS, followed by incubation overnight in 20% sucrose in PBS, 
all at 4°C. The tissue samples were frozen in TissueTek on liquid nitrogen and stored at -
80°C. Tissue pieces were sectioned at 10µm a cryostat, collected on gelatin-coated super-frost 
slides and stored at -20°C. 
For immunohistochemical analysis sections were rinsed in PBS, incubated for 10 minutes in 
0,1% Triton-100 in PBS, followed by blocking for 30 minutes in 3% BSA in PBS-T. 
Incubation with primary antibodies (anti-pERK 1:250, Cell Signaling Technology or anti-GS 
1:500, BD Transduction Laboratories, diluted in 3%BSA-PBS-T) was done overnight at 4°C 
and then followed by incubation with alexa488/568-coupled secondary antibodies (1:200, 
Molecular Probes) for 2 hours at room temperature. After final washing, sections were 
mounted in FluorSave (Calbiochem) and images were obtained with a Zeiss AxioskopII. 
pERK-positive cells within the INL were counted on 2 visual fields (100x magnification) per 
section and 10 different sections per experiment; experiments were repeated twice. 
Statistic 
Statistical significance was calculated using the Peritz “f” parametric test (18). 
Isolation and in vitro culturing of primary RMG 
RMG were isolated from porcine eyes employing a panning method as described previously 
(19) and cultured in DMEM/HEPES (GIBCO) with 10% FCS to confluence (2-3 weeks). 
Purity of these cultures is above 97% (19). 
Stimulation of RMG and preparation of cell lysates 
One day prior to stimulation, RMG were washed, transferred into serum-free medium 
(DMEM/HEPES, Gibco) and stimulated with either GDNF (100ng/ml, PeproTech), NRTN 
(100ng/ml, PeproTech) or ARTN (100ng/ml, PeproTech) for the indicated time points. 
Inhibitors were applied 20 minutes at both prior to and during stimulation at the following 
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concentrations: U0126 (Promega) 10µM, LY294002 (Promega) 50µM. For phospho-tyrosine 
detection, stimulation was performed in the presence of phosphatase inhibitor cocktail 2 
(Sigma). Stimulation was stopped by addition of liquid nitrogen and lysates were then 
prepared by addition of 300 µl lysis buffer (50mM Tris pH 7.4, 250mM NaCl, 25mM EDTA, 
1% NP-40, 10% glycerol, phosphatase inhibitor cocktail 2 and Complete protease inhibitor 
cocktail, Roche) per 10cm dish. Protein content of the lysates was determined by Bradford 
assay. 
Photoreceptor preparation and survival assay 
Porcine PR were prepared as described elsewhere (14) with the slight modifications: 
enzymatic digestion of retinal pieces was stopped by addition of DMEM/F12 medium (Gibco) 
supplemented with 2% FCS. PR were collected from supernatant and plated at 1,3 x 105 cells 
per well onto pre-coated Falcon 96well plates that were first coated with p-lysine (Sigma, 
2µg/cm2, 3 hours) followed by laminin (BD Bioscience, 1µg/cm2, overnight). Different 
concentrations of bFGF (20ng/ml, 100ng/ml, 500ng/ml or 1000ng/ml; purified bFGF from 
bovine brain, R&D) or respective GFLs (GDNF, NRTN or ARTN, all 100ng/ml, PeproTech) 
in DMEM/F12 medium or medium alone were applied on attached PR 20 hours after 
preparation. PR survival was monitored by performing an esterase calcein-fluorophore assay 
(Molecular Probes), whereby living cells fluoresce bright green. Fluorescence was measured 
daily on a different row of the plate using a fluorescence reader (BioTek, Synergy HT). All 
values were compared to initial fluorescence at the beginning of the survival assays. Relative 
fluorescence was calculated as percent of initial fluorescence, whereby every value is a mean 
of two to four wells per day. Every experiment was performed at least in triplicate. 
 
Western blots 
Protein lysates (10µg) of RMG were resolved on 10% SDS-PAGE and blotted semidry onto 
PVDF membranes. Unspecific binding was blocked for one hour with 5% BSA in TBS-T. 
PAPER 2   
 
94
Blots were incubated with primary antibodies in 5% BSA-TBS-T overnight at 4°C (anti-
pTyr100 1:1000, anti-pMEK1/2 1:1000, anti-pERK 1:5000, anti-pSAPK 1:2000, or anti-
pAKT (Ser473) 1:1000; Cell Signaling Technology), washed and incubated in HRP-coupled 
secondary antibodies (Jackson Laboratories, 1:15000). Signal was developed with the ECL+ 
kit (Amersham) according to the manufacturer’s instructions and detected on Hyperfilm ECL 
(Amersham). Blots were stripped and reprobed with anti-actin (Oncogene, 1:1000) or anti-
vimentin (clone V9, Sigma, 1:1000) antibodies to verify equivalent protein loading. 
RT-PCR 
Total RNA was prepared from retina, RMG (either directly after panning procedure or from 
confluent cultures) or PR with RNeasy kit (Qiagen) according to the manufacturer’s 
instructions. Reverse transcription was performed with RT Kit (Qiagen) and 70ng cDNA were 
set for PCR (annealing at 65°C, 35 cycles) with the following primers: RET for: 
CTGGACTCCATGGAG AACC; RET rev: TCCAGGTCTTTGCTGATGTC; GFRα-1 for: 
TAAAGGAAAACTACGCTGACTGCC; GFRα-1 rev: TGCCCGACACATTGGATTTC; 
GFRα-2 for: TTT GTC GTG AGC TCT GTG AAG C; GFRα-2 rev: GCA TGA TTG GGT 
CCG AGA TAA C; GFRα-3 for: AGG AGC CTT CAG TCC CCA AG; GFRα-3 rev: TGA 
GGC AGC GAT CCC AAT C; GDNF for: CAG TGA CTC AAA TAT GCC AGA GGA; 
GDNF rev: AGA TAC ATC CAC ACC TTT TAG CGG; vimentin for: GTT TCC AAG CCT 
GAC CTC AC; vimentin rev: AAT CTC ATC CTG CAG GCG; rhodopsin for: 
GGCTTCCCCATCAACTTCCTC; rhodopsin rev: GTGGCTGACTCCTGCTGCTG. 
Products were of expected sizes and sequenced for identity verification. 
Nothern blot analysis 
One day prior to stimulation, RMG were washed, transferred into serum-free medium 
(DMEM/HEPES) and stimulated for 24 hours with GDNF (100ng/ml, PeproTech). Northern 
blotting was performed as described elsewhere (37). Briefly, total RNA was prepared with 
RNeasy-Kit (Qiagen), examination of integrity and quantification was performed with RNA-
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nano chip on a 2100 Bioanalyzer (Agilent). Equal amounts (5µg) were loaded onto 
formaldehyde gels, resolved and blotted. Detection of bFGF transcript was performed by 
generation of a bFGF-specific DIG-labeled RNA with DIG labeling Kit (Roche) using a RT-
PCR product generated from RMG with the following primers: bFGF for: 
CAAGCGGCTGTACTGCAAAAAC; bFGF T7 promoter rev: 
TAATACGACTCACTATAGGATGTGGCCATTAAAATCAGCTCTT. The detected 
transcript was approximately 6 kbp and thus similar in size to that of the full length human 
transcript (6.774 kbp, ENST00000264498, http://www.ensembl.org/). 
bFGF-ELISA 
RMG were seeded onto 96-well culture plates at 2 x 104 cells per well, incubated for 24 hours 
in DMEM/ 25 mM HEPES in the presence of 10% FCS and then, prior to stimulation, 
incubated for an additional 24 hours without FCS. RMG were then left either unstimulated or 
stimulated with GDNF, NRTN or ARTN (all 100ng/ml, PeproTech) in the absence or 
presence of U0126 (10µM, Promega) for 16 hours. Medium from the wells was collected after 
stimulation and the amount of secreted bFGF was analyzed by a bFGF-ELISA (DuoSet, 
R&D) test according to the manufacturer’s instructions; the experiment was performed in 
triplicate. 
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Results 
GDNF receptor components are expressed on RMG in porcine retina 
In order to clarify whether GDNF-mediated PR rescue effects are exerted directly or involve 
indirect retinal pathways, we first analyzed the expression patterns of GDNF receptor 
components in porcine retina.  
Expression of transmembrane receptor RET was found in all retinal layers (Figure 1, A and 
B). Similar expression patterns were found for GFRα-1 (C and D), GFRα-2 (E and F) and 
GFRα-3 (G and H), thus indicating the possibility for a receptor expression on membranes of 
RMG, since these cells are present throughout the retina. Co-staining with the cellular RMG 
marker glutamine synthetase (Figure 1, A, C, E and G) supported this hypothesis. In order to 
localize precisely the site of expression, sections were additionally co-stained with antibodies 
against GLAST, a membrane glutamate receptor expressed in RMG (36, 38). Co-staining 
with GLAST produced exact colocalisation in overlay images, indicating that receptor 
components for GDNF, NRTN and ARTN are indeed confined to the RMG membrane 
(Figure 1, B, D, F and H). The fluorescence signal observed for PR inner and outer segments 
is due to autofluorescence and was revealed by comparison with negative controls (omission 
of primary and/or secondary antibodies, data not shown). 
Expression of GDNF receptor components on isolated RMG in vitro 
Since RMG in the whole retina were found to express GDNF receptor components, we further 
investigated the expression of these receptor components in isolated RMG. We have 
previously shown that RMG protein expression patterns are markedly altered upon in vitro 
culturing (19). Therefore, we addressed the question of whether the GDNF receptor 
components remain expressed in vitro. 
RT-PCR analysis of mRNA prepared from porcine retina, freshly isolated RMG and RMG 
cultured in vitro for two weeks, showed that whole retina and freshly isolated RMG express 
RET, GFRα-1, GFRα-2 and GFRα-3 and RMG retained expression of these components 
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after two weeks in culture (Figure 2, A, B and C). Although GDNF itself was not expressed in 
freshly isolated RMG, its expression increased after two weeks in vitro, indicating the 
establishment of an autocrine activation loop. No expression of GDNF receptor components 
was found in freshly isolated PR (Figure 2D). 
GDNF phosphorylates RMG RET receptor in vitro 
In order to investigate GDNF signalling in RMG in vitro, we first tested GDNF-induced 
tyrosine phosphorylation. Western blots incubated with an antibody specific for phospho-
tyrosine showed specific bands of the expected size for the RET receptor (170 and 150 kDa), 
appearing just 15 seconds following GDNF stimulation (Figure 3) and remained stable for 30 
minutes in the presence of phosphatase inhibitors. In the absence of phosphatase inhibitors, no 
such phosphorylation could be detected after 30 minutes. Application of phosphatase 
inhibitors in the absence of GDNF did not result in higher phosphorylation. Similar results 
were obtained after stimulation of RMG with ARTN (data not shown). 
GDNF, Neurturin and Artemin activate distinct RMG signalling cascades in vitro 
Consistent with the expression of co-receptors GFRα-1, GFRα-2 and GFRα-3 in RMG, we 
found that all three ligands (GDNF, NRTN, ARTN) could activate signalling cascades in 
RMG in vitro. Five minutes of GDNF stimulation led to maximum phosphorylation of both 
MEK and ERK (Figure 4A). Similar signalling cascades were also activated following 
stimulation with NRTN and ARTN (Figure 4, B and C). ERK phosphorylation was 
completely blocked by application of the MEK inhibitor U0126. Whereas GDNF led to strong 
phosphorylation of SAPK after 5 minutes, stimulation with ARTN resulted in weaker 
phosphorylation; NRTN induced SAPK phosphorylation after 10 minutes. In all three cases, 
SAPK activation could be partially blocked by the PI-3 kinase inhibitor LY294002, indicating 
that SAPK phosphorylation was partly induced by active PI-3 kinase. SAPK phosphorylation 
was completely blocked by the MEK inhibitor U0126. PKB/AKT was phosphorylated by 
stimulation of NRTN, ARTN and GDNF at 1, 5 and 10 minutes, respectively. This 
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phosphorylation was completely blocked by addition of the PI-3 kinase inhibitor LY294002. 
PKB/AKT phosphorylation was also blocked by the MEK inhibitor U0126. 
GDNF activates ERK in cells of the inner nuclear layer in retinal explants 
In order to confirm that GDNF is able to induce signalling in intact retina, we dissected fresh 
porcine retina and immediately treated with GDNF or medium alone for 20 minutes. Tissue 
samples were then fixed, cryopreserved and sectioned. Immunohistochemical staining for 
pERK showed intensely positive areas close to nuclei of cells in the inner nuclear layer and 
additionally in IPL and GCL of GDNF-treated sections compared to untreated sections 
(Figure 5, A and B). Coimmunolabelling for glia-specific marker glutamine synthetase (GS) 
reveals a colocalisation of all pERK-positive signals with glial cells (Figure 5C). 
Quantification of pERK-positive signals within the INL revealed a significant (p<0.001) 
increase in response to GDNF stimulation (Figure 5C). 
GDNF upregulates expression of bFGF in vitro 
An upregulation of bFGF by RMG in response to NT-3 treatment has been demonstrated (17) 
and bFGF has been shown to protect PR in vivo (12). We therefore investigated whether 
GDNF treatment could increase bFGF expression in RMG. Indeed, northern blot analysis 
demonstrated that stimulation with GDNF for 24 hours increased bFGF transcript level in 
RMG (Figure 6A). 
GDNF, NRTN and ARTN stimulate secretion of bFGF 
In order to verify that GDNF-induced upregulation of bFGF expression also led to increased 
secretion of bFGF by RMG, we quantified bFGF levels in the culture medium following 
incubation with GDNF, NRTN and ARTN using a bFGF-ELISA. All three factors induced 
secretion of bFGF by RMG compared to unstimulated controls. Unstimulated RMG medium 
contained 33.8 pg/ml (+ 3.8) bFGF, whereas GDNF stimulation resulted in an increase of 
bFGF in the medium to 46.1 pg/ml (+ 3.4), NRTN to 48.1 pg/ml (+ 1.7) and ARTN to 47.7 
pg/ml (+ 8.8). Moreover, bFGF secretion was dependent on active MEK as application of the 
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MEK inhibitor U0126 not only prevented increased secretion (Figure 6B), but also lowered 
secreted bFGF below the level observed for unstimulated RMG to 25.3 pg/ml (+ 4.3). 
bFGF prolongs survival of porcine photoreceptors in vitro 
Although the results of our studies indicate that GDNF targets RMG rather than 
photoreceptors (PR) in porcine retina, we wanted to investigate direct protective effects of 
GFLs on PR. GDNF, NRTN and ARTN were applied to porcine PR in vitro and survival was 
monitored by a calcein-esterase assay. In accordance with our hypothesis, neither of the tested 
GFLs prolonged survival of PR compared to medium alone (Figure 7A).  
In order to verify that bFGF promotes PR survival, different concentrations of bFGF were 
applied to porcine PR in vitro. We found that bFGF significantly increased numbers of 
surviving PR in a concentration-dependent manner. The survival-supporting effect of bFGF 
was already detectable after 2 days in vitro (data not shown) and was most pronounced after 5 
days in vitro (Figure 7B). Concentrations of 20ng/ml did not increase survival compared to 
the negative control, but bFGF at 100ng/ml, 500ng/ml and 1000ng/ml robustly enhanced 
survival of PR. 
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Discussion 
The large heterogeneity of retinal diseases leading to PR death and consequent loss of vision 
in patients requires development of alternative therapeutical strategies beyond corrective gene 
therapy. A promising approach has been to target dying PR with molecules known to act as 
neuroprotective in brain and, in such manner, delay disease progression. Although this has 
been achieved with several molecules in animal models of retinal degeneration (reviewed in 
(8), the underlying mechanisms of PR rescue in most of these studies remain unresolved.  
Retinal Mueller glial cells as target cell for GDNF-induced signalling in porcine retina 
One of the most effective molecules in rescuing PR function thus far has been GDNF, which 
rescued PR at both morphological and functional levels in the rd1 mouse model of retinal 
degeneration (15). The molecular mechanisms of GDNF-induced PR rescue have not been 
resolved to date, but are a fundamental prerequisite for therapeutic application of this 
molecule. In our study, we examined the expression of GDNF receptor components in the 
retina. The porcine retina was selected as model due to its high density of cone cells (21), as 
well as the close similarity between the porcine and the human eye with respect to dimension, 
anatomical and physiological features (33, 41). 
We found that the transmembrane receptor RET, as well as GDNF co-receptor GFRα-1 were 
not expressed by PR but rather by RMG in porcine retina. In addition to GFRα-1, RMG 
express the co-receptors necessary for NRTN and ARTN signalling: GFRα-2 and GFRα-3. 
Studies on the expression of GDNF receptor components in rat retina localized RET and 
GFRα-1 in PR, inner nuclear layer, inner plexiform layer and ganglion cell layer (24) 
suggesting, among other cells, a localisation on RMG, whereas Harada and coworkers (16) 
have reported expression of GFRα-1 and GFRα-2 receptors mainly in PR. Other evidence has 
reported GFRα-1 expression in retinal ganglion cells, RMG and PR (26). These discrepancies 
have been proposed to reflect specific differences between the rat strains used for the studies 
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(16). Additionally, there are indications that retinas of rodents and other mammals differ in 
the expression and distribution of neurotrophic factor receptors. As shown for CNTFRα its 
expression is absent in PR of adult and developing rodent retinas, but rather consistently 
found in rods and cones of non-rodent mammals, including pig (4). With regards to GDNF, 
our findings that GFRα receptors and RET are absent from PR but abundant on RMG lead to 
the conclusion that, in porcine retina, the neurotrophic effect exerted by GDNF is transduced 
not directly to PR but indirectly via RMG. 
There has been increasing evidence for the crucial role of RMG in prolonging PR survival 
during progressive retinal degenerations (47). Light-induced retinal degeneration studies in 
rats have shown that GFRα-2 expression in RMG is upregulated in response to GDNF (16), 
whereas others have observed an upregulation of GFRα-2 expression in response to light 
damage in the same model occurring in different retinal structures (PR and retinal pigment 
epithelium, (24)). Further, intravitreous injection of brain-derived neurotrophic factor 
(BDNF), ciliary neurotrophic factor (CNTF), or bFGF in eyes of wildtype or mutant rats and 
mice resulted in increased pERK and c-fos immunostaining in cells of the inner retina, 
particularly RMG but not PR (43, 44). In accordance to the hypothesis that BDNF, CNTF, 
and bFGF exert their effects on PR by acting indirectly through RMG activation, we propose 
here that a similar indirect survival-promoting pathway is induced following GDNF 
application. 
GDNF, NRTN and ARTN-induced signalling in RMG 
In order to examine molecular action of GDNF in detail, we used pure primary cell cultures of 
porcine RMG (19) as a tool to address GDNF-induced signalling exclusively in a GDNF-
targeted retinal cell. We found that GDNF, as well as NRTN and ARTN induced several 
distinct signalling cascades in primary RMG: MEK/ERK, SAPK and PKB/AKT, which have 
been previously described to be activated by those ligands (recently reviewed in 23). 
However, the majority of studies were performed on cell lines, especially those expressing 
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constitutively active RET mutations derived from multiple endocrine neoplasia (MEN2A and 
MEN2B). Most interestingly, our study revealed considerable crosstalk between the activated 
signalling cascades. Our results with the specific MEK inhibitor (U0126; 11) demonstrated 
that GDNF-induced MEK activation triggers not only ERK, but also regulates SAPK 
phosphorylation and PKB/AKT to a lesser extent (see Figure 8). Such communication 
between the MEK/ERK and SAPK pathways has been also proposed in growth factor-
stimulated epithelial layers of the porcine lens. There, MEK inhibition with U0126 led to 
decreased SAPK phosphorylation, suggesting close association of MEK/ERK with the SAPK 
cascade (48). Further, in our study, the specific PI-3 kinase inhibitor (LY294002; 42) blocked 
PKB/AKT phosphorylation completely and, in addition, reduced SAPK phosphorylation. 
SAPK is thus activated by at least two kinases in primary RMG: MEK and PI-3 kinase, 
whereby a complete block of SAPK phosphorylation occurs only through MEK inhibition; PI-
3 kinase inhibition is only able to reduce SAPK phosphorylation. This indicates that MEK 
acts on an unidentified target kinase which itself activates PI-3 kinase. Although GDNF, 
NRTN and ARTN activated similar signalling cascades in this study and which is consistent 
with previous reports (1, 23), the time course of activation for phosphorylation of PKB/AKT 
was remarkably different: stimulation with NRTN, ARTN and GDNF resulted in 
phosphorylation of PKB/AKT after 1, 5 and 10 minutes, respectively. Such a differential time 
lapse in response to different GFLs has, to our knowledge, not been previously reported. The 
very rapid phosphorylation of PKP/AKT following NRTN stimulation may indicate 
recruitment of different adapter proteins to the activated RET receptor, in contrast to the 
considerably later activation of PKB/AKT through GDNF stimulation. Activation of 
PKB/AKT by phosphorylated tyrosine 1062 of RET via recruitment of docking proteins SHC, 
GRB2 and Gab1 or Gab2 has been reported (reviewed in (23, 32), whereby the time lapse 
between start of activation and onset of PKB/AKT phosphorylation was between 5 and 15 
minutes (5, 20). This is in agreement with the time lapse following stimulation with GDNF in 
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our study. However, NRTN stimulation induces more rapid PKB/AKT phosphorylation and 
may indicate that stimulation with this GFL leads to either recruitment of different docking 
proteins or involves as of yet undefined kinases upstream of PKB/AKT. Moreover, we 
consistently observed GFL-associated different SAPK/JNK phosphorylation intensities: 
whereas GDNF induced strong phosphorylation, NRTN and ARTN resulted in reduced or 
very weak phosphorylation of SAPK/JNK, respectively. This indicates a differential 
triggering of signal intensities by different GFLs. Together, these findings underline that 
although these GFLs signal through the same transmembrane receptor RET (2) and induce 
phosphorylation at similar tyrosine residues of RET, intracellular signalling dynamics are 
indeed distinct.  
GDNF-induced and bFGF-mediated indirect survival pathway to photoreceptors 
Upon stimulation with GDNF, phosphorylated ERK is shuttled into the nucleus of cells. We 
found both, pERK-positive signals close to nuclei of inner nuclear layer (INL) in intact retina 
and additional signals in inner plexiform layer and ganglion cell layer. The pERK-positive 
cells within the INL show regular spacing, are all located within one row of nuclei in the INL 
and are most likely RMG. We could colocalize all pERK-positive labeling with glutamine 
synthetase, the marker for glial cells in retina (9, 30), thus confirming that ERK is selectively 
activated in RMG. 
Given that GDNF has been shown to rescue PR in the rd1-mouse and our own results indicate 
that RMG are the target cells of GDNF in the porcine retina, we specifically screened for 
GDNF-induced expression changes in secreted neuroprotective molecules. We found that 
RMG indeed respond to GDNF application with an upregulation of basic fibroblast growth 
factor (bFGF) expression. This is in agreement with the observations of Harada and 
coworkers (16), who reported GDNF-induced upregulation of bFGF in rat RMG in vitro. 
Furthermore, subretinal injection of NT-3 prior to light-induced retinal degeneration in mice 
(17) resulted in an upregulation of bFGF expression in RMG. This may therefore represent a 
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general pathway for retinal neuroprotection (44, 47). Moreover, we found increased bFGF 
secretion stimulated by GDNF, NRTN and ARTN, which may support paracrine action of 
those factors. The increased bFGF secretion is entirely dependent on GFL-induced MEK 
activation, since the presence of U0126 completely abolished enhanced secretion. Since the 
amount of secreted bFGF decreased below control levels in presence of U0126, this indicates 
that the presence of RMG-derived GDNF alone triggers basic levels of bFGF secretion.  
We verified that bFGF is able to prolong survival of porcine PR in vitro. The ability of bFGF 
to enhance survival of postnatal rat PR has been demonstrated (13), and indications for the 
long-term survival promoting effect of bFGF (after two weeks in vitro) on porcine PR 
following repeated application (40) also exist. However, the observed GDNF-induced 
secretion of bFGF occurred within 16 hours, and we therefore addressed the question of 
whether in vitro bFGF application would show faster survival-promoting effect in our system. 
Indeed, we found a pronounced and concentration-dependent effect of bFGF on survival of 
PR in vitro, detectable already two days after application (data not shown) and most 
pronounced after five days in vitro. Based on these results we propose a model for GDNF-
induced neuroprotection of porcine PR: GDNF activates distinct intracellular signalling 
pathways in RMG, namely, MEK/ERK, AKT/PKB and SAPK/JNK. Activated MEK results 
in enhanced bFGF transcription and bFGF is released from RMG and subsequently acts as 
survival factor for neighboring PR. The close proximity between RMG and PR also probably 
leads to high, local concentrations of bFGF, thus enhancing its efficacy (Figure 8). 
The functional importance of this model of PR support through RMG is further strengthened 
by the finding that RMG express three different co-receptor types for GDNF family ligand 
signalling, thus providing a redundancy also seen with striatal and hippocampal neurons (27). 
bFGF has been thus far shown to only increase PR numbers in vitro (13, 40) and in vivo (7, 
28, 29), but failed to improve electroretinogram (ERG) recordings in vivo, indicating it is 
insufficient for functional rescue. Thus, we hypothesize that GDNF modulates the expression 
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of additional molecules in RMG, which in turn enable the preservation of PR function. 
Identification of these GDNF-induced molecules are a part of our ongoing and future studies, 
where the porcine retina represents an excellent model, as it is cone-rich and in which RMG 
have been recently demonstrated to secrete a factor specifically promoting cone survival in 
vitro (3). Although specific information on this factor is presently unavailable, it remains an 
intriguing candidate for being targeted by GDNF-induced signalling in RMG. 
GDNF has been repeatedly suggested in the context of future therapeutic regimens, presented 
either alone or combined with a cell-based therapy/delivery. Previous studies in gene and cell 
therapy have revealed that application of such neurotrophic cytokines prior to an in-depth 
understanding of their mechanism of action bear unpredictable risks for the patients treated 
(10). Such, this study contributes to a better understanding of GDNF’s mechanism of action 
on primary retinal cells and tissue, and may contribute to a more rationalized risk assessment 
on this promising factor for future clinical trials. 
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Figure legends 
Figure 1: Detection of GDNF family receptors on tissue sections of porcine retina 
Porcine eyes were fixed and embedded in paraffin, sectioned (5µm) and nuclei were stained 
with DAPI. Nomarski image and blue fluorescence image were overlaid to visualize retinal 
structures (left picture in each panel). Sections are stained with primary antibodies against 
RET (A, B), GFRα-1 (C, D), GFRα-2 (E, F) or GFRα-3 (G, H), followed by visualisation 
with red fluorophore (alexa546). Additionally, all sections were stained with primary 
antibodies against RMG-specific proteins: anti-GS (A, C, E, G) or anti-GLAST (B, D, F, H) 
and visualized with green fluorophore (alexa488). Overlay images (right picture in each 
panel) demonstrates complete colocalisation of all GDNF family receptor components with 
membrane-localized RMG-specific marker, GLAST. RPE: retinal pigment epithelium; OS: 
outer segments of PR; IS: inner segments of PR; ONL: outer nuclear layer; INL: inner nuclear 
layer; GCL: ganglion cell layer. 
 
Figure 2: RT-PCR detection of receptor components 
RT-PCR of RMG day 1 and day 14 (A and B, respectively) and whole porcine retina (C) 
show expression of RET receptor and co-receptors GFRα-1, GFRα-2 and GFRα-3. 
Additionally, GDNF is expressed in whole retina and its expression is induced in RMG at day 
14 in vitro. In contrast to RMG and whole retina, isolated PR do not express any of the GDNF 
family receptors (D). Identity of all PCR products was verified by sequencing. 
 
Figure 3: GDNF-induced receptor phosphorylation 
GDNF induces rapid phosphorylation (after 15sec) of 2 bands with the expected size for the 
RET receptor (150 kDa and 170 kDa), detected with anti-phospho Tyrosine antibody 
(pTyr100, CST). Equal amounts of protein were loaded as demonstrated by re-incubation with 
anti-beta actin antibody. The data shown are representative of two independent experiments 
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Figure 4: GDNF, NRTN and ARTN-induced signalling in RMG 
A: GDNF induces phosphorylation of both MEK and ERK after 5 minutes and the latter can 
be blocked with MEK inhibitor (U0126). Further, GDNF phosphorylates SAPK/JNK after 5 
minutes, which can be also blocked completely by MEK inhibitor (U0126) and partially by 
PI3-kinase inhibitor, LY294002. In addition to activating the MAPK and SAPK pathways, a 
GDNF-induced activation of AKT/PKB was observed after 10 minutes treatment and which 
could be also blocked by PI3-kinase inhibitor and partially by MEK inhibitor. 
B: Similar signalling cascades as described in A are induced by stimulation of RMG with 
NRTN but showing a slightly different time course: SAPK/JNK phosphorylation is observed 
after 10 minutes and AKT/PKB after only 1 minute of stimulation. 
C: Similar signalling cascades as described in A are induced by stimulation of RMG with 
ARTN but showing a slightly different time course: AKT/PKB after 5 minutes of stimulation. 
Equal amounts of protein were loaded in each condition as demonstrated by re-incubation 
with anti-vimentin antibody. The data shown are representative of at least three independent 
experiments of each stimulation set. 
 
Figure 5: Detection of pERK in retina after stimulation with GDNF 
A: GDNF induces ERK phosphorylation only in cell nuclei of inner nuclear layer in intact 
retina after stimulation for 20 minutes (right panel), as compared to unstimulated controls (left 
panel). OS: outer segments of PR; IS: inner segments of PR; ONL: outer nuclear layer; INL: 
inner nuclear layer; GCL: ganglion cell layer. 
B: Quantification of pERK positive cells shows significant increase after GDNF stimulation 
(p<0.001). 
C: Colocalisation of pERK with glutamine synthetase (GS): all pERK-positive signals after 
GDNF stimulation (green) could be colocalized with the cytosolic glial-specific protein 
glutamine synthetase (GS, red). Stimulation of ERK (pERK, green) was found in the inner 
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nuclear layer (INL) in close proximity to nuclei (large arrow in upper panels and similar 
section enlarged in lower panels, counterstained with DAPI for visualisation of nuclei). 
Additionally, pERK-positive signals were found in inner plexiform layer (IPL) and ganglion 
cell layer (GCL); in all cases the signals colocalized with GS (open arrows, upper panels). 
Retinal structures are visualized with Nomarski optics (upper right panel); OS/IS: outer 
segments and inner segments of photoreceptors; ONL: outer nuclear layer consisting of 
photoreceptor nuclei. 
Figure 6: GDNF, ARTN and NRTN induce secretion of bFGF 
A: GDNF-induced upregulation of bFGF mRNA 
RMG were either incubated in medium alone or stimulated with 100ng/ml GDNF for 24 
hours, northern blot analysis was performed with 5µg RNA per lane and bFGF transcript was 
detected with DIG-labeled RNA probe. The experiment was repeated three times. GDNF 
increases bFGF transcript in RMG. Equal loading was controlled by methylene blue staining 
(data not shown). 
B: GDNF, NRTN and ARTN-induced bFGF secretion 
bFGF-ELISA of culture medium from RMG stimulated for 16 hours with GDNF, NRTN or 
ARTN in absence or presence of the MEK inhibitor U0126, as compared to unstimulated 
RMG. All three factors induce bFGF secretion and secretion of bFGF is reduced below basic 
level of bFGF secretion from unstimulated RMG with MEK inhibitor. 
 
Figure 7: bFGF prolongs survival of porcine photoreceptors in vitro 
Porcine PR were plated in 96-well culture plates, treated as indicated for five days in vitro and 
cell survival was monitored by an esterase calcein-fluorophore assay. Every value is a mean 
of two to four wells per experiment, and each experiment was performed in triplicate.  
A: Neither GDNF, nor NRTN or ARTN increase survival of photoreceptors compared to 
medium alone. 
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B: bFGF increases survival of PR in vitro in a concentration-dependent manner: whereas 
20ng/ml did not affect survival, treatment with 100, 500 and 1000ng/ml demonstrated 
increasing and significant effects on PR survival (* p<0.05, ** p<0.01). 
 
Figure 8: Model of intra and inter-cellular signalling induced by GDNF in RMG 
RET transmembrane tyrosine kinase is phosphorylated in response to GDNF, NRTN and 
ARTN. All ligands are able to induce three intracellular signalling cascades: MEK/ERK, 
SAPK and PKB/AKT pathways. Inhibitor experiments demonstrate that MEK acts upstream 
of PI-3 kinase to an unidentified target and upstream of SAPK. Both, PI-3 kinase and MEK 
are able to activate SAPK. Phosphorylated ERK is shuttled into the RMG nucleus where it 
induces increased transcription of bFGF mRNA. This leads to increased expression and 
secretion of bFGF protein, which then supports survival of PR which are in close proximity to 
RMG in intact retina. 
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Abstract 
It has been demonstrated that cultured retinal Mueller glial cells (RMG) release substances 
into the culture medium (conditioned medium) that are able to induce neurite sprouting in 
cultures of retinal ganglion cells, and that enhance survival of cones in vitro. The identity of 
these factor(s) is unknown. In order to define RMG-derived neuroprotective factors, a large-
scale photoreceptor survival assay was developed, which enabled to monitor survival of 
freshly prepared porcine photoreceptors in different media for extended times in vitro. RMG-
conditioned medium (RMG-CM) was found to promote photoreceptor survival, but the 
secreted activity is lost with prolonged RMG culturing. The activity proofed to be a protein, 
with a size above 10kDa and sub-fractionation of RMG-CM by mono-Q FPLC demonstrated 
that the active factor does not bind effectively to anionic chromatography resins. 
Consequently, composition of mono-Q FPLC flowthrough was directly determined by liquid 
mass spectrometry (LC-Q-TOF). Two Insulin-like growth factor binding proteins (IGFBP-5 
and IGFBP-7) and connective tissue growth factor (CTGF) were among the identified 
proteins of the active flowthrough. Stable expression of these three candidate factors in 
HEK293 cells produced CM enriched with the respective factor and proofed to add activity to 
the original RMG-CM, although not being active alone. This indicated that the survival 
promoting activity in RMG-CM is multi-factorial, and is triggered by IGFBP-5 and CTGF. 
PAPER 3   
 
123
Introduction 
Neuronal survival depends on neurotrophic factors released from surrounding tissues, and in 
their absence, neurons undergo programmed call death [Davies, 1994 #911]. Degeneration of 
retinal photoreceptor cells is a major cause of blindness, and although this degeneration is 
often preceded by mutation in photo transduction-relevant genes, degeneration only occurs 
delayed in life. An explanation for delayed apoptosis might be the existence of paracrine, 
neurotrophic activities produced by retinal cells, which supports photoreceptor function even 
in diseased-gene background.  
Several efforts have been made to define those neurotrophic activities. In an in vitro model of 
sympathetic neuronal survival it has been shown that medium conditioned by chick retinal 
explants and medium conditioned by chick retinal Mueller glial cells (RGM) support neuronal 
survival [Reis, 2002 #912]. The retinal Mueller glial cells (RMG), the main glial cell in the 
retina, has also been shown to secrete a factor that promotes survival and neuritogenesis of 
retinal ganglion cells in vitro [Garcia, 2002 #817] and cone photoreceptors (1). However, in 
none of these studies the protein responsible for the neuronal survival-promoting effects has 
been identified.  
In this study we aimed at investigating paracrine factors acting between RMG and retinal 
photoreceptors (RPR). RMG-conditioned medium was tested for survival-promoting activity 
on primary RPR in an especially here fore developed large-scale survival assay. In order to 
further characterise the survival-promoting activity, complexity of RMG-conditioned medium 
was reduced by subfractionation and finally, active subfractions were subject to mass-
spectrometric identification of composing proteins. We found that active fractions of RMG-
conditioned medium include at least 23 different proteins among them three potential new 
candidates for neuroprotective activity in the context of RPR survival: connective tissue 
growth factor (CTGF), insulin-like growth factor binding protein 5 (IGFBP5) and insulin-like 
growth factor binding protein 7 (IGFBP7). Expression cloning and retesting of these 
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candidates for their ability to promote RPR-survival, revealed that two of them (CTGF and 
IGFBP5) are able to increase RPR-survival when applied in combination with the original 
RMG-CM, indicating that the RMG-derived neurotrophic activity is multi-factorial. 
 
Materials and Methods 
RMG preparation 
Adult porcine eyes were provided by a local slaughterhouse. They were removed from the 
animals within 5 minutes after death and kept on ice in CO2-independent medium (GIBCO) 
until further use. Retinae were dissected from the eye and RMG were prepared as described 
previously [Gaudin, 1996 #266] [Hauck, 2003 #928]. Briefly, major blood vessels were 
removed and the retina was cut into small pieces which were washed twice in Ringer`s 
solution. Dissociation of retinal tissue was obtained by treating each retina with 2.2 units of 
activated papain (Worthington Biochemical Corporation) for 40 minutes at 37°C; papain 
enzyme activity was stopped by addition of DMEM-HEPES (Gibco) with 10% FCS. Then, 
160 kunitzunits of DNAse (Sigma) were added and the tissue was further dissociated by 
gentle trituration using a fire-polished Pasteur pipette. Dissociated cells were collected by 
centrifugation (800 g, 5 min), resuspended in DMEM containing 10% FCS and plated directly 
onto cell culture plates (NUNC). The plated cells were allowed to attach for 16 hours at 37°C 
in an incubator. Non-attached cells were then removed by gentle agitation (panning) and 
RMG were cultured for 14 days to near confluence.  
Photoreceptor preparation 
Retina was dissected from porcine eyes as described above and photoreceptors were isolated 
from retina as described (2). Briefly, retinal pieces were cut and washed as described above, 
subsequent papain treatment was 15 minutes, reaction was stopped by addition of 
DMEM/NUT-MIX F12 (GIBCO) with 2% FCS. After gentle trituration, PR were collected by 
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centrifugation (800 g, 5 min), resuspended in DMEM/NUT-MIX F12 containing 2% FCS and 
plated on 96well plates, which were pre-coated with poly-D-Lysine (Sigma, 2µg/cm2, 3 
hours) and laminin (BD Bioscience, 1µg/cm2, overnight). After incubation for 20 hours, the 
medium was removed and replaced by different conditioned media or subfractions. 
Conditioned medium 
Plates with RMG, R6-C1 or HEK293 cells were washed twice with serum free medium, 
incubated for 3 hours in serum free medium, then medium was replaced with DMEM/NUT-
MIX F12 containing 1mM sodium pyruvate (Gibco), and penicillin/streptomycin (Gibco). 
Medium was conditioned for 18 hours, then filtered (<0.2µm) to remove non-adherent cells 
and debris and either directly applied on photoreceptors in 96wells, or subfractionated as 
described below. 
Photoreceptor survival assay 
Conditioned media from either RMG or rat embryonic cell line (negative control) were 
applied on attached photoreceptors 20 hours after preparation. Photoreceptor survival was 
monitored by performing an esterase calcein-fluorophore (Molecular Probes) assay, living 
cells fluoresce bright green. Fluorescence was measured daily with a different row on the 
plate in a micro plate fluorescence reader (MWG Biotech FL600) and values were compared 
to the initial fluorescence at the beginning of the survival assays. Relative fluorescence is 
given in percent of initial fluorescence, every value is a mean of two to four wells per day and 
experiment, and every experiment was performed at least three times. 
Inhibitors: U0126 and LY294002 (both from Cell Signaling Technology) were added to the 
photoreceptor survival assay to a final concentration of 1µM and 5µM, respectively. 
Proteinase K treatment: Proteinase K (Sigma) was added to RMG-conditioned medium at a 
final concentration of  100µg/ml, incubated for 30 minutes at 37°C and reaction was stopped 
by addition of 12,5µg/ml a2-macroglobulin (Serva). 
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Expression cloning of candidate proteins 
ESTclones were ordered from RZPD: IGFBP5 (IMAGp998M039414Q3), IGFBP7 
(IMAGp998E148162Q3) and CTGF (IMAGp998F1110165Q3). The cDNAs were subcloned 
into the pcDNA3.1 V5/His TOPO Vector (Invitrogen) by PCR-amplification (Pfx, Promega) 
using following primer-pairs (sense, anti-sense): 5’-AGTGCCAACCATGACCGC-3’, 5’-
TGCCATGTCTCCGTACATCTTCC-3’ (CTGF); 5’-ACTAAGAGAAGATGGTGTTGCTC 
AC-3’, 5’-CTCAACGTTGCTGCTGTCG-3’ (IGFBP5); 5’-ACATTATACGAAGTTATGG 
ATCAGG-3’, 5’-TAGCTCGGCACCTTCACC-5’ (IGFBP7). The PCR products were 
purified by extraction from agarose gels using the QIAquick gel-extraction kit (Qiagen) and 
adenosine overhangs for TOPO-TA cloning were generated by incubation with Taq 
polymerase (Fermentas) at 72°C for 20min applying 0.2mM dATP (Fermentas). PCR-
products were then directly used in TOPO ligation according to manufacturer’s protocols 
(Invitrogen). Resulting clones were sequenced. HEK293 cells were transfected with 
expression clones (Effectene, Qiagen) and stable cell lines were generated by selection with 
neomycin (G418, 1500µg/ml, Calciochem). Proper secretion of the factors was monitored by 
western blot of conditioned media with anti-V5 antibody (Invitrogen) (data not shown). 
Subfractionation of conditioned media 
Size fractionation: 14ml of conditioned media were centrifuged at 5000g for 40minutes, 4°C 
through 50kDa or 10kDa Macrosep devices (Millipore); the remaining size-enriched 
concentrate was applied on the photoreceptor survival assay. 
Mono-Q FPLC: prior to FPLC separation, conditioned media were concentrated and 
equilibrated to 30mM sodium-phosphate buffer via Amicon 10kDa filters. 10fold 
concentrated conditioned media were loaded onto mono-Q columns (HR_5/5,Amersham) in 
30mM sodium-phosphate buffer (pH 7.5), flowthrough was collected and proteins binding to 
mono-Q matrix were eluted by a gradient 0-60% 1M NaCl within 25 minutes into 96well 
plates. Collected fractions were combined as described in results, concentrated 10fold via 
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Microsep 10kDa devices and rediluted 10fold in DMEM/NUT-MIX F12 before application 
onto photoreceptor survival assay. 
1D-PAGE  
Proteins from conditioned media or from mono-Q-FPLC fractions were precipitated with 
acetone, solved in buffer for 1D-PAGE (50mM Tris pH 7.4, 250mM NaCl, 25mM EDTA, 1% 
NP-40, 10% glycerol, Complete mini), protein content was measured by Bradford assay 
(BioRad) and samples were resolved on a 9-15% PAGE. Protein bands were visualised by 
silver stain. 
2D-PAGE 
Medium was conditioned in the presence of 0,8mCi 35S (trans-35S-label, ICN) per 10cm 
culture dish, filtered after conditioning and proteins from conditioned medium were 
precipitated with acetone. Precipitates were resolved in 2D-lysis buffer (9 M urea, 2 M 
thiourea, 1% DTE, 4% CHAPS and each 2.5 µM EGTA and EDTA) and protease inhibitors 
(complete mini, Roche) and protein content was determined by Bradford assay (BioRad). 
Electrophoretic separation was carried out as described (Hauck et al, 2003 etc) with IPGstrips 
pH 3-10 (Amersham Biosciences) in the first dimension and gradient SDS-PAGE gels (9–
15%) in the second dimension. Gels were silver stained according to [Blum, 1987 #669] and 
dried between cellophane sheets. Hyperfilms (Amersham Biosciences) were exposed with 
dried gels for 1 week to produce autoradiographs. 
Mass spectrometry 
Peptide sequence information was obtained as described before (Hauck et al, 2005) by LC-
coupled tandem-MS (MS/MS)-analysis on a Q-TOF2-System (Micromass, UK) coupled with 
a CapLC-System (Micromass, UK). Proteins from aliquots (400µl) of active FPLC-
flowthrough fraction were precipitated with acetone, resolved in 50mM ammonium 
bicarbonate, reduced in 5mM dithiothreithole (Merck) for 30 minutes at 60°C followed by 
alkylation in 15mM iodoacetamide (Merck) for 30 minutes at RT. Proteins were then 
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subjected to tryptic digest (5ng/µl sample) at 37°C overnight. Peptide samples were acidified 
to a final concentration of 5% with formic acid and sonicated for 3 min. Fifteen microliter 
aliquots were loaded on the CapLC system, trapped on a C18-pre-column (5 µm, 100 Å 
PepMap-C18, LC Packings) and separated on a 75 µm-C18 column (3 µm, 100 Å PepMap-
C18, LC Packings) by elution with a gradient (0-60% solution B: 95% acetonitrile, 0.1% 
formic acid). 
Database searching 
Database searches were performed using the Mascot software (3) at the following parameter 
settings: one miscleavage allowed, search restricted to database entries from metazoan, 0.8 Da 
peptide tolerance, 0.2 Da MS/MS tolerance. Peptide masses of the tryptic digests were 
compared to the virtually generated tryptic peptide masses of the protein databases NCBInr 
and MSDB.  
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Results 
Retinal Mueller gill cell (RMG) conditioned medium promotes porcine photoreceptor survival 
in vitro 
RMG have been suggested as important players in rescuing photoreceptors during retinal 
degeneration or toxic insults. It has been proposed that RMG release factors that inhibit 
apoptosis, but the nature of these factors remain to be elucidated. In order to define those 
potentially neuroprotective factors released by RMG, we designed an in vitro survival essay 
which enables to monitor the protective effects of RMG-conditioned media or subfractions on 
photoreceptors (see materials and methods). Photoreceptor survival is measured each day 
after replacing regular medium with respective conditioned media and compared to the 
amount of initially living cells. 
RMG conditioned medium resulted in consistently higher photoreceptor survival rates than 
application of either conditioned medium from control cells (R6-C1, a rat embryonic cell line) 
or medium alone (see Fig.1). The most significant time point of photoreceptor-survival 
promoted by RMG compared to controls is 6 days after application of conditioned media.  
The RMG-derived survival-promoting activity is lost during prolonged culturing 
We have described before that RMG dedifferentiate upon prolonged culturing (4). It could 
thus be hypothesised that RMG might loose, along with other specific marker proteins, the 
photoreceptor survival-promoting activity.  
We tested conditioned medium from RMG which have been cultured for 7 (data not shown), 
14 and 21 days before conditioning. The constantly highest survival promoting activity was 
found in conditioned medium from 14 day old RMG, after 21 days in culture the activity was 
lost compared to the controls (see Fig.2A). Medium conditioned by 7 day old RMG also 
showed lower survival effects on RPR compared to day 14 conditioned medium; this was 
accompanied by a lower overall protein content in the conditioned medium. This probably 
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resulted from lower cell densities in the culture plates of 7 day-old RMG compared to 14 and 
21 day-old RMG. 
Survival-promoting activity from RMG is a protein, separating into size fraction above 10kDa 
In order to confirm that the survival promoting activity is a protein, RMG conditioned 
medium was treated with proteinase K. Proteinase K treatment was stopped by addition of 
α2-macroglobulin, which itself proofed to be not toxic to photoreceptors in vitro. Proteinase 
K treatment completely destroyed the survival-promoting activity of RMG conditioned 
medium (see Fig.2A). 
In order to further characterise the survival-promoting factor, the conditioned medium was 
fractionated into molecular weight fractions <10kDa, between 10 and 50 kDa and above 
50kDa. RMG derived survival-promoting activity was enriched most compared to control in 
the fraction above 50kDa and to a lesser extent also in the 10kDa fraction. R6-C1 (negative 
control) conditioned medium showed a survival promoting effect in the size fraction below 
10kDa (see Fig.2B).  
Survival-promoting activity acts through PI-3 kinase dependent pathway in photoreceptors 
Cell survival can be promoted by several distinct or interacting pathways. In order to define 
the pathways responsible for RMG-mediated prolonged survival of photoreceptors in vitro, 
inhibitors were applied along conditioned medium in the survival assay. LY294002 inhibits 
selectively PI3-kinase and U0126 is an inhibitor of MEK kinase. Application of LY294002 
completely blocked survival-promoting activity of RMG-conditioned medium, whereas 
U0126 only partially reduced survival of RPR (Fig.3). In order to ensure that the application 
of the inhibitors itself would not interfere with RPR-survival both inhibitors were applied in 
combination with 2%FCS on RPR-survival assay. 2% FCS carries strong survival-promoting 
activities and neither LY294002 nor U0126 were able to prevent RPR-survival under those 
conditions (Fig.3). RPR-survival promoted by RMG-conditioned medium thus seems to 
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depend significantly on PI3-kinase pathway and only to a lesser extent on MEK-kinase 
pathway. 
RMG-conditioned medium is a complex mixture of proteins 
In order to define the factor responsible for RMG-derived RPR-survival, we first studied the 
complexity of RMG-conditioned medium. For this purpose, medium was conditioned in the 
presence of 35S, and subsequently proteins were resolved by high-resolution 2DE-PAGE. 
Radioactive labelling allows detecting proteins transcribed during the conditioning process on 
a very sensitive level. 
RMG-conditioned medium shows highly complex protein-pattern (see Fig.4). About 2200 
different protein spots were detected on autoradiographs of 2D gels. Thus, a prerequisite for 
identifying proteins responsible for the neuroprotective effect of RMG-conditioned medium is 
to reduce complexity. 
RMG-conditioned medium complexity can be diminished by separation on mono-Q FPLC  
In order to reduce complexity of RMG-conditioned medium we chose to fractionate via 
mono-Q FPLC. RMG-conditioned medium gave reproducible elution profiles from mono-Q 
columns (see Fig5A), complexity of eluting fractions was monitored by 1DE-PAGE (see 
Fig.5B). A total of 33 fractions from each run were collected into 96well plates, and 
according to the UV280nm detection the majority of proteins are eluting into fractions 20 – 
34 (see Fig.5A). 10µg of total protein from every second fraction were resolved by 1DE-
PAGE and shows that prominent bands probably representing one protein species, appear in 
approximately 6-8 consecutive fractions. 
In order to test which subfractions from FPLC separation carry the RPR-survival promoting 
activity, fractions were pooled as depicted in Fig.5B into 5 pools: A (fraction 1-7), B (fraction 
8-13), C (fraction 14-19), D (fraction 20-26), E (27-33). Flowthrough from sample application 
was also collected. 
Survival-promoting factor does not bind strongly to anion exchange column 
PAPER 3   
 
132
All pooled fractions from mono-Q FPLC along with flowthrough were tested on RPR-
survival assay for survival activity. Activity of every tested fraction was compared to an 
analogously treated conditioned medium from R6-C1 cell line, in order to evaluate selective 
RMG-derived activity. 
It showed that, compared to R6-C1 conditioned medium, most of the survival-promoting 
activity from RMG did not bind to mono-Q sepharose. The major part of the activity 
reappeared in the flowthrough from FPLC, and some in pooled fraction A, which covers very 
low eluting salt concentrations (Fig.6). Thus it showed that RMG-derived survival-promoting 
activity does not bind strongly to anion exchange matrices and could be an acidic protein. The 
activity can thus be very effectively separated from the majority of proteins included in RMG-
conditioned medium and be recovered in mono-Q sepharose flowthrough. 
Identification of proteins in mono-Q flougthrough fractions 
The enrichment of the survival-promoting activity in the mono-Q flowthrough, which is not 
very complex, makes it feasible to identify composing proteins directly and generate a list of 
probable candidates for this activity. Flowthrough was digested with trypsin and applied to Q-
TOF-MS/MS mass spectrometry in order to identify its components. 
23 different proteins were identified above significance threshold from RMG-FPLC 
flowthrough (Table 1). Among those proteins are 3 growth-factor related proteins: insulin-like 
growth factor binding protein 5 (IGFBP5), insulin-like growth factor binding protein 7 
(IGFBP7) and connective tissue growth factor (CTGF) which are good candidates for the 
RPR-survival activity. Further, superoxide-dismutase (SOD) and thioredoxin were identified 
from this fraction; both proteins might protect photoreceptors by preventing oxidative 
damage. In order to confirm the mass spectrometric identifications, we additionally monitored 
the expression of five candidate proteins by RT-PCR from RMG in vitro. RMG were found to 
express CTGF, IGFBP5, IGFBP7, SOD and thioredoxin (data not shown). 
Testing of identified candidate proteins for their survival-promoting activity on RPR 
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In order to identify which protein from active fraction is responsible for the RPR survival-
promoting effect of RMG-conditioned medium, we expression-cloned CTGF, IGFBP5 and 
IGFBP7 into HEK293 cells and generated stable cell lines secreting the respective proteins 
into the cultur medium (proper secretion monitored by western blots with antibodies against 
V5 epitope, data not shown). Additionally, we tested commercially available superoxide 
dismutase (SOD) and thioredoxin (THIO) for their activity on RPR. 
We found that compared to negative control (medium alone), SOD and THIO had no survival 
promoting effect on RPR in vitro. Effects of expression-cloned candidates were evaluated by 
comparison to empty HEK293-cell medium (Fig. 7). None of the candidates had convincing 
survival-promoting effects for RPR compared to negative control. However, when applied 
together with the original RMG-CM, CTGF and IGFBP5 could increase the survival 
promoting effect of RMG-CM, whereas SOD, THIO and IGFBP7 failed to do so (Fig. 7). 
This indicates a survival-promoting effect for CTGF and IGFBP5 which acts together with 
other factors present in RMG-CM. 
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Discussion 
In this study we aimed at identifying components specifically secreted by primary retinal 
Mueller glial cells (RMG) which support survival of retinal photoreceptors. Therefore we 
developed a large-scale in vitro survival assay that allows screening for survival promoting 
activity in 96well format. We took special effort to induce objectivity for the measurement of 
survival by measurement of overall fluorescence per well, rather then counting single 
fluorescent cells per field (5), because the latter depends on subjective field selection criteria 
by the experimentator. 
In order to select molecules specifically secreted by RMG, we compared the activity of RMG-
CM initially and during factor purification to factors secreted by a fibroblast cell line (R6). 
Interestingly, R6-CM also displayed survival-promoting activity, but in contrast to RMG-CM, 
this activity is enriched in fractions <10kDa (and 50-10kDa) from size-fractionated 
conditioned media and the activity strongly binds to monoQ sepharose, as is demonstrated by 
elution from FPLC in high salt containing fractions (Pool E, Fig. 6). It could be hypothesized 
that this activity is bFGF, because bFGF is a small protein (17kDa) with basic properties, thus 
predicted to bind strongly to anionic sepharose. 
The activity purified from RMG-CM is enriched in fractions above 50kDa and (50-10kDa) 
and does not bind to anionic resin. Moreover, the production of this activity is diminished 
with prolongued culturing underlining the specific expression by primary RMG. We 
identified 23 different proteins from FPLC-flowthrough, which was demonstrated to be the 
active fraction after FPLC separation of RMG-CM. We decided to test 5 candidate proteins 
for their activity on photoreceptor-survival: thioredoxin (THIO) and superoxide-dismutase 
(SOD), because both proteins are known be protective against reactive oxygen species and 
recently a member of thioredoxin family was identified to promotes survival of cone 
photoreceptors, which is derived from rod photoreceptors and (6). Connective tissue growth 
factor (CTGF) and insulin-like growth factor binding proteins 5 and 7 (IGFBP5, IGFBP7) 
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were chosen because they all are described as secreted proteins with cell growth or 
maintenance activity (www.expasy.org) and might thus be involved in paracrine signalling. 
The complexity of RMG-CM indicates that the survival promoting activity might be multi-
factorial, rather than induced by one single factor. Therefore we also tested the identified 
candidates in combination with the original RMG-CM. Whereas THIO, SOD and IGFBP7 did 
not increase survival of photoreceptors in vitro, CTGF and IGFBP5 were found to be active 
when applied in combination with the original CM. This is in line with our hypothesis that the 
RMG-CM derived activity on photoreceptor-survival is multi-factorial. Most interestingly, 
there has been one previous report about the expression of six IGFBP´s (IGFBP1-6) by 
porcine RMG in vitro, where the authors found that only the expression of IGFBP5 decreased 
with prolonged culturing, whereas the expression of all other IGFBP´s (IGFBP-1, -2, -3, -4 
and -6) increased (7). This may lead to the assumption that IGFBP5 is likely to be expressed 
by RMG in vivo and it underlines our finding that the activity (which may be related partly to 
IGFBP5) is lost with prolonged culturing of RMG. The importance of IGFBP5 in retina in 
vivo is further underlined by a report about its expression in developing chick retina, which 
points to a significant role during retinal development (8). 
The two active molecules found in this study, IGFBP5 and CTGF, both carry IGF-binding 
domains in their amino acid sequence (www.expasy.org). IGFBP5 binds with high affinity to 
IGF-1, is cleaved by several serine proteases (9) (10) or by matrix metalloproteases (MMP´s) 
(11) and is able to associate with extracellular matrix. When associated with the extracellular 
matrix (ECM), it appears to be protected from proteolysis, however, once released from ECM 
it is degraded (12) into a 22 kDa fragment that has low affinity for IGF-1 and -2 and a smaller 
14kDa fragment (11). In our study, expression of IGFPB5 in HEK293 cells resulted in 
conditioned media which primarily carry the uncleaved form of IGFBP5 and only a minor 
part of the protein is degraded (data not shown). Nevertheless, both, the uncleaved as well as 
the cleaved form of IGFBP5 may be responsible for the photoreceptor-survival promoting 
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activity desribed here. IGFBP-5 has recently been found to act in concert with IGF-2 in 
inducing cell proliferation of neuroblastoma cells (13).  
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Figure legends 
Fig. 1: Photoreceptor survival in vitro 
A: Primary porcine photoreceptors are plated onto 96well culture dishes and after initial 
attachment phase in the presence of 2% FCS, medium is replaced by different conditioned 
media: RMG-CM, medium conditioned for 16 hours by primary retinal Mueller glial cells; 
R6-C1, medium conditioned for 16 hours by a rat fibroblast cell line. Negative control is 
medium alone. Photoreceptor survival is measured every day (from day of medium 
replacement: d0 till 9 days after application of different media: d9) on 2-4 wells per condition 
by esterase-calcein fluorophore assay, intensity of fluorescence is compared to initial 
fluorescence and given in percent of initial fluorescence. Values are means from three 
experiments. 
RMG-CM (black bars) resulted in consistently higher photoreceptor survival rates than 
application of either conditioned medium from control cells (R6-C1, gray bars) or medium 
alone (white bars). The most significant time point of photoreceptor-survival promoted by 
RMG compared to controls is 6 days and 7 days after application of conditioned media.  
B: Porcine photoreceptors from 96well survival assay stained with calcein-fluorophore 6 days 
after application of R6-C1 conditioned medium (negative control, left panel) or RMG-CM 
(right panel) (400 x magnification). In RMG-CM a large number of photoreceptors survive 
which results in a higher overall fluorescence that can be measured photometrically as shown 
in A. 
Fig. 2: Activity from RMG-CM is a large protein 
A: Porcine photoreceptor-survival 6 days after application of medium alone (DMEM NUT 
MIX), R6C1 conditioned medium (R6-C1) and RMG-CM generated from RMG 14 days in 
vitro (RMG day14) or RMG 21 days in vitro (RMG day21). Highest survival promoting 
activity was found in conditioned medium from 14 day old RMG, after 21 days in culture the 
activity was lost compared to controls. Further, RMG-CM day14 treated with proteinase K 
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(proteinase K + a2-macroglobulin) was applied to photoreceptor survival assay. Proteinase K 
treatment was stopped by addition of α2-macroglobulin, which itself proofed to be not toxic 
to photoreceptors in vitro (a2-macroglobulin). Proteinase K treatment completely destroyed 
the survival-promoting activity of RMG-CM. 
B: Size-fractionation of RMG-CM 
RMG-CM (day14) was enriched into molecular weight fractions <10kDa, between 10 and 50 
kDa and above 50kDa. Similar fractionations were performed with R6-C1 conditioned 
medium. All fractions were monitored for their survival promoting activity on photoreceptors. 
Survival is given as relative fluorescence compared to initial fluorescence 6 days after 
application of samples. RMG derived survival-promoting activity was enriched most 
compared to control in the fraction above 50kDa and to a lesser extent also in the 10kDa 
fraction. R6-C1 (negative control) conditioned medium showed a survival promoting effect in 
the size fraction below 10kDa. 
Fig. 3: Inhibition of RMG-derived survival effect with PI3-kinase inhibitor LY294002 
RMG-CM (day 14) was applied to photoreceptor-survival assay either alone, or together with 
PI-3 kinase inhibitor LY294002 (5µM) or MEK inhibitor U0126 (1µM). Survival is given as 
relative fluorescence signal 6 days after application compared to initial fluorescence. 
Inhibitors were further applied together with medium (CDM) containing 2%FCS, in order to 
assess toxicity of the inhibitors in the presence of strong survival signal derived from FCS. 
Application of LY294002 completely blocked survival-promoting activity of RMG-
conditioned medium, whereas U0126 only partially reduced survival of PR. In the presence of 
2% FCS neither LY294002 nor U0126 were able to significantly reduce PR-survival. 
Fig. 4: Autoradiograph of RMG-CM (day 14) 
RMG-CM was prepared in the presence of 35S-methionine and 150µg total protein were 
separated by isoelectric focusing on pH 3-10 IPG strips in the first dimension and 12% SDS-
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PAGE in the second dimension. Autoradiograph was taken from dried gel. 2200 different 
protein spots could be detected by this method from RMG-CM. 
Fig. 5: monoQ-FPLC separation of proteins from RMG-CM 
A: Proteins from RMG-CM were separated by mono-Q FPLC. RMG-CM gave reproducible 
elution profiles (absorbtion at 280nm, indicated as mAU) with increasing NaCl-
concentrations (indicated as mS/cm) from mono-Q columns and proteins were collected in 33 
fractions.  
B: Proteins from every second eluting fraction were separated by 1DE-PAGE (10µg per lane) 
and visualised by silver staining. Additionally, proteins not binding to monoQ (flowthrough 
from sample application, FT) are resolved by 1DE-PAGE. Molecular weights of marker (M) 
are indicated. Fractions were pooled as depicted into 5 pools: A (fraction 1-7), B (fraction 8-
13), C (fraction 14-19), D (fraction 20-26), E (27-33). 
Fig. 6: PR-survival assay with pooled fractions from FPLC separated RMG-CM and 
R6C1-CM 
MonoQ-FPLC separation was performed with RMG-CM (day14) and R6C1-CM (negative 
control) and resulting fractions were pooled as shown in Fig. 5B. Pooled fractions (A, B, C, 
D, E) and flowthrough were tested for survival-promoting activity in photoreceptor-survival 
assay. Survival is given as relative fluorescence compared to initial fluorescence 6 days after 
application of samples. Compared to R6-C1-CM, most of the survival-promoting activity 
derived from RMG reappeared in the flowthrough from FPLC separation. 
Fig. 7: Survival promoting activity of IGFBP5 and CTGF 
Different factors were tested for their survival-promoting activity on photoreceptors: medium 
alone (negative control), RMG-CM (day 14) and RMG-CM supplemented with thioredoxin 
(THIO, 500ng/ml), with superoxide dismutase (SOD, 500ng/ml), with IGFBP5-CM (RMG-
CM + IBP5), with CTGF-CM (RMG-CM + CTGF) and with IGFBP7 (RMG-CM + IBP7). 
Survival is given as relative fluorescence compared to initial fluorescence 6 days after 
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application of samples. IGFBP5 and CTGF increase the survival-promoting activity of RMG-
CM. 
Table 1: Proteins identified from RMG-CM FPLC-flowthrough 
score SwissProt ID identity (with synonyms) acc.Nr Seq. Cov. MG 
691 CO1A2_CANFA Collagen alpha 2(I) chain [Precursor] O46392 16% 129835 
277 ENOA_HUMAN Alpha enolase, EC 4.2.1.11 P06733 14% 47350 
225 ENOB_HUMAN Beta enolase, EC 4.2.1.11 P13929 10% 47168 
199 Q29568_PIG Phosphopyruvate hydratase [Fragment] Q29568 35% 16079 
168 TPIS_RAT  Triosephosphate isomerase, EC 5.3.1.1, TIM  P48500 19% 27286 
162 Q811C8_MOUSE Insulin-Iike growth factor binding protein 7 [Fragment] Q811C8 17% 28053 
136 VINC_HUMAN  Vinculin, Metavinculin  P18206 2% 124161 
124 CATD_PIG  Cathepsin D, EC 3.4.23.5  P00795 14% 37727 
91 Q9GK25_PIG Cyclophilin, EC 5.2.1.8, Peptidyl-prolyl cis-trans isomerase Q9GK25 21% 11969 
89 CO3A1_HUMAN Collagen alpha 1(III) chain [Precursor] P02461 1% 139696 
88 PGK1_HORSE Phosphoglycerate kinase, EC 2.7.2.3  P00559 8% 44842 
70 LDHA_PIG L-lactate dehydrogenase A chain, EC 1.1.1.27, LDH-A P00339 7% 36749 
69 TAGL_HUMAN  Transgelin Q01995 6% 22522 
57 MOES_PIG  Moesin, Membrane-organizing extension spike protein  P26042 2% 67602 
55 SODC_MOUSE Superoxide dismutase [Cu-Zn], EC 1.15.1.1  P08228 7% 15973 
53 PROF1_MOUSE Profilin I P62962 20% 14988 
48 CTGF_HUMAN Connective tissue growth factor [Precursor] P29279 2% 40267 
47 K2C1_HUMAN Keratin, type II cytoskeletal 1, Cytokeratin 1, K1, CK 1 P04264 3% 66018 
47 IBP5_HUMAN Insulin-like growth factor binding protein 5, IGFBP-5 P24593 5% 31576 
46 ALDR_HUMAN Aldose reductase, EC 1.1.1.21, AR, Aldehyde reductase  P15121 3% 36099 
45 COF1_PIG Cofilin, non-muscle isoform P10668 12% 18792 
44 TSP1_HUMAN Thrombospondin-1 [Precursor] P07996 1% 133321 
43 CO4A1_HUMAN Collagen alpha 1(IV) chain [Precursor] P02462 <1% 161650 
36 THIO_BOVIN Thioredoxin O97680 23% 11959 
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Proteomic analysis of the porcine interphotoreceptormatrix
Stefanie M. Hauck1, 2, Stephanie Schoeffmann1, 2, Cornelia A. Deeg3,
Christian Johannes Gloeckner1, Magdalena Swiatek-de Lange1, 2 and Marius Ueffing1, 2
1 GSF-National Research Centre for Environment and Health, Institute of Human Genetics, Neuherberg, Germany
2 Ludwig-Maximilians University Eye Hospital, KKG Ophthalmogenetics, Munich, Germany
3 Ludwig-Maximilians University, Institute of Animal Physiology, Munich, Germany
The interphotoreceptor matrix (IPM) is located between photoreceptors and pigment epithelium
in the retina and is involved in fundamental functions of the visual cycle. These include visual
pigment chromophore exchange, retinal adhesion, metabolite trafficking, and growth factor
presentation. In general, IPM preparations are contaminated with intracellular proteins, as has
also been described for other body fluids. This study aimed at identifying new components of the
IPM by discriminating between truly secreted proteins and proteins that are part of the IPM for
secondary reasons. “Soluble” porcine IPM was extracted from retina and pigment epithelium
with PBS by two different procedures, followed by extraction with water alone that released “in-
soluble” IPM matrix sheets. Samples from all preparations were separated by 2-DE and a total of
140 protein spots were identified by MALDI-TOF and/or CapLC Q-TOF MS. Although identified
proteins included several already known in the IPM, the majority had not been previously
described in this structure. Gene ontology classifications allocated the identified proteins into
nine different functional networks. The IPM preparations also included intracellular proteins
from cells adjacent to the IPM, which may have resulted from cell disruption. This underlines
the experimental difficulties of a biochemical analysis of the IPM as an intact compartment. We
show here a strategy for predicting the probability of identified IPM proteins occurring in vivo by
combined high-resolution protein separation methods with computational prediction methods.
Thus, a set of potentially neuroprotective proteins could be extracted, including PEA-15, peroxi-
redoxin 5, alpha-B-crystallin, macrophage migration inhibitory factor, 78 kDa glucose-regulated
protein (GRP78), protein disulfide-isomerase, and PEP-19, which have not been previously
associated with the IPM. Furthermore, with immunohistochemical staining we could confirm
the localization of GRP78 in the IPM on porcine eye sections, thus validating the proposed pre-
diction method.
Received: October 13, 2004
Revised: December 1, 2004
Accepted: December 27, 2004
Keywords:
Extracellular matrix / Eye / Neuroprotection / Retina / Secretion
Proteomics 2005, 5, 3623–3636 3623
1 Introduction
The interphotoreceptor matrix (IPM) is a carbohydrate-
rich complex occupying the extracellular compartment
between the outer neural retina and the apical surface of
the retinal pigment epithelium (RPE) in the vertebrate
eye [1]. As such, it surrounds the elongate, light-sensitive
photoreceptors extending from the outer retinal surface.
Several structural and functional activities of fundamental
importance to vision have been proposed to occur within
the IPM, including visual pigment chromophore
exchange, retinal adhesion, metabolite trafficking, photo-
Correspondence: Dr. Marius Ueffing, GSF-National Research
Center for Environment and Health, Institute of Human Genetics,
Ingolstaedter Landstrasse 1, D-85764 Neuherberg, Germany
E-mail: marius.ueffing@gsf.de
Fax: 149-89-31874426
Abbreviations: GO, gene ontology; GRP78, 78 kDa glucose-regu-
lated protein; HA, hyaluronan; IPM, interphotoreceptor matrix;
IRBP, interphotoreceptor retinoid-binding protein; MIF, macro-
phage inhibitory factor; PEA-15, astrocytic phosphoprotein; PEP-
19, neuron-specific protein; PEDF, pigment epithelium-derived
factor; PNA, peanut agglutinin; RMG, retinal Mueller glia; RPE,
retinal pigment epithelium
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receptor alignment, and cell–cell interactions, thought to
be involved in photoreceptor membrane turnover
(reviewed in [2]).
Initial studies of the IPM described it as unstructured
and amorphous [1]. Saline rinses of the outer retinal surface
removed “soluble” IPM components, such as inter-
photoreceptor retinoid-binding protein (IRBP), a variety of
enzymes, mucins, and immunoglobins (for review, see [2]).
However, later work revealed distinct matrix domains sur-
rounding rod and cone photoreceptors that resist saline rin-
ses of the outer retinal surface. This “insoluble” IPM can be
isolated by hypotonic treatment, which frees the solid IPM
from the outer retina as a relatively intact, sheet-like unit [3–
5]. The “insoluble” IPM consists of a scaffold of hyaluronan
(HA) to which the secreted glycoprotein SPACR and chon-
droitin sulfate proteoglycan SPACRCAN bind via HA-bind-
ing motifs in their polypeptides [6]. Other molecules con-
taining specific HA-binding motifs have been identified in
the plasma membranes of adjacent cells, e.g., CD44 expres-
sed in the apical region of retinal Mueller glia (RMG) [7] and
RHAMM in the apical region of RPE [8].
A number of ubiquitous growth, survival, and neuro-
trophic factors have been identified in the IPM of normal and
pathological retinas. Basic fibroblast growth factor has been
localized to the IPM of monkeys, humans, and mice [2, 9–11]
but was not detected in the IPM of rats or cows [12, 13].
Whereas insulin-like growth factor 1 (IGF-I) and insulin-like
growth factor binding-protein (IGF-BP) have been found in
human IPM, IGF receptors were found on rod outer seg-
ments and RPE cells, thus suggesting the presence of an
outer retina autocrine/paracrine system [14]. Neuron-specific
enolase (NSE), an enzyme participating in glycolysis which
has been described as potential neuronal survival factor in the
central nervous system, has been isolated from bovine IPM
[15]. Pigment epithelium-derived factor (PEDF), a member of
the serine protease inhibitor family [16], is presumably
secreted by RPE cells into the IPM [17, 18] and is responsible
for the neurotrophic activity of crude IPM extracts on Y79
retinoblastoma cells [19, 20]. PEDF carries a RHAMM-type
motif in its primary sequence through which it binds HA,
thus being strongly attached to the insoluble IPM scaffold [6].
Due to its key location and putative role in supporting
photoreceptor function, additional information on IPM
composition could prove useful for developing therapeutic
rescue strategies against photoreceptor degeneration. This
study was aimed at identifying proteins from porcine IPM in
an unbiased, non-candidate approach by combining high-
resolution 2-DE with mass spectrometric protein identifica-
tion [21, 22]. In order to evaluate the existing IPM prepara-
tion methods, we first compared two different extraction
methods for “soluble” IPM, “conventional” [23] and cannu-
lation methods [24], followed by 2-DE analysis. The remain-
ing “insoluble” IPM sheets, along with proteins tightly
attached to these sheets, were subsequently released with
water [25, 26] and also resolved by 2-DE analysis. The maps
of both IPM extractions, which we hereafter refer to as “sol-
uble” and “insoluble” IPM, were compared and the identity
of 140 silver-stained protein spots was determined byMS.We
present here a strategy (combination of high-resolution
separations techniques with bioinformatics prediction tools)
for discriminating between de facto secreted IPM proteins
and those present in the IPM for secondary reasons. Thus,
we extracted from the large number of identified proteins
those most likely to be present in IPM in vivo and for one of
these proteins we demonstrated its localization in the IPM
on sections of porcine eyes.
2 Material and methods
2.1 Preparation of the IPM
Adult porcine eyes were provided by a local slaughterhouse.
They were removed from the animals within 5 min after
death and kept on ice in CO2-independent medium (Gibco)
until further use. Within 1 h after the death of the animals,
the anterior portion of the eyes, including the lens and vitre-
ous humor, were carefully removed and exposed retinae were
then rinsed in PBS to remove any protein contaminants
from the vitreous.
2.1.1 Preparation of “soluble” IPM
Two different preparation methods for “soluble” IPM were
applied. For conventional “soluble” IPM preparation (adapt-
ed from [23]), retinae were carefully dissected from the eye
and incubated in PBS containing protease inhibitors (Com-
plete-mini; Roche) under gentle agitation for 20 min at 07C.
In addition, the exposed RPE layer in the eyecup was incu-
bated in PBS containing protease inhibitors for 20 min at
47C. After incubation, both retina and RPE samples contain-
ing the soluble IPM proteins were pooled and centrifuged for
10 min (10 0006 g, 47C). The protein-containing super-
natant was then precipitated with acetone [27].
Alternatively, in order to prepare “soluble” IPM free of
intracellular contamination, the cannulation method was
applied as described previously [23, 24]. Briefly, after careful
removal of vitreous, 0.4 mL of cold PBS containing protease
inhibitors was introduced through the retina into the sub-
retinal space with a syringe forming a bleb of fluid. After 30 s
of incubation the fluid was withdrawn through the intro-
ductory puncture hole. Approximately 0.3 mL of PBS-IPM
lavage could be recovered from each eye; lavage from several
eyes was pooled, centrifuged for 10 min (10 0006g, 47C),
and the protein-containing supernatant was then pre-
cipitated with acetone.
2.1.2 Preparation of “insoluble” IPM
The dissected retinal tissues remaining from the above pro-
cedure (conventional “soluble” IPM preparation) were once
again rinsed for 2 min in PBS (47C) and subsequently incu-
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bated for 10 min in water at 07C. This hypotonic incubation
frees the “insoluble” IPM matrix sheets from the outer
retina. IPM matrix sheets in water were collected along with
the surrounding water and subjected to acetone precipita-
tion. For quality control of the IPM matrix sheets, aliquots of
sheets were stained with alexa488-coupled lectin-peanut
agglutinin (PNA; Molecular Probes).
2.2 Preparation of protein extract and 2-DE
Acetone precipitates of “soluble” IPM (both preparation
methods) and “insoluble” IPM were centrifuged at 20 0006g
for 30 min and the protein pellets were dissolved directly
in 2-DE lysis buffer (9 M urea, 2 M thiourea, 1% DTE,
4% CHAPS, and 2.5 mM EGTA and EDTA each) and protease
inhibitors; protein content was determined using the Brad-
ford assay (Bio-Rad).
Immobiline DryStrips (IPG, Pharmacia, pH 3–10 NL,
24 cm) were swollen overnight in lysis buffer containing a
110 mg protein sample and additional 1% pharmalyte pH 3–10
(Merck) as well as 0.5% bromophenol blue. IEF of the
preswollen IPG strips was performed on a Multiphor (Amers-
ham Biosciences) at 207C for a total of 100 kVh. Focused IPG
strips were loaded onto gradient SDS-PAGE gels (9–15%) and
electrophoresed at constant 3 W per gel overnight (Ettan;
Amersham Biosciences). Gels were silver stained as described
elsewhere [28] and dried between cellophane sheets.
2.3 SDS-PAGE and Western blots
”Soluble” IPM, prepared using the cannulation method, and
“insoluble” IPM protein extracts in 2-DE lysis buffer were addi-
tionally solubilized by four-fold dilution with buffer containing
1% SDS. Subsequently, 20 mg or 2 mg of “soluble” IPM, pre-
paredwith thecannulationmethod,was resolvedbySDS-PAGE
and gels were stainedwith 0.25% Coomassie Blue R-250 [24] or
silver [28], respectively. Lectin PNA-binding proteins were
detected on blots as described elsewhere [25], except that sepa-
rated proteins were blotted onto PVDFmembranes.
2.4 Preparation of samples for MS
Selected spots were excised from dried silver-stained gels,
washed for 30 min in 100 mL nanopure water, destained [29],
and dehydrated in 100 mL of 40% ACN (3615 min). Samples
were subjected to tryptic proteolysis in 5–10 mL 1 mM Tris-
HCl pH 7.5 containing 0.01 mg/mL trypsin (Sequencing
Grade Modified Trypsin; Promega) overnight at 377C.
2.5 MS
MALDI-TOF peptide mass fingerprints were obtained on a
Bruker Reflex III mass spectrometer (Bruker Daltonics, Bre-
men, Germany). Aliquots of each tryptic digest were cocrys-
tallized with matrix consisting of 2,5-dihydroxybenzoic acid
(Sigma) (20 mg/mL in 20% ACN, 0.1% TFA) and 2-hydroxy-
5-methoxybenzoic acid (Fluka) (20 mg/mL in 20% ACN,
0.1% TFA) in a 9:1 ratio v/v on 400 mm AnchorChip targets
(Bruker Daltonics). Peptide sequence information was
obtained by LC-coupled MS/MS analysis on a Q-TOF2 sys-
tem (Micromass, UK) coupled with a CapLC system (Micro-
mass). Peptide samples subjected to tryptic digests were
mixed with 10 mL of 5% formic acid and sonicated for
15 min. Aliquots of 10 mL each were loaded on the CapLC
system, trapped on a C18 pre-column (5 mM, 100 PepMap-
C18; LC Packings), and separated on a 75 mmC18 column (3-
mm, 100 PepMap-C18; LC Packings) by elution with a gra-
dient (5–60% solution B: 95% ACN, 0.1% formic acid).
2.6 Database searching
Database searches were performed using the MASCOT soft-
ware [30] (http://matrixscience.com) at the following param-
eter settings: one miscleavage allowed, search restricted to
database entries from metazoan; MALDI: 100 ppm mass
accuracy; Q-TOF: 0.8 Da peptide tolerance; 0.2 Da MS/MS
tolerance. Peptide masses of the tryptic digests were com-
pared with the virtually generated tryptic peptide masses of
the protein databases NCBInr and MSDB.
Signal peptide prediction was performed with the pro-
gram SignalP version 3.0 (http://www.cbs.dtu.dk/services/
SignalP/); predictions of proteins secreted via non-classical
secretory pathway were performed with the program Secre-
tomeP, version 1.0 (http://www.cbs.dtu.dk/services/Secreto-
meP/).
2.7 Immunohistochemistry
Porcine eyes were fixed in 10% formalin. For adequate and
fast fixation, the cornea and the lens were removed and the
aqueous humor was replaced by fixative. After dehydration,
the eyes were embedded in paraffin.
Tissue sections were cut at 5 mm either vertically or
transversally at the level of photoreceptors and mounted on
coated slides (Super Frost Plus), deparaffinized, and rehy-
drated. High-temperature antigen retrieval was performed
using 1 mM EDTA buffer pH 8.0 as described elsewhere [31].
Slides were rinsed in TBS-T (pH 7.3) and non-specific bind-
ing was blocked with horse serum with 1% BSA. Sections
were then incubated with primary antibody (anti-GRP78; BD
Transduction Laboratories, 10 mg/mL in TBS-T) overnight at
47C in a humid chamber. Vertical sections were then incu-
bated with alexa488 goat anti-mouse IgG conjugate for 2 h
(Molecular Probes, 1:200) and mounted in FluorSave (Cal-
biochem). Transversal sections were incubated with second-
ary antibody anti-mouse IgG biotin (Linaris, Wertingen,
Germany) for 1 h (1:1000 dilution), followed by incubation
with peroxidase-conjugated streptavidin (Vectastain ABC-
Elite:HRP kit; Linaris). Binding was visualized with the Vec-
tor HRP substrate kit VIP, which results in violet color
(Linaris). Images were obtained with a Zeiss APO-TOM and
a Zeiss AxioscopII.
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3 Results
3.1 Quality control of “soluble” and “insoluble” IPM
preparations
For the preparation of “soluble” IPM proteins, there exist two
different strategies: one is based on incubation of dissected
intact retina along with the remaining RPE surface with PBS
in order to extract proteins that readily solubilize in an iso-
osmotic salt solution [23]. This method results in high pro-
tein yields but may interfere with the integrity of the cells
bordering the IPM in vivo. Thus, an alternative method [24]
aimed at inducing minimal damage to tissues adjacent to the
IPM was applied, namely, careful subretinal injection of PBS
and retraction after a short incubation through the same
puncture hole (cannulation method). In this method, tissue
disruption can be reduced to the puncture hole. In order to
verify that the quality of the IPM prepared by the cannulation
method presented here is equal to the originally published
protocol, we applied 20 mg of the protein extract obtained
from respective preparations onto SDS-PAGE and stained
with CBB similarly to the original publication [24]. Only one
prominent band was detectable in this extract (Fig. 1A,
lane 1), this being in line with the original publication. This
band has been shown to be formed by IRBP [24], the domi-
nant protein present in soluble IPM. A second faint band
was detected at the size of approximately 70 kDa, which can
be hypothesized to be albumin by alignment of the 1-D gel
(Fig. 1A) with the identifications on the 2-D gel (spots 102
and 103 in Fig. 2). Recovering the IPM by cannulation and
staining the corresponding 1-D gels by a 30-fold [32] more
sensitive silver stain [28] however, reveals that apart from
IRBP and albumin many other protein bands are present
(Fig. 1A, lane 2).
Figure 1. Quality of IPM preparations. (A) Detection of protein complexity in
“soluble” IPM preparations: “Soluble” IPM was prepared with the cannulation
method (for details, see Section 2); 20 mg (lane 1) or 2 mg (lane 2) was resolved by
SDS-PAGE and proteins stained with 0.25% Coomassie Blue R-250 (lane 1) or sil-
ver (lane 2). Sensitive silver stain reveals that in “soluble” IPM preparations,
many more proteins are present than detected with previously described Coo-
massie staining [24]. (B) Visualization of cone–matrix sheets from “insoluble”
IPM preparation, stained with alexa488-coupled lectin PNA. (C) Lectin-binding
proteins are only present in preparations of “insoluble” IPM: 2 mg of “soluble”
IPM (prepared with the cannulation method; lane 1) and “insoluble” IPM (lane 2)
were resolved by SDS-PAGE, blotted, and incubated with HRP-coupled lectin
PNA. Lectin PNA-binding proteins were labeled according to their size and com-
pared with previously described lectin PNA-binding glycoproteins.
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”Insoluble” matrix sheets are prepared after PBS
extraction of the “soluble” matrix by hypo-osmotic treat-
ment of the retina. Cone matrix sheets swell and float off
the retinal surface, and can be visualized by staining with
fluorophore-coupled lectin PNA [25, 26]. Figure 1B shows
an example of a cone matrix sheet present in preparations
of “insoluble” IPM before being processed for 2-DE. To
further confirm that preparations of “insoluble” matrix
contain lectin-binding proteins, we performed SDS-PAGE
of “insoluble” IPM and “soluble” IPM preparation followed
by blotting and incubation with HRP-coupled lectin PNA.
The resulting pattern of lectin PNA-binding bands (Fig. 1C,
lane 2) appears highly similar to the pattern previously
reported for porcine “insoluble” IPM [25], yielding the
previously described glycoproteins GP29/30, GP39/40,
GP42, GP45, GP54 and GP60. GP88, another previously
described lectin PNA-binding protein, could only be
detected after longer exposure of the film (data not shown).
“Soluble” IPM preparation performed with the cannulation
method did not show any lectin PNA-binding band
(Fig. 1C, lane 1).
3.2 Proteins identified from 2-D gels of IPM
preparations belong to miscellaneous functional
networks
A total of 117 different proteins were identified from a total of
140 spots from “soluble” (Fig. 2) and “insoluble” IPM (Fig. 3)
(a detailed list of all identifications with the respective sig-
nificance is given as a supplementary table). Sixteen spots
were found to include more than one protein species and
23 proteins were represented by more than one spot, indi-
cating the existence of different isoforms and/or modifica-
tions. Gene ontology (GO) classifications allocated the iden-
tified proteins to different functional networks (Table 1),
spanning the categories metabolism (27%), signaling pro-
tein (16%), chaperone (12%), protein turnover (9%), struc-
tural protein (8%), transport protein (8%), reactive oxygen
metabolism (4%), Ca21-binding protein (4%), or vision (3%).
Six proteins belonged to more than one category and 11 pro-
teins, which could not be assigned to any of these categories,
were thus designated as “other” (9%) (Fig. 4).
3.3 Comparison of “soluble” and “insoluble” IPM on
the level of 2-D gel analysis
Comparison of “soluble” IPM prepared by cannulation and
“insoluble” IPM components showed that, from a total of
117 different proteins, 42 and 43 proteins were enriched in
“soluble” and “insoluble” IPM, respectively, and the remain-
der (32) were equally intense in both (Table 1).
Preparation of “insoluble” IPM by hypo-osmotic treat-
ment predisposes the preparation to contamination with
intracellular proteins due to cell disruption. Thus, proteins
enriched in “insoluble” IPM may represent contaminants
from adjacent cells (Table 1). Proteins enriched in “soluble”
IPM prepared by cannulation compared to “insoluble” IPM
(Table 1) are more likely to occur in the IPM compartment in
Figure 2. 2-DE analysis of “soluble” IPM pre-
pared with the cannulation method. “Soluble”
IPM was prepared with the cannulation method
(for details, see Section 2). 2-DE was performed
on precast IPG strips pH 3–10 NL (24 cm) with
110 mg protein load and focused for a total of
100 kVh to equilibrium. The strips were loaded
on 9–15% SDS-PAGE and proteins were resolved
at constant 3 W overnight. Proteins were visual-
ized by silver staining. Spots which were excised
and identified by MS are circled and numbered.
These are also presented in Table 1 and in the
supplementary table.
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Figure 3. 2-DE analysis of “insoluble” IPM. “In-
soluble” IPM sheets along with associated pro-
teins were extracted from porcine retinae by
hypo-osmotic treatment. 2-DE of this extract was
performed as described in Fig. 2. Protein spots
which were excised and identified by MS are cir-
cled and numbered; they are also presented in
Table 1 and in the supplementary table.
Table 1. Proteins identified from the IPM
Identity Accession ID Spot ID gel Enriched in
soluble IPM
Enriched in
insoluble IPM
SecretomeP
score
Metabolism
3-Phosphoglycerate dehydrogenase Q8C603 4 x 0.531
Aconitate hydratase, mitochondrial, (EC 4.2.1.3) ACON_PIG 125 x 0.361
Alcohol dehydrogenase (NADP1), EC 1.1.1.2 AKA1_PIG 8 x 0.511
Aldehyde dehydrogenase family 7 member A1, EC 1.2.1.3 D7A1_HUMAN 106 x 0.600
Alpha enolase, EC 4.2.1.11 ENOA_HUMAN 10, 11, 12, 13 0.492
Aspartate aminotransferase, cytoplasmic, EC 2.6.1.1 AATC_PIG 16 x 0.428
ATP synthase beta chain, mitochondrial, EC 3.6.3.14 ATPB_HUMAN 18 0.591
Carbonic anhydrase II, EC 4.2.1.1 CAH2_SHEEP 23 0.494
Carbonyl reductase (NADPH) 1, EC 1.1.1.184 DHCA_HUMAN 23 0.614
Creatine kinase, B chain, EC 2.7.3.2 KCRB_CANFA 6, 26, 27 x 0.260
Cytochrome c oxidase polypeptide Va EC 1.9.3.1 COXA_BOVIN 29 0.420
Fructose-bisphosphate aldolase C, EC 4.1.2.13 ALFC_HUMAN 40 x 0.312
Gamma enolase, EC 4.2.1.11, NSE ENOG_MOUSE 41, 42 x 0.595
Glucose-6-phosphate isomerase, EC 5.3.1.9 G6PI_PIG 44 x 0.497
Glutamine synthetase, EC 6.3.1.2 GLNA_PIG 45, 46, 47 0.385
Glyceraldehyde 3-phosphate dehydrogenase, EC 1.2.1.12 G3P_PIG 51, 129 x 0.522
Guanylate kinase, EC 2.7.4.8 KGUA_PIG 54 x 0.829
Hexokinase, type I, EC 2.7.1.1 HXK1_MOUSE 134 x 0.352
Inosine-5’-monophosphate dehydrogenase 1, EC 1.1.1.205 IMD1_MOUSE 4, 66, 67 0.448
Isocitrate dehydrogenase (NADP) cytoplasmic, EC 1.1.1.42 IDHC_MICOH 69 x 0.532
Lactoylglutathione lyase, EC 4.4.1.5 LGUL_HUMAN 70 x 0.428
L-lactate dehydrogenase A chain EC 1.1.1.27 LDHA_PIG 135 x 0.625
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Table 1. Continued
Identity Accession ID Spot ID gel Enriched in
soluble IPM
Enriched in
insoluble IPM
SecretomeP
score
L-lactate dehydrogenase B chain LDHB_PIG 71, 72, 130 0.607
Malate dehydrogenase, cytoplasmic, EC 1.1.1.37 MDHC_PIG 75 0.372
Phosphoglycerate kinase 1, EC 2.7.2.3 PGK1_HUMAN 86 0.398
Phosphoglycerate kinase EC 2.7.2.3 PGK_CRIGR 136, 137 0.411
Phosphoglycerate mutase 1, EC 5.4.2.1, EC 5.4.2.4 PMG1_HUMAN 87 x 0.381
Pyruvate kinase, M1 isozyme, EC 2.7.1.40 KPYM_FELCA 92 0.430
Pyruvate kinase, isozymes M1/M2, EC 2.7.1.40 KPYM_RAT 93 0.469
Succinyl-CoA ligase (ADP-forming) beta-chain, EC 6.2.1.5 SCB1_PIG 109 x 0.415
Triosephosphate isomerase EC 5.3.1.1., TIM TPIS_HUMAN 52, 115 0.391
Vacuolar ATP synthase subunit B, brain isof. EC 3.6.3.14 VAB2_BOVIN 121 x 0.633
Transketolase EC 2.2.1.1 TKT_MOUSE 113 x 0.484
Signaling
14-3-3 protein epsilon, Protein kinase C inhibitor protein-1 143E_HUMAN 1 x 0.330
14-3-3 protein gamma 143G_BOVIN 2 x 0.297
14-3-3 protein zeta/delta, Protein kinase C inhibitor protein-1 143Z_HUMAN 3 x 0.252
Astrocytic phosphoprotein PEA-15 PE15_MOUSE 17 x 0.898
Dihydropyrimidinase related protein-2, CRMP-2 DPY2_HUMAN 32 x 0.411
DJ-1 protein Q99497 33 0.493
GTP-binding nuclear protein RAN, Ran GTPase RAN_HUMAN 52 0.582
Guanine nucleotide-binding protein G(I)/G(S)/G(T) beta subunit 1 GBB1_HUMAN 71, 130 0.420
Guanine nucleotide-binding protein G(T) gamma-T1 subunit GBG1_BOVIN 53 x 0.645
Inhibitor-1 of protein phosphatase type 2A Q8HY67 65 0.062
Nucleoside diphosphate kinase B, EC 2.7.4.6 NDKB_HUMAN 79 x 0.330
Parathymosin THYP_BOVIN 80 0.669
Rab GDP dissociation inhibitor alpha, Rab GDI alpha GDIA_RAT 94 0.441
Serine/threonine protein phosphatase 2A, 65 kDa reg. subunit A 2AAA_PIG 101 0.563
Calmodulin CALM_HUMAN 22 x 0.706
Similar to calmodulin 2, Phosphorylase kinase, delta Q9BRL5 104 x 0.738
Protein disulfide-isomerase, EC 5.3.4.1, ER60 precursor PDA3_HUMAN 90 x 0.707
Retinoic acid-binding protein I, cellular, (CRABP-I) RET3_HUMAN 96 x 0.696
Chaperone
78 kDa glucose-regulated protein (Precursor), GRP 78 GR78_HUMAN 5 x 0.745
Alpha-B-crystallin chain CRAB_HUMAN 9 x 0.864
dnaK-type molecular chaperone HS7C_HUMAN 56, 127 x 0.229
Fascin, Singed-like protein, 55 kDa actin bundling protein FSC1_HUMAN 30, 35, 36 x 0.390
FK506-binding protein 4, EC 5.2.1.8 FKB4_RABIT 38, 39 0.155
Heat shock 70 kDa protein 4 HS74_HUMAN 55,131 x 0.223
Heat shock protein HSP 90-alpha HS9A_PIG 132, 133 x 0.173
Heat shock protein, HSP 90-alpha, HSP 86 HS9A_HUMAN 57, 58 x 0.172
Peptidylprolyl isomerase, EC 5.2.1.8 A PPIA_BOVIN 82 x 0.338
Stress-induced phosphoprotein 1 IEFS_HUMAN 108 x 0.344
T-complex protein 1, alpha subunit A TCP1_MOUSE 111 0.503
T-complex protein 1, beta subunit, TCP-1-beta TCPB_HUMAN 139 x 0.446
T-complex protein 1, eta subunit, TCP-1-eta TCPH_HUMAN 112 x 0.382
T-complex protein 1, gamma subunit, TCP-1-gamma TCPG_HUMAN 140 x 0.484
T-complex protein 1, zeta subunit, TCP-1-zeta TCPZ_RABIT 141 x 0.477
Transitional endoplasmic reticulum ATPase, TER ATPase TERA_PIG 142 x 0.168
Protein turnover
Cytosol aminopeptidase, EC 3.4.11.1 AMPL_BOVIN 30, 36 x 0.398
Elongation factor 2 (EF-2) EF2_HUMAN 128 x 0.384
Eukaryotic initiation factor 4A-II, eIF4A-II, eIF-4A-II IF42_MOUSE 34 x 0.494
Puromycin-sensitive aminopeptidase EC 3.4.11. PSA_HUMAN 91 x 0.436
Similar to ubiquitin/ribosomal fusion protein (Fragment) Q862M4 107 x 0.693
Translation elongation factor eEF-1 alpha-1 chain EF11_HUMAN 143 x 0.155
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Table 1. Continued
Identity Accession ID Spot ID gel Enriched in
soluble IPM
Enriched in
insoluble IPM
SecretomeP
score
Ubiquitin carboxyl-terminal hydrolase isozyme L1, EC 3.4.19.12 UBL1_MOUSE 118 x 0.540
Ubiquitin-activating enzyme E1 UBA1_HUMAN 145 x 0.530
Ubiquitin-conjugating enzyme E2 N EC 6.3.2.19 UBCN_HUMAN 119 x 0.730
Ubiquitin-conjugating enzyme E2-25 kDa UBC1_HUMAN 120 x 0.627
Structure
Actin, cytoplasmic type 5 ACT5_CHICK 6, 7 x 0.502
Coactosin-like protein COAC_HUMAN 25 x 0.765
Cofilin, non-muscle isoform COF1_MOUSE 59 x 0.629
Beta crystallin A3 CRBA_BOVIN 19 x 0.491
Destrin, actin-depolymerizing factor DEST_HUMAN 31 x 0.622
Profilin II PRO2_HUMAN 89 0.549
Tubulin alpha-1 chain TBA1_HUMAN 116 x 0.472
Tubulin beta chain TBB_PIG 15 0.526
Tubulin beta-2 chain TBB2_HUMAN 117 x 0.501
Tubulin beta-4 chain TBB4_MOUSE 14, 144 x 0.503
Protein and metabolite transport
Apolipoprotein A-I (Precursor), Apo-AI APA1_PIG 70 x 0.883
Cellular retinaldehyde-binding protein, CRALBP CRAL_BOVIN 24 x 0.510
Fatty acid-binding protein, brain, B-FABP FABB_HUMAN 37 x 0.450
Hemoglobin alpha chain HBA_PIG 59, 60 x 0.348
Hemoglobin beta chain HBB_PIG 61, 62 0.464
Phosphatidylethanolamine-binding protein PEBP PEBP_HUMAN 85 x 0.654
Retinol-binding protein I, cellular; CRBP RET1_BOVIN 97 x 0.381
Serum albumin (Precursor) (Fragment) ALBU_PIG 102, 103 x 0.592
Transferrin, Serotransferrin TRFE_PIG 114 x 0.379
Interphotoreceptor retinoid-binding protein (Precursor), IRBP IRBP_BOVIN 68 x 0.569
Reactive oxygen metabolism/detoxification
Glutathione S-transferase P, EC 2.5.1.18, GST class-pi GTP_PIG 48, 49 x 0.338
Peroxiredoxin 2 (Fragment) EC 1.11.1 PDX2_PIG 83 x 0.629
Peroxiredoxin 5 Q9GLW8 84 x 0.888
Phospholipid hydroperoxide glutathione peroxidase, EC 1.11.1.9 GPX4_PIG 88 0.868
Superoxide dismutase (Cu-Zn) EC 1.15.1.1 SODC_PIG 110 x 0.549
Ca21-binding
Calbindin, Vitamin D-dependent calcium-binding protein CABV_HUMAN 21 x 0.402
Parvalbumin alpha PRVA_MACFU 81 0.178
Recoverin, P26 RECO_BOVIN 83, 95 x 0.297
Vision
Arrestin-C (ARR3 gene) CAD92082 14, 15 x 0.501
S-arrestin, retinal S-antigen ARRS_PIG 47, 99, 100, 138 x 0.375
Other
Beta-synuclein SYUB_HUMAN 20, 126 x 0.136
Cystatin B CYTB_PIG 28 0.417
Gamma-synuclein, Synoretin SYUG_HUMAN 43 0.110
Histidine triad nucleotide-binding protein 1 HNT1_MOUSE 62 0.790
Immunoglobulin gamma-chain AAA51295 63, 64 x 0.801
Macrophage migration inhibitory factor (Fragment) MIF_HUMAN 73 x 0.747
Mu crystallin CRYM_RAT 76 0.619
Myotrophin MTPN_HUMAN 77 0.330
Neuron-specific protein PEP-19 PE19_HUMAN 78 x 0.723
Ribose-phosphate pyrophosphokinase I, EC 2.7.6.1 KPR1_HUMAN 98 x 0.428
Selenium binding protein 1 Q96GX7 105, 106 x 0.496
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Figure 4. Allocation of all identified proteins from the IPM to
functional groups.
situ, although intracellular contamination cannot be ruled
out in this preparation method as well (see below). In order
to further confirm that proteins enriched in “soluble IPM”
are likely to occur in the IPM in vivo, we predicted the exist-
ence of a secretion-signal peptide with the program SignalP
[33]. Only three proteins were predicted to carry a signal
peptide for secretion: albumin, apolipoprotein A-I, and IRBP
(Fig. 5A). Another two proteins, transferrin and macrophage
migration inhibitory factor (MIF), were classified as extra-
cellular according to GO. The major parts of the identified
proteins, however, are listed as intracellular proteins or pro-
teins with unknown cellular component. As MIF is one of
only 13 proteins known to be secreted by an unconventional
pathway without signal peptide [34, 35], we decided to predict
the probability of all identified proteins occurring in an
extracellular compartment with the program SecretomeP.
This program was recently designed to predict secreted pro-
teins without signal peptides, according to properties of the
mature protein, such as number of positively charged resi-
dues, low complexity regions, number of atoms, and pre-
dicted propeptides [35]. We found that 49 of 117 proteins
were predicted to be located extracellularly with a score
above 0.5 (Fig. 5A and Table 1). The distribution of all scores
(Fig. 5B) resembles a normal distribution (maximum fre-
quency at 0.5) with no bias toward extracellular proteins. In
order to verify our hypothesis that proteins enriched in “sol-
uble” IPM preparations are most likely to occur in the IPM in
vivo (see also above), the population of proteins was divided
into three groups: those most prominent in “soluble” IPM,
those most prominent in “insoluble” IPM, and the remain-
der not clearly assignable to either group (Table 1). The score
distributions of those subsets clearly show a shift to higher
scores for proteins enriched in “soluble” IPM with a max-
imum frequency at scores around 0.7 and lower scores
(maximum frequency at scores around 0.4) for proteins
enriched in “insoluble” IPM (Fig. 5c). This underlines the
hypothesis that the subset of proteins enriched in “soluble”
IPM preparations is actually present in the IPM in vivo.
Figure 5. SignalP and SecretomeP score predictions for proteins
identified from the IPM. (A) Three proteins identified from the
IPM carry a signal peptide (SignalP-score positive), another two
proteins are classified as being secreted according to gene
ontology classification and 48proteins are predicted to occur
extracellularly according to SecretomeP (Secretome P-score
positive, 0 , 0.5). (B) Distribution of SecretomeP scores for all
identified proteins peaks at 0.5. (C) Distribution of SecretomeP
scores for different subsets of the identified proteins: proteins
enriched in “soluble” IPM (dotted line with rhombus) have sig-
nificantly higher SecretomeP scores (maximum frequency at 0.7)
than proteins enriched in “insoluble” IPM (dashed line with rec-
tangles, maximum frequency at 0.4). Distribution of SecretomeP
scores for proteins found to be equally intense in both prepara-
tions (line with triangles) is similar to distribution of all proteins
in (B) (maximum frequency 0.5).
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3.4 The IPM contains potentially neuroprotective
proteins
In order to extract from the large list of identified proteins
those that most likely occur in the IPM in vivo, we selected
for proteins that are (i) enriched in “soluble” IPM and (ii) are
predicted to occur extracellularly with a very high Secreto-
meP score (.0.700). This filtering generated a subset of
13 proteins, 12 of them not previously linked to the IPM
(Table 2). One protein from this subset, namely immu-
noglobulin, has been previously shown to be present in the
IPM [2]. Seven of these proteins have been described in the
literature to act in an anti-apoptotic or neuroprotective man-
ner: namely, astrocytic phosphoprotein (PEA)-15 (score
0.898), peroxiredoxin 5 (score 0.888), alpha-B-crystallin chain
(score 0.864), MIF (score 0.747), GRP78 (score 0.745), neu-
ron-specific protein PEP-19 (score 0.723), and protein di-
sulfide-isomerase ER60 (score 0.707).
Moreover, we could identify the cysteine protease inhib-
itor cystatin B for the first time in ocular tissue; however,
the SecretomeP score for this protein is only 0.417. Cystatin
B knock-out mice show neuronal atrophy and apoptosis
[36].
3.5 GRP78 is located in the IPM on porcine eye
sections
In order to verify the prediction method for extracellular
localization of newly identified proteins in the IPM, we sec-
tioned porcine eyes and stained the sections for GRP78.
Special care was taken to preserve the fragile structure of the
IPM and adjacent tissue. Sections were cut vertically and
GRP78 localization was detected with fluorescent secondary
antibody as shown in Fig. 6. GRP78 immunoreactivity was
found in all layers of the retina and the RPE, which was in
line with the ubiquitous expression of this protein. However,
the strongest immunoreactivity on the sections was indeed
found in the IPM. We further wanted to inquire whether
GRP78 is localized extracellularly or within photoreceptors.
As inner and outer segments of photoreceptors show high
auto-fluorescence, GRP78 immunoreactivity on transversally
cut sections was detected with a violet color reaction. Trans-
versally cut photoreceptor segments (Fig. 6G, open arrow)
show no immunoreactivity for GRP78 within the cells,
whereas strong immunoreactivity was found between the
segments (Fig. 6G, closed arrows), thus verifying the extra-
cellular localization of GRP78 in the IPM.
4 Discussion
The aim of this study was to profile and characterize the IPM
for previously unknown components and to elucidate poten-
tially novel functions in this structure. We applied high-res-
olution 2-DE and subsequent MS identification to reveal the
IPM composition in more detail than described so far.
The most noteworthy finding was the striking protein
complexity of the IPM, as well as its high content of intra-
cellular proteins, a finding that cannot be satisfactorily
explained by contamination due to preparation alone. In our
work, we compared “soluble” IPM samples prepared by con-
ventional and cannulation methods, the latter designed to
minimize cell disruption [23, 24]. Interestingly, using 2-DE
analysis we found high proportions of intracellular proteins
in samples derived from both preparation methods, al-
though 1-D Western blots with a cellular RMG marker pro-
tein (glutamine-synthetase) and a photoreceptor marker
protein (arrestin) did not reveal this contamination (data not
shown). Thus, we show here that even the gentlest IPM
preparation method leads to some disruption of adjacent
cells with subsequent “spilling out” of intracellular proteins.
Contamination with intracellular proteins also occurs in
Table 2. Proteins enriched in “soluble” IPM with SecretomeP scores above 0.7
Identity Accession ID SecretomeP
score
GO classification entry:
extracellular (via human
ortholog, ensembl entry)
Astrocytic phosphoprotein PEA-15 PE15_MOUSE 0.898 No
Peroxiredoxin 5 Q9GLW8 0.888 No
Apolipoprotein A-I (Precursor), Apo-AI APA1_PIG 0.883 GO:0005576 extracellular
Alpha-B-crystallin chain CRAB_HUMAN 0.864 No
Immunoglobulin gamma-chain AAA51295 0.801 No
Coactosin-like protein COAC_HUMAN 0.765 No
Macrophage migration inhibitory factor (Fragment) MIF_HUMAN 0.747 GO:0005615, extracellular space
78 kDa glucose-regulated protein (Precursor), GRP 78 GR78_HUMAN 0.745 No
Similar to calmodulin 2, Phosphorylase kinase, delta Q9BRL5 0.738 No
Ubiquitin-conjugating enzyme E2 N EC 6.3.2.19 UBCN_HUMAN 0.730 No
Neuron-specific protein PEP-19 PE19_HUMAN 0.723 No
Protein disulfide-isomerase, EC 5.3.4.1, ER60 precursor PDA3_HUMAN 0.707 No
Calmodulin CALM_HUMAN 0.706 No
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Figure 6. Immunohistochemical stainings for
GRP78 on porcine eye sections. Sections (5 mm)
of porcine eyes labeled with mouse anti-GRP78
antibody. (A–F) Vertical sections; (G) transversal
section. GRP78 immunostaining (shown in
green, panels B, C, E, F) is found in all layers of
retina and RPE (overlay with DAPI-stained nuclei
in panels C and F). Staining is most intense on
the level of the IPM (compare to Nomarski
image, panels A and D). (A–C) Magnification
4006; (D–F) magnified view (Adobe Photoshop)
of corresponding sections. (G) Transversal sec-
tion of porcine eye at the level of the IPM; GRP78
immunoreactivity is visualized by violet staining.
Photoreceptor outer segments (open arrow) are
free of staining, while outside of the photo-
receptor segments (closed arrows) intense
GRP78 immunoreactivity is observed (magnifi-
cation 6006).
several other extracellular compartments, and has been dis-
covered due to the increasing sensitivity of proteomics
methods, e.g., in plasma [37, 38], in cerebrospinal fluid [39],
and in lymph [40]. Nevertheless, the high resolution of 2-DE
allows for an extensive comparison of spot intensities be-
tween “soluble” and “insoluble” IPM preparations. Thus, the
identified proteins can be grouped into subsets: one which
contains proteins enriched in “soluble” IPM and another
containing proteins enriched in “insoluble” IPM prepara-
tions. As the preparation method for “insoluble” IPM is
comparatively harsh (with hypo-osmotic treatment of the
dissected retina), proteins enriched in these preparations
more likely derive from intracellular contamination. We then
predicted the probability of every identified protein occurring
in extracellular compartments with the prediction program
SecretomeP [35]. The resultant score distribution for all pro-
teins peaked at 0.5, whereas the score distribution of the two
subsets of proteins showed a clear separation of maxima.
Proteins enriched in “soluble” IPM have significantly higher
scores than proteins enriched in “insoluble” IPM prepara-
tions and are thus likely to be present in the IPM in vivo.
We verified that one of the proteins enriched in “soluble”
IPM and carrying a high SecretomeP score (0.745), namely
GRP78, is indeed localized to the IPM in vivo by means of
immunostaining on sections of porcine eyes. GRP78 is a
constitutively expressed resident protein of the endoplasmic
reticulum (ER) of all eukaryotic cells and is involved in poly-
peptide translocation, protein folding, and presumably pro-
tein degradation (for review, see [41]). However, there has been
one report so far on GRP78 being secreted from intact cells
into culturemedium [42], so that, together with our results, an
extracellular occurrence can be assumed. This significantly
underlines the fact that the applied filter method can correctly
predict protein localization in the IPM in vivo.
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Within the subset of proteins enriched in “soluble” IPM
are proteins with very high probability scores for an extra-
cellular location. One of them is MIF, which was identified
here for the first time from IPM preparations. MIF is one of
very few proteins already known to be secreted by a non-
classical secretory pathway [34, 35]. The existence of MIF in
“soluble” IPM preparations indicates that proteins might be
shuttled into this compartment not only via the classical but
also via a non-classical secretory pathway.
The protein with the highest SecretomeP score (0.898)
was astrocytic phosphoprotein PEA-15, although so far PEA-
15 was only known to be located intracellularly. However, the
enrichment of PEA-15 in “soluble” IPM, together with the
high SecretomeP score, suggests that this might be a candi-
date for a non-classically secreted protein. PEA-15 was first
identified as an abundant phosphoprotein in brain astrocytes
and subsequently found to be widely expressed in different
tissues, including retinal Mueller glia [43]. PEA-15 is regu-
lated by multiple calcium-dependent phosphorylation path-
ways that account for its differently phosphorylated forms
[44–47]. In our IPM 2-DE proteome map, the pI of the spot
identified as PEA-15 was approximately 4 and might thus
represent this protein in a phosphorylated form. Phospho-
rylated PEA-15 inhibits TNF-alpha-induced apoptosis in
astrocytes in a PKC-dependent manner [48–50]. Most inter-
estingly, PEA-15 levels are lower in proliferating than in non-
proliferating astrocytes in vitro [43] and PEA-15 knock-out
mice exhibit a marked increase in cell proliferation in several
lineages, including astrocytes, lymphocytes, and hepatocytes
[51]. Although PEA-15 function in the IPM remains highly
speculative, one could expect that increased expression of
this protein would hinder retinal and RPE cell proliferation,
which would be deleterious to retinal function. Thus, PEA-15
may be a candidate for therapeutic intervention in pro-
liferative vitreo-retinopathy.
The second highest SecretomeP score was found for
peroxiredoxin 5 (score 0.888), the most recently identified
member of the peroxiredoxin family [52]. It has been shown
to protect cells from reactive oxygen-induced apoptosis [53]
and protects Xenopus embryos from alcohol-induced
anomalies [54]. Peroxiredoxin 5 has been described to be
intracellularly localized to mitochondria, peroxisomes, the
cytosol, and, to a lesser extent, the nucleus [55], but its
finding in the IPM is the first indication of an extracellular
localization.
Alpha-B-crystallin (SecretomeP score 0.864), a member
of the small HSP family identified here from the IPM, has
been shown to protect cultured cells from apoptosis induced
by staurosporine [56], okadaic acid [57], UVA irradiation [58],
TNF-alpha and Fas [56], and oxidative stress [59]. Elevated
levels of alpha-B-crystallin have been described in several
neurodegenerative diseases (for review, see [60]). In the rd-
mouse, an animal model for inherited retinal degeneration,
photoreceptor death is accompanied by elevated alpha-B-
crystallin in retinal glial cells and photoreceptors [61]. Iden-
tification of alpha-B-crystallin along with many other HSPs
in the IPM might implicate its potential involvement in anti-
apoptotic processes and in prevention from neurodegenera-
tion in diseased retinae.
PEP-19 (SecretomeP score 0.723), together with neuro-
modulin (GAP-43) and neurogranin (RC3), belongs to the
neuron-specific calmodulin-binding proteins. All three have
been proposed to play a role in calcium homeostasis by reg-
ulating calmodulin. In contrast to GAP-43 and RC3, PEP-19
is not inactivated by phosphorylation through PKC, and
should thus remain an active calmodulin regulator even
under excitotoxic conditions. In this respect, PEP-19 expres-
sion might lead to an enhanced survival of neurons exposed
to insults associated with the pathophysiology of neurode-
generative processes.
In this study, many new compounds of “soluble” IPM
were identified, and a noticeable number of them can be
linked to neuroprotective mechanisms. Further, the combi-
nation of high-resolution protein separation methods in
conjunction with computational prediction methods allowed
us to overcome the unresolved problem of intracellular con-
tamination in preparations of this fragile extracellular com-
partment.
However, there are clearly limitations within the applied
methods. None of the proteoglycans known to build together
with HA the scaffold of solid IPM sheets, was identified on
2-DE gels of “insoluble” IPM, although we showed that PNA-
binding proteins were detectable on 1-D gels of these pre-
parations. IEF in combination with SDS-PAGE might selec-
tively exclude these large scaffold proteins and favor the
contaminating intracellular proteins. Additionally, PEDF, a
potent neuroprotective factor expressed by retinal pigment
epithelium and secreted into the IPM (reviewed in [62]), was
not among the selected candidates for identification. PEDF is
known to bind tightly to the scaffold proteins of insoluble
IPM [6] and might thus be retained from separation. For
further investigation of the composition of insoluble IPM
matrix sheets, it will be necessary to apply different strategies
additionally to those described here.
Future studies are needed to validate the proper localiza-
tion of all the newly identified IPM components as true
components of the IPM in situ. However, the current panel of
constituents and especially the new candidate components of
the IPM strengthen the view that this acellular retinal com-
partment serves diverse functions. Besides inhibiting neo-
angiogenesis, it appears likely that the IPM actively protects
photoreceptors from metabolic stress. In addition, it seems
to provide yet unknown anti-apoptotic signals by neuroactive
molecules that have not yet been characterized in detail with
respect to their function in the retina.
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Erratum
Proteomic analysis of the porcine
interphotoreceptor matrix
Stefanie M. Hauck et al., vol. 5, issue 14,
pp. 3623–3636
DOI 10.1002/pmic.200401223
The gels in figures 2 and 3 were been repro-
duced in different sizes so that a direct com-
parsion between them was not possible.
Below are the correctly sized figures.
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